Citations

Citations to this article as recorded by  

• Relationship between patient outcomes and patterns of fragmented cancer care in older adults with gastric cancer: A nationwide cohort study in South Korea
  Dong-Woo Choi, Seungju Kim, Sun Jung Kim, Dong Wook Kim, Kwang Sun Ryu, Jae Ho Kim, Yoon-Jung Chang, Kyu-Tae Han
  Journal of Geriatric Oncology.2024; 15(2): 101685.     CrossRef
• Pattern of practice for postoperative management of endometrial cancer in Korea: a survey by the Korean Gynecologic Oncology Group and the Korean Radiation Oncology Group (KGOG 2028-KROG 2104)
  Sung Uk Lee, Joo-Young Kim, Min Kyu Kim, Young Seok Kim, Yeon Joo Kim, Keun-Yong Eom, Chan Woo Wee
  Journal of Gynecologic Oncology.2023;[Epub]     CrossRef
• The Future of Adjuvant Therapy in Renal Cell Carcinoma: Recent Insights and Prospects
  Hyerim Ha, Joo Han Lim
  Journal of Urologic Oncology.2023; 21(3): 208.     CrossRef
• Validation of the Korean Version of the Patient-Reported Outcomes Measurement Information System 29 Profile V2.1 among Cancer Survivors
  Danbee Kang, Youngha Kim, Jihyun Lim, Junghee Yoon, Sooyeon Kim, Eunjee Kang, Heesu Nam, Sungkeun Shim, Mangyeong Lee, Haesook Bok, Sang-Won Lee, Soo-Yong Shin, Jin Seok Ahn, Dongryul Oh, Juhee Cho
  Cancer Research and Treatment.2022; 54(1): 10.     CrossRef
• Comparison of Cancer-Related Spending and Mortality Rates in the US vs 21 High-Income Countries
  Ryan D. Chow, Elizabeth H. Bradley, Cary P. Gross
  JAMA Health Forum.2022; 3(5): e221229.     CrossRef

Citations

Citations to this article as recorded by  

• PD-L1 as a Biomarker in Gastric Cancer Immunotherapy
  Yunjoo Cho, Soomin Ahn, Kyoung-Mee Kim
  Journal of Gastric Cancer.2025; 25(1): 177.     CrossRef
• CT radiomics-based intratumoral and intertumoral heterogeneity indicators for prognosis prediction in gastric cancer patients receiving neoadjuvant chemotherapy
  Jiazheng Li, Zhenhui Li, Yinkui Wang, Yuzhuo Li, Jing Zhang, Ziyu Li, Lei Tang
  European Radiology.2025;[Epub]     CrossRef
• Biomarkers in gastroesophageal cancer 2025: an updated consensus statement by the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Pathology (SEAP)
  Maria Alsina Maqueda, Ana Teijo Quintáns, Miriam Cuatrecasas, Maria Jesús Fernández Aceñero, Ana Fernández Montes, Carlos Gómez Martín, Paula Jiménez Fonseca, Carolina Martínez Ciarpaglini, Fernando Rivera Herrero, Mar Iglesias Coma
  Clinical and Translational Oncology.2025;[Epub]     CrossRef
• Treatment Selection for Patients with HER2-Negative Metastatic Gastric Cancer Expressing Claudin 18.2 and PD-L1
  Yusuke Miyajima, Takeshi Kawakami
  Cancers.2025; 17(7): 1120.     CrossRef
• Efficacy of the first-line immune checkpoint inhibitor plus chemotherapy for gastroesophageal cancer: A meta-analysis of phase III trials including unreported PD-L1 subgroups
  Choong-kun Lee, Sejung Park, Yaeji Lee, Choa Yun, Moonki Hong, Chung Mo Nam, Hyun Cheol Chung, Sun Young Rha
  Cancer Letters.2025; 623: 217718.     CrossRef
• Biomarker-Driven Approaches to Bone Metastases: From Molecular Mechanisms to Clinical Applications
  Youssef Elshimy, Abdul Rahman Alkhatib, Bilal Atassi, Khalid S. Mohammad
  Biomedicines.2025; 13(5): 1160.     CrossRef
• Helicobacter pylori is associated with less tumor-infiltrating lymphocytes and a poor prognosis in gastric cancer
  Zetian Chen, Zhijun Zhang, Hongxin Huang, Chen Lu, Qingya Li, Mengpei Yan, Chengjun Zhu, Sen Wang, Hongda Liu, Zekuan Xu, Zheng Li
  BMC Gastroenterology.2025;[Epub]     CrossRef
• Neoadjuvant Immunotherapy in Gastroesophageal Cancer: A Promising Early Signal?
  Mojun Zhu, Harry H. Yoon
  Journal of Clinical Oncology.2024; 42(4): 373.     CrossRef
• Programmed death ligand-1 (PD-L1) clone 22C3 expression in resected colorectal cancer as companion diagnostics for immune checkpoint inhibitor therapy: A comparison study and inter-rater agreement evaluation across proposed cut-offs and predictive (TPS, C
  Dordi Lea, Claudia Zaharia, Kjetil Søreide
  Cancer Treatment and Research Communications.2024; 38: 100788.     CrossRef
• The relationship between high ratios of CD4/FOXP3 and CD8/CD163 and the improved survivability of metastatic triple-negative breast cancer patients: a multicenter cohort study
  Jeffry Beta Tenggara, Andhika Rachman, Joedo Prihartono, Lisnawati Rachmadi, Sonar Soni Panigoro, Didik Setyo Heriyanto, Noorwati Sutandyo, Intan Russianna Nasution, Familia Bella Rahadiati, Ricci Steven, Rachelle Betsy, Samuel Juanputra, Aru Wisaksono Su
  BMC Research Notes.2024;[Epub]     CrossRef
• Who Should Receive Immunotherapy for Advanced Gastroesophageal Cancer?
  Suhaib Khateeb, Ludimila Cavalcante, Noor Alnairat, Meghana Singh, Ibrahim Halil Sahin, Azhar Saeed, Anwaar Saeed
  Current Treatment Options in Oncology.2024; 25(4): 496.     CrossRef
• Evaluation of PD-L1 Expression in Colorectal Carcinomas by Comparing Scoring Methods and Their Significance in Relation to Clinicopathologic Parameters
  Mirela Frančina, Mislav Mikuš, Marin Mamić, Tihomir Jovanović, Mario Ćorić, Božica Lovrić, Ivan Vukoja, Goran Zukanović, Kristijan Matković, Jasmina Rajc, Ferdinand Slišurić, Mateja Jurić-Marelja, Goran Augustin, Ilijan Tomaš
  Diagnostics.2024; 14(10): 1007.     CrossRef
• The tumor immune composition of mismatch repair deficient and Epstein-Barr virus-positive gastric cancer: A systematic review
  J. Bos, T.S. Groen-van Schooten, C.P. Brugman, F.S. Jamaludin, H.W.M. van Laarhoven, S. Derks
  Cancer Treatment Reviews.2024; 127: 102737.     CrossRef
• Discordant PD-L1 results between 28–8 and 22C3 assays are associated with outcomes of gastric cancer patients treated with nivolumab plus chemotherapy
  Hyung-Don Kim, Jinho Shin, In Hye Song, Jaewon Hyung, Hyungeun Lee, Min-Hee Ryu, Young Soo Park
  Gastric Cancer.2024; 27(4): 819.     CrossRef
• Claudin-18 status and its correlation with HER2 and PD-L1 expression in gastric cancer with peritoneal dissemination
  Haruki Ogawa, Hiroyuki Abe, Koichi Yagi, Yasuyuki Seto, Tetsuo Ushiku
  Gastric Cancer.2024; 27(4): 802.     CrossRef
• Interpretation of PD-L1 expression in gastric cancer: summary of a consensus meeting of Korean gastrointestinal pathologists
  Soomin Ahn, Yoonjin Kwak, Gui Young Kwon, Kyoung-Mee Kim, Moonsik Kim, Hyunki Kim, Young Soo Park, Hyeon Jeong Oh, Kyoungyul Lee, Sung Hak Lee, Hye Seung Lee
  Journal of Pathology and Translational Medicine.2024; 58(3): 103.     CrossRef
• PD-L1 Immunohistochemistry in Gastric Cancer: Comparison of Combined Positive Score and Tumor Area Positivity Across 28-8, 22C3, and SP263 Assays
  Samuel J. Klempner, Eric S. Cowden, Samuel L. Cytryn, Matteo Fassan, Hisato Kawakami, Hideaki Shimada, Laura H. Tang, Daniel-Christoph Wagner, Yasushi Yatabe, Alexander Savchenko, Jennifer Salcius, Dorhyun Johng, Jing Chen, Giuliana Montenegro, Markus Moe
  JCO Precision Oncology.2024;[Epub]     CrossRef
• PD-L1 expression in squamous cervical carcinomas of Mozambican women living with or without HIV
  Lucília Lovane, Satish Tulsidás, Carla Carrilho, Christina Karlsson
  Scientific Reports.2024;[Epub]     CrossRef
• First-line immune checkpoint inhibitors in low programmed death-ligand 1-expressing population
  Feiyang Zhang, Guoming Chen, Yixin Yin, Xiaojiang Chen, Runcong Nie, Yingbo Chen
  Frontiers in Pharmacology.2024;[Epub]     CrossRef
• Concordance of PD-L1 status in primary gastroesophageal adenocarcinoma and matched peritoneal metastases: a single institution study
  V. Massa, F. Signorini, F. Salani, M.E. Filice, G. Grelli, P. Lippolis, P. Faviana, V. Genovesi, S. Santi, C. Vivaldi, S. Cesario, A. Bertolucci, C. Cremolini, V. Nardini, G. Masi, C. Ugolini, L. Fornaro
  ESMO Gastrointestinal Oncology.2024; 5: 100089.     CrossRef
• A Phase 1a/1b Dose Escalation/Expansion Study of the Anti-PD-1 Monoclonal Antibody Nofazinlimab in Chinese Patients with Solid Tumors or Lymphoma
  Jifang Gong, Ye Guo, Yanqiao Zhang, Yi Ba, Tong Chen, Wei Li, Caicun Zhou, Mengzhao Wang, Haiyan Yang, Yuhong Zhou, Qiqing Cai, Ziping Wang, Gang Huang, Wei Zhang, Rila Su, Zhongheng Cai, Zenglian Yue, Jinzhou Dou, Peiqi Li, Rachel Wu, Archie N. Tse, Lin
  Targeted Oncology.2024; 19(5): 723.     CrossRef
• Immune checkpoint inhibitors in advanced gastroesophageal adenocarcinoma: a series of patient-level meta-analyses in different programmed death-ligand 1 subgroups
  A.G. Leone, A.S. Mai, K.Y. Fong, D.W.T. Yap, K. Kato, E. Smyth, M. Moehler, J.T.C. Seong, R. Sundar, J.J. Zhao, F. Pietrantonio
  ESMO Open.2024; 9(11): 103962.     CrossRef
• HIPEC for Metastatic Gastric Cancer: Moving the Needle Towards 3-Year Survival
  Neal Bhutiani, Y. David Seo, Kristen A. Robinson, Michael G. White, Naruhiko Ikoma, Paul F. Mansfield, Jenny J. Li, Mariela Blum Murphy, Jaffer A. Ajani, Brian D. Badgwell
  European Journal of Surgical Oncology.2024; : 108790.     CrossRef
• Biomarkers for Predicting Response to Personalized Immunotherapy in Gastric Cancer
  Moonsik Kim, Ji Yun Jeong, An Na Seo
  Diagnostics.2023; 13(17): 2782.     CrossRef
• Development of an automated combined positive score prediction pipeline using artificial intelligence on multiplexed immunofluorescence images
  Abhishek Vahadane, Shreya Sharma, Devraj Mandal, Madan Dabbeeru, Josephine Jakthong, Miguel Garcia-Guzman, Shantanu Majumdar, Chung-Wein Lee
  Computers in Biology and Medicine.2023; 152: 106337.     CrossRef
• CT-based delta radiomics in predicting the prognosis of stage IV gastric cancer to immune checkpoint inhibitors
  Jiazheng Li, Zifan Chen, Yang Chen, Jie Zhao, Meng He, Xiaoting Li, Li Zhang, Bin Dong, Xiaotian Zhang, Lei Tang, Lin Shen
  Frontiers in Oncology.2023;[Epub]     CrossRef
• Efficacy of PD-1/PD-L1 inhibitors in gastric or gastro-oesophageal junction cancer based on clinical characteristics: a meta-analysis
  Gengwei Huo, Wenjie Liu, Peng Chen
  BMC Cancer.2023;[Epub]     CrossRef
• Clinical relevance of PD-1 positive CD8 T-cells in gastric cancer
  Joan Choo, Ley Fang Kua, Mu Yar Soe, Bernadette Reyna Asuncion, Benjamin Kye Jyn Tan, Chong Boon Teo, Ryan Yong Kiat Tay, Jimmy So, Asim Shabbir, Kim Guowei, Hon Lyn Tan, Gloria Chan, Haoran Ma, Gokula Krishnan Ramachandran, Jeffrey H. Y. Lum, Cheng Ean C
  Gastric Cancer.2023; 26(3): 393.     CrossRef
• Genetic and immune microenvironment characterization of HER2‐positive gastric cancer: Their association with response to trastuzumab‐based treatment
  Hyun Jung Kwon, Yujun Park, Soo Kyung Nam, Enoch Kang, Ka‐Kyung Kim, Inhae Jeong, Yoonjin Kwak, Jeesun Yoon, Tae‐Yong Kim, Keun‐Wook Lee, Do‐Youn Oh, Seock‐Ah Im, Seong‐Ho Kong, Do Joong Park, Hyuk‐Joon Lee, Hyung‐Ho Kim, Han‐Kwang Yang, Hye Seung Lee
  Cancer Medicine.2023; 12(9): 10371.     CrossRef
• High Interobserver Variability Among Pathologists Using Combined Positive Score to Evaluate PD-L1 Expression in Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma
  Marie E. Robert, Josef Rüschoff, Bharat Jasani, Rondell P. Graham, Sunil S. Badve, Manuel Rodriguez-Justo, Liudmila L. Kodach, Amitabh Srivastava, Hanlin L. Wang, Laura H. Tang, Giancarlo Troncone, Federico Rojo, Benjamin J. Van Treeck, James Pratt, Iryna
  Modern Pathology.2023; 36(5): 100154.     CrossRef
• Heterogeneous distribution pattern of CD3+ tumor-infiltrated lymphocytes (TILs) and high combined positive score (CPS) favored the prognosis of resected early stage small-cell lung cancer
  Liang Zhu, Guoping Cheng, Meijuan Wu, Ming Chen, Ying Jin
  Translational Oncology.2023; 34: 101697.     CrossRef
• The Role of Immunotherapy in Esophageal and Gastric Cancer
  Hans Dedecker, Laure-Anne Teuwen, Timon Vandamme, Andreas Domen, Hans Prenen
  Clinical Colorectal Cancer.2023; 22(2): 175.     CrossRef
• Tissue- and liquid biopsy-based biomarkers for immunotherapy in breast cancer
  Luca Licata, Marco Mariani, Federico Rossari, Giulia Viale, Giulia Notini, Matteo Maria Naldini, Carlo Bosi, Marta Piras, Matteo Dugo, Giampaolo Bianchini
  The Breast.2023; 69: 330.     CrossRef
• PD‐L1andHLA‐class I expression status and their therapeutic implication in oesophageal small‐cell carcinoma
  Satoshi Yamashita, Hiroyuki Abe, Hiroharu Yamashita, Koichi Yagi, Yasuyuki Seto, Tetsuo Ushiku
  Histopathology.2023; 83(2): 264.     CrossRef
• Programmed death-ligand 1 expression and overall survival in Thai patients with gastric cancer
  Taned Chitapanarux, Pawut Gumrai, Sarawut Kongkarnka, Komson Wannasai, Nirush Lertprasertsuke
  Scientific Reports.2023;[Epub]     CrossRef
• Efficacy of Pd-1/Pd-L1 Inhibitors in Advanced Gastroesophageal Cancer Based on Characteristics: A Meta-Analysis
  Wenjie Liu, Gengwei Huo, Peng Chen
  Immunotherapy.2023; 15(10): 751.     CrossRef
• Immunology and immunotherapy in gastric cancer
  Xiaqing Xu, Jiaxing Chen, Wenxing Li, Chenlu Feng, Qian Liu, Wenfang Gao, Meng He
  Clinical and Experimental Medicine.2023; 23(7): 3189.     CrossRef
• Targeted Therapies and Developing Precision Medicine in Gastric Cancer
  Rille Pihlak, Caroline Fong, Naureen Starling
  Cancers.2023; 15(12): 3248.     CrossRef
• Programmed death ligand 1 (PD-L1) expression in gastric cancer: literature review
  T. N. Sotnikova, N. V. Danilova, P. G. Malkov, T. V. Polushkina
  Advances in Molecular Oncology.2023; 10(2): 70.     CrossRef
• Novel Biomarkers of Gastric Cancer: Current Research and Future Perspectives
  Yasushi Sato, Koichi Okamoto, Yutaka Kawano, Akinari Kasai, Tomoyuki Kawaguchi, Tamotsu Sagawa, Masahiro Sogabe, Hiroshi Miyamoto, Tetsuji Takayama
  Journal of Clinical Medicine.2023; 12(14): 4646.     CrossRef
• Programmed death-ligand 1 (PD-L1) expression in primary gastric adenocarcinoma and matched metastases
  Drolaiz H. W. Liu, Heike I. Grabsch, Beat Gloor, Rupert Langer, Bastian Dislich
  Journal of Cancer Research and Clinical Oncology.2023; 149(14): 13345.     CrossRef
• Chemoimmunotherapy for esophageal squamous cell carcinoma—Summary and discussion of recent clinical trials
  Zhen Zhang, Jiaqian Huang, Yuhong Xu, Huiyan Luo
  MedComm – Future Medicine.2023;[Epub]     CrossRef
• Next generation immuno-oncology biomarkers in gastrointestinal cancer: what does the future hold?
  Hassan Abushukair, Obada Ababneh, Ayah Al-Bzour, Ibrahim Halil Sahin, Anwaar Saeed
  Expert Review of Molecular Diagnostics.2023; 23(10): 863.     CrossRef
• Impact of programmed death‐ligand 1 (PD‐L1) positivity on clinical and molecular features of patients with metastatic gastric cancer
  Minkyue Shin, Soomin Ahn, Jaeyun Jung, Sujin Hyung, Kyoung‐Mee Kim, Seung Tae Kim, Won Ki Kang, Jeeyun Lee
  Cancer Medicine.2023; 12(18): 18633.     CrossRef
• Regulatory T cells in gastric cancer: Key controllers from pathogenesis to therapy
  Ion Negura, Mariana Pavel-Tanasa, Mihai Danciu
  Cancer Treatment Reviews.2023; 120: 102629.     CrossRef
• The prognostic value of a combined immune score in tumor and immune cells assessed by immunohistochemistry in triple-negative breast cancer
  Ji Eun Choi, Jae Seok Lee, Min-Sun Jin, Ilias P. Nikas, Kwangsoo Kim, Sunah Yang, Soo Young Park, Jiwon Koh, Sohyeon Yang, Seock-Ah Im, Han Suk Ryu
  Breast Cancer Research.2023;[Epub]     CrossRef
• Comparison of SP142 and 22C3 Immunohistochemistry PD-L1 Assays for Clinical Efficacy of Atezolizumab in Non–Small Cell Lung Cancer: Results From the Randomized OAK Trial
  Shirish Gadgeel, Fred R. Hirsch, Keith Kerr, Fabrice Barlesi, Keunchil Park, Achim Rittmeyer, Wei Zou, Namrata Bhatia, Hartmut Koeppen, Sarah M. Paul, David Shames, Jing Yi, Christina Matheny, Marcus Ballinger, Mark McCleland, David R. Gandara
  Clinical Lung Cancer.2022; 23(1): 21.     CrossRef
• Adrenal Nodules Detected at Staging CT in Patients with Resectable Gastric Cancers Have a Low Incidence of Malignancy
  Hae Young Kim, Won Chang, Yoon Jin Lee, Ji Hoon Park, Jungheum Cho, Hee Young Na, Hyungwoo Ahn, Sung Il Hwang, Hak Jong Lee, Young Hoon Kim, Kyoung Ho Lee
  Radiology.2022; 302(1): 129.     CrossRef
• Immunohistochemistry as predictive and prognostic markers for gastrointestinal malignancies
  Matthew W. Rosenbaum, Raul S. Gonzalez
  Seminars in Diagnostic Pathology.2022; 39(1): 48.     CrossRef
• Histopathology of Gastrointestinal Immune-related Adverse Events
  M. Lisa Zhang, Vikram Deshpande
  American Journal of Surgical Pathology.2022; 46(1): e15.     CrossRef
• Safety and efficacy of HER2 blockade by trastuzumab-based chemotherapy-containing combination strategies in HER2+ gastroesophageal adenocarcinoma
  D.V.T. Catenacci, H.C. Chung, L. Shen, M. Moehler, H.H. Yoon, M.K. Rosales, Y.-K. Kang
  ESMO Open.2022; 7(1): 100360.     CrossRef
• PD-L1 and HER2 expression in gastric adenocarcinoma and their prognostic significance
  Jie Lian, Guanjun Zhang, Yun Zhang, Heng Liu, Jiaojiao Zhang, Pengfei Nan, Wei Tian
  Digestive and Liver Disease.2022; 54(10): 1419.     CrossRef
• Tissue miR-200c-3p and circulating miR-1290 as potential prognostic biomarkers for colorectal cancer
  Enoch Kang, Sung Cheol Jung, Soo Kyung Nam, Yujun Park, Soo Hyun Seo, Kyoung Un Park, Heung-Kwon Oh, Duck-Woo Kim, Sung-Bum Kang, Hye Seung Lee
  Scientific Reports.2022;[Epub]     CrossRef
• Gastric Cancer: Mechanisms, Biomarkers, and Therapeutic Approaches
  Sangjoon Choi, Sujin Park, Hyunjin Kim, So Young Kang, Soomin Ahn, Kyoung-Mee Kim
  Biomedicines.2022; 10(3): 543.     CrossRef
• Immunotherapy use in oesophagogastric cancers—a review of the literature
  Annabel Smith, Amitesh Roy, Christos S. Karapetis, Vy Broadbridge, Timothy Price
  British Journal of Cancer.2022; 127(1): 21.     CrossRef
• Interspatial Distribution of Tumor and Immune Cells in Correlation with PD-L1 in Molecular Subtypes of Gastric Cancers
  Bastian Dislich, Kirsten D. Mertz, Beat Gloor, Rupert Langer
  Cancers.2022; 14(7): 1736.     CrossRef
• Immunotherapy in Gastro-Oesophageal Cancer: Current Practice and the Future of Personalised Therapy
  Mary E. Booth, Elizabeth C. Smyth
  BioDrugs.2022; 36(4): 473.     CrossRef
• Anlotinib Combined with Toripalimab as Second-Line Therapy for Advanced, Relapsed Gastric or Gastroesophageal Junction Carcinoma
  Man Jiang, Chuantao Zhang, Yabin Hu, Tianjun Li, Guangjie Yang, Guanqun Wang, Jingjuan Zhu, Changfeng Shao, Helei Hou, Na Zhou, Kewei Liu, Xiaochun Zhang
  The Oncologist.2022; 27(11): e856.     CrossRef
• Abdominal Computed Tomography Enhanced Image Features under an Automatic Segmentation Algorithm in Identification of Gastric Cancer and Gastric Lymphoma
  Lihua Zhou, Hao Hu, Lei Zhou, Yi Zhou, Ahmed Faeq Hussein
  Computational and Mathematical Methods in Medicine.2022; 2022: 1.     CrossRef
• Margetuximab with retifanlimab as first-line therapy in HER2+/PD-L1+ unresectable or metastatic gastroesophageal adenocarcinoma: MAHOGANY cohort A
  D.V.T. Catenacci, Y.-K. Kang, H.H. Yoon, B.Y. Shim, S.T. Kim, D.-Y. Oh, A.I. Spira, S.V. Ulahannan, E.J. Avery, P.M. Boland, J. Chao, H.C. Chung, F. Gardner, S.J. Klempner, K.-W. Lee, S.C. Oh, J. Peguero, M.B. Sonbol, L. Shen, M. Moehler, J. Sun, D. Li, M
  ESMO Open.2022; 7(5): 100563.     CrossRef
• Advances in molecular biomarkers research and clinical application progress for gastric cancer immunotherapy
  Hongzhen Cai, Man Li, Ruiyi Deng, Mopei Wang, Yanyan Shi
  Biomarker Research.2022;[Epub]     CrossRef
• Immune Checkpoint Inhibitors for Gastrointestinal Malignancies: An Update
  Kathryn DeCarli, Jonathan Strosberg, Khaldoun Almhanna
  Cancers.2022; 14(17): 4201.     CrossRef
• Immunotherapy for Gastroesophageal Tumors: Is there still Hope for Efficacy?
  Hannah Christina Puhr, Aysegul Ilhan-Mutlu
  Current Cancer Drug Targets.2022; 22(8): 651.     CrossRef
• The seen and the unseen: Molecular classification and image based-analysis of gastrointestinal cancers
  Corina-Elena Minciuna, Mihai Tanase, Teodora Ecaterina Manuc, Stefan Tudor, Vlad Herlea, Mihnea P. Dragomir, George A. Calin, Catalin Vasilescu
  Computational and Structural Biotechnology Journal.2022; 20: 5065.     CrossRef
• Ornithine aminotransferase and carbamoyl phosphate synthetase 1 involved in ammonia metabolism serve as novel targets for early stages of gastric cancer
  Zhen Jiang, Chen Wei, Yaomin Luo, Yang Xiao, Li Wang, Wubin Guo, Xiaoxia Yuan
  Journal of Clinical Laboratory Analysis.2022;[Epub]     CrossRef
• Indirect Clinical Validation of a Programmed Death-Ligand 1 Laboratory-Developed Test for Gastric/Gastroesophageal Junction Adenocarcinoma with 22C3 Antibody Concentrate
  Ji Min Kim, Binnari Kim, Eunji Kim, Minsun Jang, Jun Hun Cho, Hye Seung Lee, Yoonjin Kwak, Lingkang Huang, Radha Krishnan, Sally Y. Bai, Mounia Mounawar, Kyoung-Mee Kim
  Molecular Diagnosis & Therapy.2022; 26(6): 679.     CrossRef
• High interobserver and intraobserver reproducibility among pathologists assessing PD‐L1 CPS across multiple indications
  Shanthy Nuti, Yiwei Zhang, Nabila Zerrouki, Charlotte Roach, Gudrun Bänfer, George L Kumar, Edward Manna, Rolf Diezko, Kristopher Kersch, Josef Rüschoff, Bharat Jasani
  Histopathology.2022; 81(6): 732.     CrossRef
• Validation of E1L3N antibody for PD-L1 detection and prediction of pembrolizumab response in non-small-cell lung cancer
  Lianxi Song, Liang Zeng, Huan Yan, Qinqin Xu, Qing Xia, Jian Lei, Xiaoyan Chen, Xiaoping Hu, Zhan Wang, Hong Liu, Nong Yang, Yongchang Zhang
  Communications Medicine.2022;[Epub]     CrossRef
• Loss of SATB2 expression correlates with cytokeratin 7 and PD-L1 tumor cell positivity and aggressiveness in colorectal cancer
  Jan Hrudka, Radoslav Matěj, Andrej Nikov, Igor Tomyak, Hana Fišerová, Karolína Jelínková, Petr Waldauf
  Scientific Reports.2022;[Epub]     CrossRef
• Programmed cell death protein 1/programmed death ligand 1 but not HER2 is a potential therapeutic target in gastric neuroendocrine carcinoma
  Satoshi Yamashita, Hiroyuki Abe, Akiko Kunita, Hiroharu Yamashita, Yasuyuki Seto, Tetsuo Ushiku
  Histopathology.2021; 78(3): 381.     CrossRef
• MAHOGANY: Margetuximab Combination in HER2+ Unresectable/metastatic Gastric/gastroesophageal Junction Adenocarcinoma
  Daniel V T Catenacci, Minori Rosales, Hyun Cheol Chung, Harry H Yoon, Lin Shen, Markus Moehler, Yoon-Koo Kang
  Future Oncology.2021; 17(10): 1155.     CrossRef
• PD-L1 expression in paired biopsies and surgical specimens in gastric adenocarcinoma: A digital image analysis study
  You Jeong Heo, Binnari Kim, Hyunjin Kim, Soi Kim, Min Sun Jang, Kyoung-Mee Kim
  Pathology - Research and Practice.2021; 218: 153338.     CrossRef
• Targeting Oncoimmune Drivers of Cancer Metastasis
  Chie Kudo-Saito, Yukinori Ozaki, Hiroshi Imazeki, Hideyuki Hayashi, Jun Masuda, Hiroki Ozawa, Yamato Ogiwara
  Cancers.2021; 13(3): 554.     CrossRef
• PD-L1 as a biomarker of response to immune-checkpoint inhibitors
  Deborah Blythe Doroshow, Sheena Bhalla, Mary Beth Beasley, Lynette M. Sholl, Keith M. Kerr, Sacha Gnjatic, Ignacio I. Wistuba, David L. Rimm, Ming Sound Tsao, Fred R. Hirsch
  Nature Reviews Clinical Oncology.2021; 18(6): 345.     CrossRef
• Cancer Immunotherapy Update: FDA-Approved Checkpoint Inhibitors and Companion Diagnostics
  Julianne D. Twomey, Baolin Zhang
  The AAPS Journal.2021;[Epub]     CrossRef
• High Expression of PD-L1 Is Associated with Better Survival in Pancreatic/Periampullary Cancers and Correlates with Epithelial to Mesenchymal Transition
  Nishant Thakur, Kwang Yeol Paik, Gyoyeon Hwang, Yosep Chong
  Diagnostics.2021; 11(4): 597.     CrossRef
• Prädiktive Diagnostik für Checkpoint-Inhibitoren
  Hans-Ulrich Schildhaus, Wilko Weichert
  Der Pathologe.2021; 42(4): 380.     CrossRef
• PD-1/PD-L1 in Cancer: Pathophysiological, Diagnostic and Therapeutic Aspects
  Enrico Munari, Francesca R. Mariotti, Linda Quatrini, Pietro Bertoglio, Nicola Tumino, Paola Vacca, Albino Eccher, Francesco Ciompi, Matteo Brunelli, Guido Martignoni, Giuseppe Bogina, Lorenzo Moretta
  International Journal of Molecular Sciences.2021; 22(10): 5123.     CrossRef
• PD-L1 expression in gastric cancer: interchangeability of 22C3 and 28-8 pharmDx assays for responses to immunotherapy
  Soomin Ahn, Kyoung-Mee Kim
  Modern Pathology.2021; 34(9): 1719.     CrossRef
• PD-L1 Expression Harmonization in Gastric Cancer Using 22C3 PharmDx and SP263 Assays
  Tamara Z. Dabbagh, Maher A. Sughayer
  Applied Immunohistochemistry & Molecular Morphology.2021; 29(6): 462.     CrossRef
• Expression of the immune checkpoint receptors PD-1, LAG3, and TIM3 in the immune context of stage II and III gastric cancer by using single and chromogenic multiplex immunohistochemistry
  Yujun Park, An Na Seo, Jiwon Koh, Soo Kyoung Nam, Yoonjin Kwak, Sang-Hoon Ahn, Do Joong Park, Hyung-Ho Kim, Hye Seung Lee
  OncoImmunology.2021;[Epub]     CrossRef
• Appropriate PD-L1 Cutoff Value for Gastric Cancer Immunotherapy: A Systematic Review and Meta-Analysis
  Tong Xie, Zhening Zhang, Xiaotian Zhang, Changsong Qi, Lin Shen, Zhi Peng
  Frontiers in Oncology.2021;[Epub]     CrossRef
• Prediction of TP53 mutations by p53 immunohistochemistry and their prognostic significance in gastric cancer
  Hye Jung Hwang, Soo Kyung Nam, Hyunjin Park, Yujun Park, Jiwon Koh, Hee Young Na, Yoonjin Kwak, Woo Ho Kim, Hye Seung Lee
  Journal of Pathology and Translational Medicine.2020; 54(5): 378.     CrossRef

Citations

Citations to this article as recorded by  

• Clinicopathological characteristics and genomic profiling of pure mucinous breast cancer
  Qianyi Lu, Hanxing Zhou, Jianwei Zhang, Kaping Lee, Limin Chen, Ruoxi Hong, Kuikui Jiang, Fei Xu, Wen Xia, Boyang Cao, Jingmin Zhang, Kang Shao, Peng Sun, Shusen Wang
  The Breast.2024; 76: 103760.     CrossRef
• A clinicopathologic analysis of 70 patients with mucinous breast carcinoma
  Rupali Sood, Karin Miller, Hua-Ling Tsai, Ashley Cimino-Mathews, Roisin M. Connolly
  Current Problems in Cancer: Case Reports.2024; 15: 100304.     CrossRef
• Clinicopathological features and prognosis of mucinous breast carcinoma with a micropapillary structure
  Beibei Yang, Menglu Shen, Bo Sun, Jing Zhao, Meng Wang
  Thoracic Cancer.2024; 15(36): 2530.     CrossRef
• Distribution, Chemotherapy Use, and Outcome of the 21-Gene Recurrence Score Between Chinese and White breast Cancer in the United States
  Guan-Qiao Li, Jia Yao, Ping Zhou, Dan-Xia Chen, Chen-Lu Lian, Shi-Ping Yang, Cai-Hong Huang, San-Gang Wu
  Clinical Breast Cancer.2022; 22(3): 279.     CrossRef
• Association of tumor immune microenvironment profiling and 21-gene recurrence assay in early breast cancer patients
  Yiwei Tong, Jiahui Huang, Weili Ren, Jing Yu, Xu Zhang, Zheng Wang, Jin Hong, Weiqi Gao, Jiayi Wu, Min Ji, Kunwei Shen, Xiaosong Chen
  European Journal of Medical Research.2022;[Epub]     CrossRef
• Concordance of the 21-gene assay between core needle biopsy and resection specimens in early breast cancer patients
  Peng Qi, Yu Yang, Qian-ming Bai, Tian Xue, Min Ren, Qian-lan Yao, Wen-tao Yang, Xiao-yan Zhou
  Breast Cancer Research and Treatment.2021; 186(2): 327.     CrossRef
• Oncotype DX 21‑gene test has a low recurrence score in both pure and mixed mucinous breast carcinoma
  Rui Chen, Yun Wang, Taolang Li, Junyuan Lv, Guoli Feng, Na Tan, Jinjing Wang, Xiaoming Cheng
  Oncology Letters.2021;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Whole Exome-Wide Association Identifies Rare Variants in GALNT9 Associated with Middle Eastern Papillary Thyroid Carcinoma Risk
  Rong Bu, Abdul K. Siraj, Saud Azam, Kaleem Iqbal, Zeeshan Qadri, Maha Al-Rasheed, Saif S. Al-Sobhi, Fouad Al-Dayel, Khawla S. Al-Kuraya
  Cancers.2023; 15(17): 4235.     CrossRef
• Feasibility of targeted cascade genetic testing in the family members of BRCA1/2 gene pathogenic variant/likely pathogenic variant carriers
  Jeeyeon Lee, Ji Yeon Ham, Ho Yong Park, Jin Hyang Jung, Wan Wook Kim, Byeongju Kang, Yee Soo Chae, Soo Jung Lee, In Hee Lee, Nan Young Lee
  Scientific Reports.2022;[Epub]     CrossRef
• Molecular Characterization of BRCA1 c.5339T>C Missense Mutation in DNA Damage Response of Triple-Negative Breast Cancer
  Jeong Dong Lee, Won-Ji Ryu, Hyun Ju Han, Tae Yeong Kim, Min Hwan Kim, Joohyuk Sohn
  Cancers.2022; 14(10): 2405.     CrossRef
• Discovery of BRCA1/BRCA2 founder variants by haplotype analysis
  Won Kyung Kwon, Hyeok-Jae Jang, Jeong Eon Lee, Yeon Hee Park, Jai Min Ryu, Jonghan Yu, Ja-Hyun Jang, Jong-Won Kim
  Cancer Genetics.2022; 266-267: 19.     CrossRef
• Local Laboratory Testing of Germline BRCA Mutations vs. Myriad: A Single-Institution Experience in Korea
  Joohyun Hong, Jiyun Lee, Minsuk Kwon, Ji-Yeon Kim, Jong-Won Kim, Jin Seok Ahn, Young-Hyuck Im, Yeon Hee Park
  Diagnostics.2021; 11(2): 370.     CrossRef
• Analysis of BRCA1/2 variants of unknown significance in the prospective Korean Hereditary Breast Cancer study
  Joo Heung Kim, Sunggyun Park, Hyung Seok Park, Ji Soo Park, Seung-Tae Lee, Sung-Won Kim, Jong Won Lee, Min Hyuk Lee, Sue K. Park, Woo-Chul Noh, Doo Ho Choi, Wonshik Han, Sung Hoo Jung
  Scientific Reports.2021;[Epub]     CrossRef
• A Population-Based Analysis of BRCA1/2 Genes and Associated Breast and Ovarian Cancer Risk in Korean Patients: A Multicenter Cohort Study
  Kyung-Sun Park, Woochang Lee, Moon-Woo Seong, Sun-Young Kong, Kyung-A Lee, Jung-Sook Ha, Eun-Hae Cho, Sung-Hee Han, Inho Park, Jong-Won Kim
  Cancers.2021; 13(9): 2192.     CrossRef

Citations

Citations to this article as recorded by  

• Genetic Alterations, Therapy Response, and Survival Among Patients With Triple-Negative Breast Cancer
  Lisa Richters, Oleg Gluz, Nana Weber-Lassalle, Matthias Christgen, Heinz Haverkamp, Sherko Kuemmel, Mohamad Kayali, Ronald E. Kates, Eva-Maria Grischke, Janine Altmüller, Helmut Forstbauer, Holger Thiele, Michael Braun, Mathias Warm, Anna Ossowski, Rachel
  JAMA Network Open.2025; 8(2): e2461639.     CrossRef
• Comprehensive analysis of HER2 Low Breast Cancer Response to Neoadjuvant Chemotherapy, a Retrospective Cohort Study
  Jie Lian, Ru Yao, Siyuan Pang, Xinyu Ren, Bo Pan, Yidong Zhou
  Clinical Breast Cancer.2025;[Epub]     CrossRef
• Clinicopathologic and Whole Exome Sequencing Analyzes of High-Grade Serous Carcinoma-Like Carcinoma of the Breast Reveal Unique Genetic Profile and Poor Clinical Outcome
  Wen-Yu Hsiao, Thi Truc Anh Nguyen, Wei Yang, Hu Yan, Zaibo Li, Linsheng Zhang, Jingjing Yang, Xiaoxian Li
  American Journal of Surgical Pathology.2025;[Epub]     CrossRef
• High frequency of the PIK3CA H1047L mutation in Indonesian breast cancer across molecular subtypes
  Yan Wisnu Prajoko, Didik Setyo Heriyanto, Bayu Tirta Dirja, Susanto Susanto, Vincent Lau, Andrew Nobiantoro Gunawan, Brigitta Natasya Halim, Nur Dina Amalina, Rashi Kalra
  PLOS One.2025; 20(5): e0322154.     CrossRef
• The Precision-Guided Use of PI3K Pathway Inhibitors for the Treatment of Solid Malignancies
  Alexa E. Schmitz, Shirsa Udgata, Katherine A. Johnson, Dustin A. Deming
  Biomedicines.2025; 13(6): 1319.     CrossRef
• Clinical and Morphological Features of ER-Positive HER2-Negative Breast Tumors with PIK3CA Mutations in Russian Patients
  Tatyana N. Sokolova, Grigory A. Yanus, Svetlana N. Aleksakhina, Yana V. Belysheva, Aleksandra P. Chernyakova, Yulia S. Zharnakova, Alisa S. Nikitina, Tatyana M. Stebneva, Aleksandr S. Martianov, Alla Yu. Goryainova, Mark I. Gluzman, Rashida V. Orlova, Ana
  Cancers.2025; 17(11): 1833.     CrossRef
• PIK3CA Mutations: Are They a Relevant Target in Adult Diffuse Gliomas?
  Ana Tomás, Marta Pojo
  International Journal of Molecular Sciences.2025; 26(11): 5276.     CrossRef
• Clinicopathological and prognostic analysis of PIK3CA mutated invasive breast cancer in Chinese women
  Juhang Chu, Luyao Huang, Yaru Wang, Mingping Qian
  Clinics.2025; 80: 100702.     CrossRef
• Atezolizumab in Combination With Carboplatin and Survival Outcomes in Patients With Metastatic Triple-Negative Breast Cancer
  Brian D. Lehmann, Vandana G. Abramson, E. Claire Dees, Payal D. Shah, Tarah J. Ballinger, Claudine Isaacs, Cesar A. Santa-Maria, Hanbing An, Paula I. Gonzalez-Ericsson, Melinda E. Sanders, Kimberly C. Newsom, Richard G. Abramson, Quanhu Sheng, Chih-Yuan H
  JAMA Oncology.2024; 10(2): 193.     CrossRef
• Circulating tumour mutation detection in triple-negative breast cancer as an adjunct to tissue response assessment
  Elena Zaikova, Brian Y. C. Cheng, Viviana Cerda, Esther Kong, Daniel Lai, Amy Lum, Cherie Bates, Wendie den Brok, Takako Kono, Sylvie Bourque, Angela Chan, Xioalan Feng, David Fenton, Anagha Gurjal, Nathalie Levasseur, Caroline Lohrisch, Sarah Roberts, Ta
  npj Breast Cancer.2024;[Epub]     CrossRef
• Somatic Mutations in Latin American Breast Cancer Patients: A Systematic Review and Meta-Analysis
  Gabriela A. Martínez-Nava, Laura Keren Urbina-Jara, Saúl Lira-Albarrán, Henry L. Gómez, Erika Ruiz-García, María Tereza Nieto-Coronel, Rocio Ortiz-Lopez, Kenia Nadiezhda Martínez Villalba, Mariana Muñoz-Sánchez, Dione Aguilar, Liliana Gómez-Flores-Ramos,
  Diagnostics.2024; 14(3): 287.     CrossRef
• Discovery of Pyridopyrimidinones that Selectively Inhibit the H1047R PI3Kα Mutant Protein
  John M. Ketcham, Stephen J. Harwood, Ruth Aranda, Athenea N. Aloiau, Briana M. Bobek, David M. Briere, Aaron C. Burns, Kersti Caddell Haatveit, Andrew Calinisan, Jeffery Clarine, Adam Elliott, Lars D. Engstrom, Robin J. Gunn, Anthony Ivetac, Benjamin Jone
  Journal of Medicinal Chemistry.2024; 67(6): 4936.     CrossRef
• Prevalence and effect of PIK3CA H1047R somatic mutation among Indian head and neck cancer patients
  Arjita Ghosh, Anbalagan Moorthy
  Saudi Journal of Biological Sciences.2024; 31(8): 104029.     CrossRef
• Impact of microRNA variants on PI3K/AKT signaling in triple-negative breast cancer: comprehensive review
  Ehsan Mehrtabar, Amirreza Khalaji, Mojtaba Pandeh, Aram Farhoudian, Nadia Shafiee, Atefe Shafiee, Fatemeh Ojaghlou, Parinaz Mahdavi, Mehdi Soleymani-Goloujeh
  Medical Oncology.2024;[Epub]     CrossRef
• Exploring the Inhibitory Efficacy of Resokaempferol and Tectochrysin on PI3Kα Protein by Combining DFT and Molecular Docking against Wild-Type and H1047R Mutant Forms
  Cristina Paraschiv, Steluța Gosav, Catalina Mercedes Burlacu, Mirela Praisler
  Inventions.2024; 9(5): 96.     CrossRef
• Global biomarker trends in triple-negative breast cancer research: a bibliometric analysis
  Xingxin Wang, Xuhao Li, Tiantian Dong, Wenyan Yu, Zhixia Jia, Yi Hou, Jiguo Yang, Yuanxiang Liu
  International Journal of Surgery.2024; 110(12): 7962.     CrossRef
• Prognostic Factors for Triple-Negative Breast Cancer with Residual Disease after Neoadjuvant Chemotherapy
  Zhijun Li, Yiqun Han, Jiayu Wang, Binghe Xu
  Journal of Personalized Medicine.2023; 13(2): 190.     CrossRef
• Triple-Negative Breast Cancer and Predictive Markers of Response to Neoadjuvant Chemotherapy: A Systematic Review
  Nadine S. van den Ende, Anh H. Nguyen, Agnes Jager, Marleen Kok, Reno Debets, Carolien H. M. van Deurzen
  International Journal of Molecular Sciences.2023; 24(3): 2969.     CrossRef
• A light-up fluorescence platform based DNA: RNA hybrid G-quadruplet for detecting single nucleotide variant of ctDNA and miRNA-21
  Gaihua Cao, Keyi Long, Yue Qiu, Lan Peng, Haiyan Han, Yongzhong Wang, Danqun Huo, Changjun Hou
  Talanta.2023; 257: 124373.     CrossRef
• Phosphoinositide 3-Kinase (PI3K) Inhibitors and Breast Cancer: An Overview of Current Achievements
  Alexandre Bertucci, François Bertucci, Anthony Gonçalves
  Cancers.2023; 15(5): 1416.     CrossRef
• Identification of Kinase Targets for Enhancing the Antitumor Activity of Eribulin in Triple-Negative Breast Cell Lines
  Xuemei Xie, Jangsoon Lee, Jon A. Fuson, Huey Liu, Toshiaki Iwase, Kyuson Yun, Cori Margain, Debu Tripathy, Naoto T. Ueno
  Biomedicines.2023; 11(3): 735.     CrossRef
• Synergistic actions of Alpelisib and Melatonin in breast cancer cell lines with PIK3CA gene mutation
  Bianca Lara Venâncio de Godoy, Marina Gobbe Moschetta-Pinheiro, Luiz Gustavo de Almeida Chuffa, Noam Falbel Pondé, Russel J. Reiter, Jucimara Colombo, Debora Aparecida Pires de Campos Zuccari
  Life Sciences.2023; 324: 121708.     CrossRef
• Molecularly Targeted Therapies for Triple Negative Breast Cancer: History, Advances, and Future Directions
  Nicholas Mai, Nour Abuhadra, Komal Jhaveri
  Clinical Breast Cancer.2023; 23(8): 784.     CrossRef
• Role of epigenetics variation with focus on DNA methylation in triple-negative breast cancer patients
  GDeepthi Reddy, V Brahmaiah, BY Kavitha, Jayalatha Nethagani, ElizabethCaroline Palaparthi, RajasekharReddy Lebaka, G Deepika
  Archives of Medicine and Health Sciences.2023; 11(1): 96.     CrossRef
• RETRACTED: Potential Protective Role of Melatonin in Benign Mammary Cells Reprogrammed by Extracellular Vesicles from Malignant Cells
  Caroline Procópio de Oliveira, Barbara Frigieri, Heidge Fukumasu, Luiz Chuffa, Adriana Novais, Debora Zuccari
  Biomedicines.2023; 11(10): 2837.     CrossRef
• Role of Epigenetics Variation with Focus on DNA Methylation in Triple-Negative Breast Cancer Patients
  G. Deepthi Reddy, V. Brahmaiah, B. Y. Kavitha, Jayalatha Nethagani, Elizabeth Caroline Palaparthi, Rajasekhar Reddy Lebaka, G. Deepika
  Archives of Medicine and Health Sciences.2023; 11(1): 96.     CrossRef
• Sclerosing Polycystic Adenoma: Conclusive Clinical and Molecular Evidence of Its Neoplastic Nature
  Juan C. Hernandez-Prera, Daryoush Saeed-Vafa, Amin Heidarian, Kathleen Gewandter, Kristen Otto, Bruce M. Wenig
  Head and Neck Pathology.2022; 16(2): 416.     CrossRef
• PIK3CA Mutations in Diffuse Gliomas: An Update on Molecular Stratification, Prognosis, Recurrence, and Aggressiveness
  Cheila Brito, Ana Tomás, Ana Azevedo, Susana Esteves, Manuela Mafra, Lúcia Roque, Marta Pojo
  Clinical Medicine Insights: Oncology.2022;[Epub]     CrossRef
• Baseline Mutations and Up-Regulation of PI3K-AKT Pathway Serve as Potential Indicators of Lack of Response to Neoadjuvant Chemotherapy in Stage II/III Breast Cancer
  Menghao Dong, Benjie Shan, Xinghua Han, Xiaotian Zhao, Fufeng Wang, Liuqing Zhu, Qiuxiang Ou, Xiaopeng Ma, Yueyin Pan
  Frontiers in Oncology.2022;[Epub]     CrossRef
• Clinical and morphological features of breast tumors with PIK3CA mutations in Russian patients: Observational study
  Tatyana N. Sokolova, Tatyana I. Solov'eva, Svetlana N. Aleksakhina, Marina B. Bolieva, Viktor E. Goldberg, Marianna V. Kibisheva, Konstantin V. Menshikov, Dmitrii V. Ryazanov, Aleksandr V. Shkradyuk, Yana S. Chapko, Anna A. Shchukina, Idris M. Khabr
  Journal of Modern Oncology.2022; 24(1): 12.     CrossRef
• PIK3CAMutations in Breast Cancer Subtypes Other Than HR-Positive/HER2-Negative
  Liliana Ascione, Paola Zagami, Eleonora Nicolò, Edoardo Crimini, Giuseppe Curigliano, Carmen Criscitiello
  Journal of Personalized Medicine.2022; 12(11): 1793.     CrossRef
• Precision Medicine and Triple-Negative Breast Cancer: Current Landscape and Future Directions
  Fokhrul Hossain, Samarpan Majumder, Justin David, Lucio Miele
  Cancers.2021; 13(15): 3739.     CrossRef
• Single-nucleotide variant of PIK3CA H1047R gene assay by CRISPR/Cas12a combined with rolling circle amplification
  Gaihua Cao, Xiaolong Chen, Yuanyi Deng, Fuping Nie, Yin Liu, Guoming Wang, Danqun Huo, Changjun Hou
  Analytica Chimica Acta.2021; 1182: 338943.     CrossRef
• Identification of effective natural PIK3CA H1047R inhibitors by computational study
  Naimeng Liu, Xinhui Wang, Xuan Li, Xiaye Lv, Haoqun Xie, Zhen Guo, Jing Wang, Gaojing Dou, Ye Du, Dong Song
  Aging.2021; 13(16): 20246.     CrossRef
• Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatment
  Hua Sun, Song Cao, R. Jay Mashl, Chia-Kuei Mo, Simone Zaccaria, Michael C. Wendl, Sherri R. Davies, Matthew H. Bailey, Tina M. Primeau, Jeremy Hoog, Jacqueline L. Mudd, Dennis A. Dean, Rajesh Patidar, Li Chen, Matthew A. Wyczalkowski, Reyka G. Jayasinghe,
  Nature Communications.2021;[Epub]     CrossRef
• Molecular Biomarkers Predict Pathological Complete Response of Neoadjuvant Chemotherapy in Breast Cancer Patients: Review
  Ana Julia Aguiar de Freitas, Rhafaela Lima Causin, Muriele Bertagna Varuzza, Cassio Murilo Trovo Hidalgo Filho, Vinicius Duval da Silva, Cristiano de Pádua Souza, Márcia Maria Chiquitelli Marques
  Cancers.2021; 13(21): 5477.     CrossRef
• Clinical value and potential mechanisms of COL8A1 upregulation in breast cancer: a comprehensive analysis
  Wei Peng, Jian-Di Li, Jing-Jing Zeng, Xiao-Ping Zou, Deng Tang, Wei Tang, Min-Hua Rong, Ying Li, Wen-Bin Dai, Zhong-Qing Tang, Zhen-Bo Feng, Gang Chen
  Cancer Cell International.2020;[Epub]     CrossRef
• Novel miRNA Targets and Therapies in the Triple-Negative Breast Cancer Microenvironment: An Emerging Hope for a Challenging Disease
  Amal Qattan
  International Journal of Molecular Sciences.2020; 21(23): 8905.     CrossRef

Citations

Citations to this article as recorded by  

• Comprehensive germline and somatic profiling of high-risk Thai breast cancer via next-generation sequencing
  Kornyok Kamdee, Ekkapong Roothumnong, Wanna Thongnoppakhun, Krittiya Korphaisarn, Panee Nakthong, Peerawat Dungort, Chutima Meesamarnpong, Supakit Wiboontanasarn, Warisara Tansa-nga, Kittiporn Punuch, Khontawan Pongsuktavorn, Warunya Tititumjariya, Chitta
  Scientific Reports.2025;[Epub]     CrossRef
• Next-generation sequencing in cancer diagnosis and treatment: clinical applications and future directions
  Nima Ghoreyshi, Reza Heidari, Arezoo Farhadi, Mohsen Chamanara, Nastaran Farahani, Mahmood Vahidi, Javad Behroozi
  Discover Oncology.2025;[Epub]     CrossRef
• Next-Generation Sequencing in Breast Cancer Patients: Real-World Data for Precision Medicine
  Hyunwoo Lee, Yoon Ah Cho, Deok Geun Kim, Eun Yoon Cho
  Cancer Research and Treatment.2024; 56(1): 149.     CrossRef
• Identification of pathogenic germline variants in a large Chinese lung cancer cohort by clinical sequencing
  Zhe Yu, Zirui Zhang, Jun Liu, Xiaoying Wu, Xiaojun Fan, Jiaohui Pang, Hua Bao, Jiani Yin, Xue Wu, Yang Shao, Zhengcheng Liu, Fang Liu
  Molecular Oncology.2024; 18(5): 1301.     CrossRef
• Germline mutations of 4567 patients with hereditary breast-ovarian cancer spectrum in Thailand
  Chalermkiat Kansuttiviwat, Pongtawat Lertwilaiwittaya, Ekkapong Roothumnong, Panee Nakthong, Peerawat Dungort, Chutima Meesamarnpong, Warisara Tansa-Nga, Khontawan Pongsuktavorn, Supakit Wiboonthanasarn, Warunya Tititumjariya, Nannipa Phuphuripan, Chittap
  npj Genomic Medicine.2024;[Epub]     CrossRef
• Assessment of genome mutation analysis for tumor-informed detection of circulating tumor DNA in patients with breast cancer
  Mugip Rahaman Abdul Wahab, Thirunavukkarasu Palaniyandi, Swarnakala Thamada, Sandhiya Viswanathan, Gomathy Baskar, Hemapreethi Surendran, P Baraneedharan, J Kannan, Maddaly Ravi, Suba Rajinikanth, Mohamed A. El-Tayeb, Shaban Syed
  Clinica Chimica Acta.2024; 561: 119818.     CrossRef
• Towards targeting the breast cancer immune microenvironment
  Michael A. Harris, Peter Savas, Balaji Virassamy, Megan M. R. O’Malley, Jasmine Kay, Scott N. Mueller, Laura K. Mackay, Roberto Salgado, Sherene Loi
  Nature Reviews Cancer.2024; 24(8): 554.     CrossRef
• Genetic Testing Among Breast Cancer Patients in the Eastern Region of Saudi Arabia: Single-Center Experience
  Ghadeer Al Ghareeb, Zainab Al Nass, Salma Abu-Grain, Alia Alnaji, Hani Almohanna, Hadi Al Shaikh Nasser, Saad Al Shahrani
  Journal of Epidemiology and Global Health.2024; 14(3): 1351.     CrossRef
• The Genomic and Biologic Landscapes of Breast Cancer and Racial Differences
  Sapthala P Loku Galappaththi, Kelly R. Smith, Enas S. Alsatari, Rachel Hunter, Donna L. Dyess, Elba A. Turbat-Herrera, Santanu Dasgupta
  International Journal of Molecular Sciences.2024; 25(23): 13165.     CrossRef
• Clinical usefulness of NGS multi-gene panel testing in hereditary cancer analysis
  Federico Anaclerio, Lucrezia Pilenzi, Anastasia Dell’Elice, Rossella Ferrante, Simona Grossi, Luca Maria Ferlito, Camilla Marinelli, Simona Gildetti, Giuseppe Calabrese, Liborio Stuppia, Ivana Antonucci
  Frontiers in Genetics.2023;[Epub]     CrossRef
• Triple-negative breast cancer: epidemiology, molecular mechanisms, and modern vaccine-based treatment strategies
  Asad Mustafa Karim, Jeong Eun Kwon, Tanveer Ali, Jinsoo Jang, Irfan Ullah, Yeong-Geun Lee, Dae Won Park, Juha Park, Jin Woo Jeang, Se Chan Kang
  Biochemical Pharmacology.2023; 212: 115545.     CrossRef
• Klinische Anwendungsbeispiele einer Next-Generation-Sequencing-basierten Multi-Genpanel-Analyse
  Dietmar Enko, Erich Schaflinger, Daniel J. Müller
  DMW - Deutsche Medizinische Wochenschrift.2023; 148(11): 695.     CrossRef
• A study of clinical and molecular characteristics in bilateral primary breast cancer
  Bin Li, Weiqi Xu, Jianing Cao, Duancheng Guo, Zhonghua Tao, Juan Jin, Xichun Hu
  Cancer Medicine.2023; 12(15): 15881.     CrossRef
• Klinische Anwendungsbeispiele einer Next-Generation-Sequencing-basierten Multi-Genpanel-Analyse
  Dietmar Enko, Erich Schaflinger, Daniel J. Müller
  TumorDiagnostik & Therapie.2023; 44(06): 401.     CrossRef
• Frequency of germline pathogenic variants in breast cancer predisposition genes among young Turkish breast cancer patients
  Aysun Dauti Isiklar, Lamiya Aliyeva, Ahmet Yesilyurt, Aykut Soyder, Gul Basaran
  Breast Cancer Research and Treatment.2023; 202(2): 297.     CrossRef
• Investigation of germline variants in Bahraini women with breast cancer using next-generation sequencing based-multigene panel
  Ghada Al-Kafaji, Ghufran Jassim, Amani AlHajeri, Amna Mohamed Tayeb Alawadhi, Mariam Fida, Ibrahim Sahin, Faisal Alali, Elias Fadel, Amy McCart Reed
  PLOS ONE.2023; 18(9): e0291015.     CrossRef
• Low prevalence of germline TP53 and PALB2 mutations in unselected cohort of breast cancer patients from Brunei Darussalam
  Siti Nur Idayu Matusin, Zen Huat Lu, Mas Rina Wati Haji Abdul Hamid
  F1000Research.2023; 12: 1537.     CrossRef
• Should all patients undergoing genetic testing for hereditary breast cancer syndromes be offered a multigene panel?
  Erica L. Silver, Mariana Niell-Swiller
  Current Opinion in Obstetrics & Gynecology.2022; 34(1): 36.     CrossRef
• The emerging roles of NGS in clinical oncology and personalized medicine
  Bashdar Mahmud Hussen, Sara Tharwat Abdullah, Abbas Salihi, Dana Khdr Sabir, Karzan R. Sidiq, Mohammed Fatih Rasul, Hazha Jamal Hidayat, Soudeh Ghafouri-Fard, Mohammad Taheri, Elena Jamali
  Pathology - Research and Practice.2022; 230: 153760.     CrossRef
• Increased incidence of pathogenic variants in ATM in the context of testing for breast and ovarian cancer predisposition
  P. Macquere, S. Orazio, F. Bonnet, N. Jones, V. Bubien, J. Chiron, D. Lafon, E. Barouk-Simonet, J. Tinat, L. Venat-Bouvet, P. Gesta, M. Longy, N. Sevenet
  Journal of Human Genetics.2022; 67(6): 339.     CrossRef
• Novel Insights From the Germline Landscape of Breast Cancer in Brazil
  Daniel Barbalho, Renata Sandoval, Erika Santos, Janina Pisani, Carla Quirino, Bernardo Garicochea, Benedito Rossi, Maria Isabel Achatz
  Frontiers in Oncology.2022;[Epub]     CrossRef
• Evaluation of a Four-Gene Panel for Hereditary Cancer Risk Assessment
  Angela Secondino, Flavio Starnone, Iolanda Veneruso, Maria Di Tella, Serena Conato, Carmine De Angelis, Sabino De Placido, Valeria D’Argenio
  Genes.2022; 13(4): 682.     CrossRef
• Multi-gene panel testing increases germline predisposing mutations’ detection in a cohort of breast/ovarian cancer patients from Southern Italy
  Marcella Nunziato, Federica Di Maggio, Matilde Pensabene, Maria Valeria Esposito, Flavio Starnone, Carmine De Angelis, Alessandra Calabrese, Massimiliano D’Aiuto, Gerardo Botti, Sabino De Placido, Valeria D’Argenio, Francesco Salvatore
  Frontiers in Medicine.2022;[Epub]     CrossRef
• Targeted Sequencing of Germline Breast Cancer Susceptibility Genes for Discovering Pathogenic/Likely Pathogenic Variants in the Jakarta Population
  Sonar Soni Panigoro, Rafika Indah Paramita, Kristina Maria Siswiandari, Fadilah Fadilah
  Diagnostics.2022; 12(9): 2241.     CrossRef
• Frequency of Pathogenic Germline Mutations in Early and Late Onset Familial Breast Cancer Patients Using Multi-Gene Panel Sequencing: An Egyptian Study
  Auhood Nassar, Abdel-Rahman N. Zekri, Mahmoud M. Kamel, Mostafa H. Elberry, Mai M. Lotfy, Mohamed G. Seadawy, Zeinab K. Hassan, Hany K. Soliman, Ahmed M. Lymona, Amira Salah El-Din Youssef
  Genes.2022; 14(1): 106.     CrossRef
• Germline molecular data in hereditary breast cancer in Brazil: Lessons from a large single-center analysis
  Renata Lazari Sandoval, Ana Carolina Rathsam Leite, Daniel Meirelles Barbalho, Daniele Xavier Assad, Romualdo Barroso, Natalia Polidorio, Carlos Henrique dos Anjos, Andréa Discaciati de Miranda, Ana Carolina Salles de Mendonça Ferreira, Gustavo dos Santos
  PLOS ONE.2021; 16(2): e0247363.     CrossRef
• Molecular Diagnosis of Neurofibromatosis by Multigene Panel Testing
  Zeng-Yun-Ou Zhang, Yuan-Yuan Wu, Xin-ying Cai, Wen-Liang Fang, Feng-Li Xiao
  Frontiers in Genetics.2021;[Epub]     CrossRef
• Analysis of Sequence and Copy Number Variants in Canadian Patient Cohort With Familial Cancer Syndromes Using a Unique Next Generation Sequencing Based Approach
  Pratibha Bhai, Michael A. Levy, Kathleen Rooney, Deanna Alexis Carere, Jack Reilly, Jennifer Kerkhof, Michael Volodarsky, Alan Stuart, Mike Kadour, Karen Panabaker, Laila C. Schenkel, Hanxin Lin, Peter Ainsworth, Bekim Sadikovic
  Frontiers in Genetics.2021;[Epub]     CrossRef
• Impact of deleterious variants in other genes beyond BRCA1/2 detected in breast/ovarian and pancreatic cancer patients by NGS-based multi-gene panel testing: looking over the hedge
  M. Bono, D. Fanale, L. Incorvaia, D. Cancelliere, A. Fiorino, V. Calò, A. Dimino, C. Filorizzo, L.R. Corsini, C. Brando, G. Madonia, A. Cucinella, R. Scalia, N. Barraco, F. Guadagni, E. Pedone, G. Badalamenti, A. Russo, V. Bazan
  ESMO Open.2021; 6(4): 100235.     CrossRef
• Summary of BARD1 Mutations and Precise Estimation of Breast and Ovarian Cancer Risks Associated with the Mutations
  Malwina Suszynska, Piotr Kozlowski
  Genes.2020; 11(7): 798.     CrossRef
• Detection of Germline Mutations in a Cohort of 139 Patients with Bilateral Breast Cancer by Multi-Gene Panel Testing: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2
  Daniele Fanale, Lorena Incorvaia, Clarissa Filorizzo, Marco Bono, Alessia Fiorino, Valentina Calò, Chiara Brando, Lidia Rita Corsini, Nadia Barraco, Giuseppe Badalamenti, Antonio Russo, Viviana Bazan
  Cancers.2020; 12(9): 2415.     CrossRef

Citations

Citations to this article as recorded by  

• Fusion MRI/Ultrasound-Guided Transperineal Biopsy: A Game Changer in Prostate Cancer Diagnosis
  Ilias Giannakodimos, Aris Kaltsas, Napoleon Moulavasilis, Zisis Kratiras, Dionysios Mitropoulos, Michael Chrisofos, Konstantinos Stravodimos, Evangelos Fragkiadis
  Journal of Clinical Medicine.2025; 14(2): 453.     CrossRef
• Rapid diagnostic pathways for prostate cancer: A realist synthesis
  Katie Jones, Arya Chandran, Jaynie Rance
  Journal of Cancer Policy.2024; 42: 100514.     CrossRef
• Diagnostic performance of transperineal prostate targeted biopsy alone according to the PI-RADS score based on bi-parametric magnetic resonance imaging
  Tae Il Noh, Ji Sung Shim, Seok Ho Kang, Jun Cheon, Sung Gu Kang
  Frontiers in Oncology.2023;[Epub]     CrossRef
• Efficacy of Tadalafil in Penile Rehabilitation Started Before Nerve-Sparing Robot-Assisted Radical Prostatectomy: A Double-Blind Pilot Study
  Tae Il Noh, Ji Sung Shim, Sung Gu Kang, Jun Cheon, Jeong Gu Lee, Seok Ho Kang
  Sexual Medicine.2022; 10(3): 1.     CrossRef
• Concordance between biparametric MRI, transperineal targeted plus systematic MRI-ultrasound fusion prostate biopsy, and radical prostatectomy pathology
  Tae Il Noh, Ji Sung Shim, Sung Gu Kang, Jun Cheon, Jeong Gu Lee, Jeong Hyeon Lee, Seok Ho Kang
  Scientific Reports.2022;[Epub]     CrossRef
• Three-dimensional ultrasound integrating nomogram and the blood flow image for prostate cancer diagnosis and biopsy: A retrospective study
  Dong Chen, Yingjie Niu, Haitao Chen, Dequan Liu, Rong Guo, Nan Yao, Zhiyao Li, Xiaomao Luo, Hongyang Li, Shicong Tang
  Frontiers in Oncology.2022;[Epub]     CrossRef
• Comparison between biparametric and multiparametric MRI in predicting muscle invasion by bladder cancer based on the VI-RADS
  Tae Il Noh, Ji Sung Shim, Sung Gu Kang, Deuk Jae Sung, Jun Cheon, Ki Choon Sim, Seok Ho Kang
  Scientific Reports.2022;[Epub]     CrossRef
• A Predictive Model Based on Bi-parametric Magnetic Resonance Imaging and Clinical Parameters for Clinically Significant Prostate Cancer in the Korean Population
  Tae Il Noh, Chang Wan Hyun, Ha Eun Kang, Hyun Jung Jin, Jong Hyun Tae, Ji Sung Shim, Sung Gu Kang, Deuk Jae Sung, Jun Cheon, Jeong Gu Lee, Seok Ho Kang
  Cancer Research and Treatment.2021; 53(4): 1148.     CrossRef
• PSA Based Biomarkers, Imagistic Techniques and Combined Tests for a Better Diagnostic of Localized Prostate Cancer
  Vlad Cristian Munteanu, Raluca Andrada Munteanu, Diana Gulei, Vlad Horia Schitcu, Bogdan Petrut, Ioana Berindan Neagoe, Patriciu Achimas Cadariu, Ioan Coman
  Diagnostics.2020; 10(10): 806.     CrossRef

Citations

Citations to this article as recorded by  

• Factors associated with unmet supportive care needs among adult cancer survivors in South Korea: a cross-sectional survey
  Dal-Lae Jin, Young Ae Kim, Su Jung Lee, Hyun-Ju Seo, Seok-Jun Yoon
  Journal of Cancer Survivorship.2025;[Epub]     CrossRef
• Role performance and factors affecting quality of life in bladder cancer survivors with ileal orthotopic neobladder
  So Hee Kim, Eunjung Ryu, Byong Chang Jeong
  Asia-Pacific Journal of Oncology Nursing.2024; 11(6): 100490.     CrossRef
• Effects of stigma on quality of life of cancer survivors: Preliminary evidence from a survivorship programme in Kenya
  Koech J. Maureen, Judy Mwangi, Benda Kithaka, Serah Kimaru, Ndinda Kusu, Lucy Munyi, Sidney Chahonyo, Francis Makokha
  Heliyon.2024; 10(9): e30165.     CrossRef
• Perception of Korean healthy adolescents on cancer and adolescent cancer survivors: a cross-sectional survey
  Min Kyung Hyun, Yeonseung Lee, Hyun Jeong Lee, Young Ae Kim
  BMC Public Health.2024;[Epub]     CrossRef
• Experiences of Cancer Survivors Returning to Work in Korean Society: A Qualitative Study
  Kisook Kim, Hyohyoen Yoon, Booyoung Oh
  Asian Oncology Nursing.2024; 24(3): 114.     CrossRef
• A Multilabel Text Classifier of Cancer Literature at the Publication Level: Methods Study of Medical Text Classification
  Ying Zhang, Xiaoying Li, Yi Liu, Aihua Li, Xuemei Yang, Xiaoli Tang
  JMIR Medical Informatics.2023; 11: e44892.     CrossRef
• How should the healthcare system support cancer survivors? Survivors’ and health professionals’ expectations and perception on comprehensive cancer survivorship care in Korea: a qualitative study
  Su Jung Lee, Dal-Lae Jin, Young Ae Kim, Hyun-Ju Seo, Seok-Jun Yoon
  BMC Cancer.2023;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Hydrogels as a Potential Biomaterial for Multimodal Therapeutic Applications
  Harpreet Kaur, Bishmita Gogoi, Ira Sharma, Deepak Kumar Das, Mohd Ashif Azad, Devlina Das Pramanik, Arindam Pramanik
  Molecular Pharmaceutics.2024; 21(10): 4827.     CrossRef
• Injectable hydrogels for personalized cancer immunotherapies
  Neda Mohaghegh, Amir Ahari, Fatemeh Zehtabi, Claire Buttles, Saya Davani, Hanna Hoang, Kaylee Tseng, Benjamin Zamanian, Safoora Khosravi, Ariella Daniali, Negar Hosseinzadeh Kouchehbaghi, Isabel Thomas, Hamed Serati Nouri, Danial Khorsandi, Reza Abbasghol
  Acta Biomaterialia.2023; 172: 67.     CrossRef
• Efficacy of radiotherapy combined with immune checkpoint inhibitors in patients with melanoma: a systemic review and meta-analysis
  Gaofei Yin, Wei Guo, Zhigang Huang, Xiaohong Chen
  Melanoma Research.2022; 32(2): 71.     CrossRef
• The pharmacotherapeutic management of nail unit and acral melanomas
  Julianne M. Falotico, Shari R. Lipner
  Expert Opinion on Pharmacotherapy.2022; 23(11): 1273.     CrossRef
• A Comparison of 2 Disease Burden Assessment Methods (3D Volume Versus the Number of Lesions) for Prognostication of Survival in Metastatic Melanoma: Implications for the Characterization of Oligometastatic Disease
  Jina Kim, Jee Suk Chang, Wonmo Sung, Jin Sung Kim, Tae Hyung Kim, Seo Hee Choi, Kyung Hwan Kim, Heejoo Ko, Hye Sun Lee, Soyoung Jeon, Sang Joon Shin, Mitchell Liu, Robert Olson
  International Journal of Radiation Oncology*Biology*Physics.2022; 114(5): 883.     CrossRef
• Prediction of Immune-Checkpoint Blockade Monotherapy Response in Patients With Melanoma Based on Easily Accessible Clinical Indicators
  Hwa Kyung Byun, Jee Suk Chang, Minkyu Jung, Woong Sub Koom, Kee Yang Chung, Byung Ho Oh, Mi Ryung Roh, Kyung Hwan Kim, Choong-Kun Lee, Sang Joon Shin
  Frontiers in Oncology.2021;[Epub]     CrossRef
• Effectiveness and safety of immune checkpoint inhibitors in combination with palliative radiotherapy in advanced melanoma: A systematic review
  Jennifer Ben Shimol, Yuli Guzman-Prado, Maria Karlinskaya, Tima Davidson
  Critical Reviews in Oncology/Hematology.2021; 167: 103499.     CrossRef

Citations

Citations to this article as recorded by  

• Therapeutic Management in Elderly Male Breast Cancer Patients: A Scoping Review
  Alessia Di Rito, Antonietta Grillo, Roberta Carbonara
  Current Oncology Reports.2025; 27(2): 120.     CrossRef
• HER2 expression and pathway status in male breast cancer patients: results of an integrated analysis among 6,150 patients
  Boqiang Lyu, Shidi Zhao, Hui Wang, Shouping Gong, Biyuan Wang
  Scientific Reports.2025;[Epub]     CrossRef
• Comparative Net Survival Analysis of Men and Women With Breast Cancer in Japan: A Population‐Based Study
  Daisy Sibale Mojoo, Isao Oze, Hiroshi Tsuge, Yukari Taniyama, Yuriko N. Koyanagi, Sayaka Yamamoto, Megumi Hori, Kayo Nakata, Hiromi Sugiyama, Isao Miyashiro, Izumi Oki, Yoshikazu Nishino, Yuri Ito, Kota Katanoda, Akiko Shibata, Tomohiro Matsuda, Keitaro M
  Cancer Science.2025;[Epub]     CrossRef
• Trends and Age-Period-Cohort Effect on Incidence of Male Breast Cancer from 1980 to 2019 in Taiwan and the USA
  Jhao-Yang Peng, Yu-Kwang Lee, Rong-Qi Pham, Xiao-Han Shen, I-Hui Chen, Yong-Chen Chen, Hung-Shu Fan
  Cancers.2024; 16(2): 444.     CrossRef
• The features of male breast cancer in China: A real-world study
  Yuxuan Gao, Mengmeng Zhang, Gang Sun, Li Ma, Jianyun Nie, Zhongyu Yuan, Zhenzhen Liu, Yali Cao, Jianbin Li, Qiang Liu, Songqing Ye, Bo Chen, Yuhua Song, Kun Wang, Yu Ren, Guolin Ye, Ling Xu, Shu Liu, Qianjun Chen, Weiwen Li, Xinxin Chen, Peifen Fu, Wei We
  The Breast.2024; 76: 103762.     CrossRef
• Clinicopathologic Features and Prognoses of Male Patients With Breast Cancer
  Meiling Huang, Jingjing Xiao, Changjiao Yan, Rui Ling, Ting Wang
  American Journal of Men's Health.2024;[Epub]     CrossRef
• Stage and Type of Male Breast Cancer Presented at Mankweng Academic Hospital from 2015-2023
  Fumani Charles Makhandule, Mirza Mohamod Zahir Uddin Bhuiyan
  European Journal of Medical and Health Sciences.2024; 6(6): 1.     CrossRef
• Impacts of Subtype on Clinical Feature and Outcome of Male Breast Cancer: Multicenter Study in Korea (KCSG BR16-09)
  Jieun Lee, Keun Seok Lee, Sung Hoon Sim, Heejung Chae, Joohyuk Sohn, Gun Min Kim, Kyung-Hee Lee, Su Hwan Kang, Kyung Hae Jung, Jae-ho Jeong, Jae Ho Byun, Su-Jin Koh, Kyoung Eun Lee, Seungtaek Lim, Hee Jun Kim, Hye Sung Won, Hyung Soon Park, Guk Jin Lee, S
  Cancer Research and Treatment.2023; 55(1): 123.     CrossRef
• Risk of Lymphedema and Death after Lymph Node Dissection with Neoadjuvant and Adjuvant Treatments in Patients with Breast Cancer: An Eight-Year Nationwide Cohort Study
  Ye-Seul Lee, Yu-Cheol Lim, Jiyoon Yeo, Song-Yi Kim, Yoon Jae Lee, In-Hyuk Ha
  Healthcare.2023; 11(13): 1833.     CrossRef
• Diagnostic performance of screening mammography according to menstrual cycle among Asian women
  Mi-ri Kwon, Yoosoo Chang, Inyoung Youn, Shin Ho Kook, Yoosun Cho, Boyoung Park, Seungho Ryu
  Breast Cancer Research and Treatment.2023; 202(2): 357.     CrossRef
• Clinicopathological features and correlation analysis of male breast cancer
  Lei Xi, Jinxing Zhou, Yan Wu, Rong Rong
  Medicine.2023; 102(30): e34408.     CrossRef
• Germline variants profiling of BRCA1 and BRCA2 in Chinese Hakka breast and ovarian cancer patients
  Yunuo Zhang, Heming Wu, Zhikang Yu, Liang Li, Jinhong Zhang, Xinhong Liang, Qingyan Huang
  BMC Cancer.2022;[Epub]     CrossRef
• Poor prognosis of male triple-positive breast Cancer patients: a propensity score matched SEER analysis and molecular portraits
  Biyuan Wang, Hui Wang, Andi Zhao, Mi Zhang, Jin Yang
  BMC Cancer.2021;[Epub]     CrossRef
• Prognostic difficulties of men with breast cancer
  Ian S. Fentiman
  The Breast Journal.2021; 27(12): 877.     CrossRef
• Clinicopathological features and prognosis of male breast cancer
  Xinli Wang, Shusong Liu, Yan Xue
  Journal of International Medical Research.2021;[Epub]     CrossRef
• Prognostic Factors in Male Breast Cancer: A Retrospective Nationwide Study in South Korea by the Study of SMARTSHIP Group
  Sungmin Park, Ho Hur, Ji Sung Lee, JaeSun Yoon, Sung Mo Hur, Il Yong Chung, Jong Won Lee, Hyun Jo Youn, Se Jeong Oh, Cheol Wan Lim, Jihyoun Lee
  Journal of Breast Cancer.2021; 24(6): 561.     CrossRef
• Male breast cancer: A closer look at patient and tumor characteristics and factors associated with survival
  Jing Zhao, Bin Wang, Jing Zhao, Yiran Mao, Jun Liu, Yanfang Yang
  Thoracic Cancer.2020; 11(11): 3107.     CrossRef

Citations

Citations to this article as recorded by  

• Unveiling the role of MDH1 in breast cancer drug resistance through single-cell sequencing and schottenol intervention
  Jian Lu, Feng Ding, Yongjie Sun, Yu Zhao, Wenbiao Ma, Huan Zhang, Bo Shi
  Cellular Signalling.2025; 127: 111608.     CrossRef
• Amplifying mRNA vaccines: potential versatile magicians for oncotherapy
  Chaoying Hu, Jianyang Liu, Feiran Cheng, Yu Bai, Qunying Mao, Miao Xu, Zhenglun Liang
  Frontiers in Immunology.2023;[Epub]     CrossRef
• STING activation normalizes the intraperitoneal vascular-immune microenvironment and suppresses peritoneal carcinomatosis of colon cancer
  Seung Joon Lee, Hannah Yang, Woo Ram Kim, Yu Seong Lee, Won Suk Lee, So Jung Kong, Hye Jin Lee, Jeong Hun Kim, Jaekyung Cheon, Beodeul Kang, Hong Jae Chon, Chan Kim
  Journal for ImmunoTherapy of Cancer.2021; 9(6): e002195.     CrossRef
• Comprehensive Analysis of the Prognostic Value and Immune Function of Immune Checkpoints in Stomach Adenocarcinoma
  Kai Shen, Tong Liu
  International Journal of General Medicine.2021; Volume 14: 5807.     CrossRef

Citations

Citations to this article as recorded by  

• Gene-Mutation-Based Algorithm for Prediction of Treatment Response in Colorectal Cancer Patients
  Heather Johnson, Zahra El-Schich, Amjad Ali, Xuhui Zhang, Athanasios Simoulis, Anette Gjörloff Wingren, Jenny L. Persson
  Cancers.2022; 14(8): 2045.     CrossRef
• Putative anoikis resistant subpopulations are enriched in lymph node metastases and indicate adverse prognosis in colorectal carcinoma
  Taneli T. Mattila, Madhura Patankar, Juha P. Väyrynen, Kai Klintrup, Jyrki Mäkelä, Anne Tuomisto, Pentti Nieminen, Markus J. Mäkinen, Tuomo J. Karttunen
  Clinical & Experimental Metastasis.2022; 39(6): 883.     CrossRef
• Clinical Application of Targeted Deep Sequencing in Metastatic Colorectal Cancer Patients: Actionable Genomic Alteration in K-MASTER Project
  Youngwoo Lee, Soohyeon Lee, Jae Sook Sung, Hee-Joon Chung, Ah-reum Lim, Ju Won Kim, Yoon Ji Choi, Kyong Hwa Park, Yeul Hong Kim
  Cancer Research and Treatment.2021; 53(1): 123.     CrossRef
• Comparison of metastatic castration-resistant prostate cancer in bone with other sites: clinical characteristics, molecular features and immune status
  Zhengquan Xu, Yanhong Ding, Wei Lu, Ke Zhang, Fei Wang, Guanxiong Ding, Jianqing Wang
  PeerJ.2021; 9: e11133.     CrossRef
• High Concordance of Genomic Profiles between Primary and Metastatic Colorectal Cancer
  Seung Eun Lee, Ha Young Park, Dae-Yong Hwang, Hye Seung Han
  International Journal of Molecular Sciences.2021; 22(11): 5561.     CrossRef
• Comprehensive Imaging Characterization of Colorectal Liver Metastases
  Drew Maclean, Maria Tsakok, Fergus Gleeson, David J. Breen, Robert Goldin, John Primrose, Adrian Harris, James Franklin
  Frontiers in Oncology.2021;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• What the Clinician Needs to Know About Laboratory Analyses of Circulating Tumor DNA
  Cecilie Mondrup Jacobsen, Luisa Matos do Canto, Søren Kahns, Torben Frøstrup Hansen, Rikke Fredslund Andersen
  Clinical Colorectal Cancer.2025; 24(2): 109.     CrossRef
• Circulating Tumour DNA for Ovarian Cancer Diagnosis and Treatment Monitoring: What Perspectives for Clinical Use?
  Du-Bois Asante, Domenico Tierno, Gabriele Grassi, Bruna Scaggiante
  International Journal of Molecular Sciences.2025; 26(5): 1889.     CrossRef
• ctDNA as an Objective Marker for Postoperative Residual Disease in Primary Advanced High-Grade Serous Ovarian Cancer
  Valentina Glueck, Christoph Grimm, Magdalena Postl, Christian Brueffer, Nuria Segui, Miguel Alcaide, Lucia Oton, Yilun Chen, Lao H. Saal, Gerda Hofstetter, Stephan Polterauer, Leonhard Muellauer
  Cancers.2025; 17(5): 786.     CrossRef
• Cell-Free DNA (cfDNA) Regulates Metabolic Remodeling in the ES-2 Ovarian Carcinoma Cell Line, Influencing Cell Proliferation, Quiescence, and Chemoresistance in a Cell-of-Origin-Specific Manner
  Isabel Lemos, Catarina Freitas-Dias, Ana Hipólito, José Ramalho, Fabrizio Carteni, Luís G. Gonçalves, Stefano Mazzoleni, Jacinta Serpa
  Metabolites.2025; 15(4): 244.     CrossRef
• Integrating comprehensive genomic profiling in the management of oncology patients: applications and challenges in Taiwan
  Chen-Yang Huang, Wen-Kuan Huang, Kun-Yun Yeh, John Wen-Cheng Chang, Yung-Chang Lin, Wen-Chi Chou
  Biomedical Journal.2025; : 100851.     CrossRef
• Liquid biopsy in gynecological cancers: a translational framework from molecular insights to precision oncology and clinical practice
  Canio Martinelli, Alfredo Ercoli, Giuseppe Vizzielli, Sharon Raffaella Burk, Maria Cuomo, Vrunda Satasiya, Housem Kacem, Simone Braccia, Giulio Mazzarotti, Irene Miriello, Manuela Nana Tchamou, Stefano Restaino, Martina Arcieri, Alice Poli, Veronica Tius,
  Journal of Experimental & Clinical Cancer Research.2025;[Epub]     CrossRef
• Improving cell-free DNA detection in advanced-stage high-grade serous ovarian cancer using combined TP53 mutational status and copy number changes
  Hein S. Zelisse, Ymke van der Pol, Florent Mouliere, Frederike Dijk, Johannes B.G. Halfwerk, Banafsche Mearadji, Ludo F.M. Beenen, Roy J. Reinten, Saskia A.G.M. Cillessen, Gerrit K.J. Hooijer, Malou L.H. Snijders, Marc J. van de Vijver, Mignon D.J.M. van
  Pathology - Research and Practice.2025; 272: 156038.     CrossRef
• Extensive mutational ctDNA profiles reflect High-grade serous cancer tumors and reveal emerging mutations at recurrence
  Giovanni Marchi, Anna Rajavuori, Mai T.N. Nguyen, Kaisa Huhtinen, Sinikka Oksa, Sakari Hietanen, Sampsa Hautaniemi, Johanna Hynninen, Jaana Oikkonen
  Translational Oncology.2024; 39: 101814.     CrossRef
• Current Applications and Challenges of Next-Generation Sequencing in Plasma Circulating Tumour DNA of Ovarian Cancer
  Ricardo Roque, Ilda Patrícia Ribeiro, Margarida Figueiredo-Dias, Charlie Gourley, Isabel Marques Carreira
  Biology.2024; 13(2): 88.     CrossRef
• Serial Circulating Tumor DNA Analysis with a Tumor-Naïve Next-Generation Sequencing Panel Detects Minimal Residual Disease and Predicts Outcome in Ovarian Cancer
  Jinho Heo, Yoo-Na Kim, Saeam Shin, Kyunglim Lee, Ji-Hyun Lee, Yong Jae Lee, Zisun Choi, Jihyang Park, Seungki Min, Sang Wun Kim, Jong Rak Choi, Sunghoon Kim, Seung-Tae Lee, Jung-Yun Lee
  Cancer Research.2024; 84(3): 468.     CrossRef
• Liquid biopsy into the clinics: Current evidence and future perspectives
  Myrto Boukovala, C. Benedikt Westphalen, Victoria Probst
  The Journal of Liquid Biopsy.2024; 4: 100146.     CrossRef
• Cell-free DNA in plasma and ascites as a biomarker of bevacizumab response- a translational research sub-study of the REZOLVE (ANZGOG-1101) clinical trial
  Bonnita Werner, Katrin M Sjoquist, David Espinoza, Sonia Yip, Garry Chang, Michelle M Cummins, Linda Mileshkin, Sumitra Ananda, Catherine Shannon, Michael Friedlander, Kristina Warton, Caroline E. Ford
  Translational Oncology.2024; 43: 101914.     CrossRef
• Clinical relevance of circulating tumor DNA in ovarian cancer: current issues and future opportunities
  Elena Trevisi, Cristiana Sessa, Ilaria Colombo
  Exploration of Targeted Anti-tumor Therapy.2024; 5(3): 627.     CrossRef
• Cell‐free DNA from ascites identifies clinically relevant variants and tumour evolution in patients with advanced ovarian cancer
  Bonnita Werner, Elyse Powell, Jennifer Duggan, Marilisa Cortesi, Yeh Chen Lee, Vivek Arora, Ramanand Athavale, Michael Dean, Kristina Warton, Caroline E. Ford
  Molecular Oncology.2024; 18(11): 2668.     CrossRef
• Phenotyping Tumor Heterogeneity through Proteogenomics: Study Models and Challenges
  Diletta Piana, Federica Iavarone, Elisa De Paolis, Gennaro Daniele, Federico Parisella, Angelo Minucci, Viviana Greco, Andrea Urbani
  International Journal of Molecular Sciences.2024; 25(16): 8830.     CrossRef
• Biomarkers in high grade serous ovarian cancer
  Mark Bates, Bashir M. Mohamed, Faye Lewis, Sharon O’Toole, John J. O’Leary
  Biochimica et Biophysica Acta (BBA) - Reviews on Cancer.2024; 1879(6): 189224.     CrossRef
• Malignant ascites in pancreatic cancer: Pathophysiology, diagnosis, molecular characterization, and therapeutic strategies
  Margaret Y. Han, Erkut H. Borazanci
  Frontiers in Oncology.2023;[Epub]     CrossRef
• Clinical application of liquid biopsy based on circulating tumor DNA in non-small cell lung cancer
  Liu Xin, Yang Yue, Ren Zihan, Cui Youbin, Lu Tianyu, Wang Rui
  Frontiers in Physiology.2023;[Epub]     CrossRef
• Advances in application of circulating tumor DNA in ovarian cancer
  Ting Xia, Chenyan Fang, Yaqing Chen
  Functional & Integrative Genomics.2023;[Epub]     CrossRef
• Minimal residual disease in solid tumors: an overview
  Yarui Ma, Jingbo Gan, Yinlei Bai, Dandan Cao, Yuchen Jiao
  Frontiers of Medicine.2023; 17(4): 649.     CrossRef
• The prognostic impact of peritoneal tumour DNA in gastrointestinal and gynaecological malignancies: a systematic review
  Zexi Allan, Sasha Witts, Jeanne Tie, Niall Tebbutt, Nicholas J. Clemons, David S. Liu
  British Journal of Cancer.2023; 129(11): 1717.     CrossRef
• Homologous recombination deficiency (HRD) testing on cell-free tumor DNA from peritoneal fluid
  Cyril Roussel-Simonin, Felix Blanc-Durand, Roseline Tang, Damien Vasseur, Audrey Le Formal, Laure Chardin, Elisa Yaniz, Sébastien Gouy, Amandine Maulard, Stéphanie Scherier, Claire Sanson, Ludovic Lacroix, Sophie Cotteret, Lea Mauny, François Zaccarini, E
  Molecular Cancer.2023;[Epub]     CrossRef
• Genetic landscape of pancreatic adenocarcinoma patients: a pilot study from Pakistan
  Saleema Mehboob Ali, Yumna Adnan, Zubair Ahmad, Hasnain Ahmed Farooqui, Tabish Chawla, S. M. Adnan Ali
  Molecular Biology Reports.2022; 49(2): 1341.     CrossRef
• Ascites and Serial Plasma Circulating Tumor DNA for Predicting the Effectiveness of Hyperthermic Intraperitoneal Chemotherapy in Patients With Peritoneal Carcinomatosis
  Xiaolin Pu, Zongyuan Li, Xiaoying Wang, Hua Jiang
  Frontiers in Oncology.2022;[Epub]     CrossRef
• Transcending Blood—Opportunities for Alternate Liquid Biopsies in Oncology
  Bonnita Werner, Kristina Warton, Caroline E. Ford
  Cancers.2022; 14(5): 1309.     CrossRef
• Potential clinical utility of liquid biopsies in ovarian cancer
  Jie Wei Zhu, Parsa Charkhchi, Mohammad R. Akbari
  Molecular Cancer.2022;[Epub]     CrossRef
• Whole-Exome Sequencing Reveals Clinical Potential of Circulating Tumor DNA from Peritoneal Fluid and Plasma in Endometrial Cancer
  Hye-Yeon Ju, Jung Yoon Ho, Jun Kang, Soo Young Hur, Sejin Kim, Youn Jin Choi, Mi-Ryung Han
  Cancers.2022; 14(10): 2506.     CrossRef
• Circulating tumour DNA — looking beyond the blood
  Ann Tivey, Matt Church, Dominic Rothwell, Caroline Dive, Natalie Cook
  Nature Reviews Clinical Oncology.2022; 19(9): 600.     CrossRef
• Mutation analysis of circulating tumor DNA and paired ascites and tumor tissues in ovarian cancer
  Xiaoxiang Jie, Ming Du, Meng Zhang, Xiayu Jin, Qingqing Cai, Congjian Xu, Xiaoyan Zhang
  Experimental and Therapeutic Medicine.2022;[Epub]     CrossRef
• Liquid biopsy: current technology and clinical applications
  Mina Nikanjam, Shumei Kato, Razelle Kurzrock
  Journal of Hematology & Oncology.2022;[Epub]     CrossRef
• Circulating Tumor DNA—A Novel Biomarker of Tumor Progression and Its Favorable Detection Techniques
  Xiaosha Wen, Huijie Pu, Quan Liu, Zifen Guo, Dixian Luo
  Cancers.2022; 14(24): 6025.     CrossRef
• Epithelial ovarian cancer and the use of circulating tumor DNA: A systematic review
  Christine Fribert Thusgaard, Malene Korsholm, Kristina Magaard Koldby, Torben A. Kruse, Mads Thomassen, Kirsten Marie Jochumsen
  Gynecologic Oncology.2021; 161(3): 884.     CrossRef
• Cell-free DNA is abundant in ascites and represents a liquid biopsy of ovarian cancer
  Bonnita Werner, Nicole Yuwono, Jennifer Duggan, Dongli Liu, Catherine David, Sivatharsny Srirangan, Pamela Provan, Anna DeFazio, Vivek Arora, Rhonda Farrell, Yeh Chen Lee, Kristina Warton, Caroline Ford
  Gynecologic Oncology.2021; 162(3): 720.     CrossRef
• Prediction of the treatment response in ovarian cancer: a ctDNA approach
  Mina Sharbatoghli, Somayeh Vafaei, Hamidreza Aboulkheyr Es, Mohsen Asadi-Lari, Mehdi Totonchi, Zahra Madjd
  Journal of Ovarian Research.2020;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Prospects of current AXL-targeting therapies in early phase cancer trials
  Juhye Yim, Chloe Hope, Justus M. Huelse, Douglas K. Graham
  Expert Opinion on Investigational Drugs.2025; : 1.     CrossRef
• Biomarker in Hepatocellular Carcinoma
  Pooja Basthi Mohan, Rajiv Lochan, Shiran Shetty
  Indian Journal of Surgical Oncology.2024; 15(S2): 261.     CrossRef
• From MASH to HCC: the role of Gas6/TAM receptors
  Daria Apostolo, Luciana L. Ferreira, Federica Vincenzi, Nicole Vercellino, Rosalba Minisini, Federico Latini, Barbara Ferrari, Michela E. Burlone, Mario Pirisi, Mattia Bellan
  Frontiers in Immunology.2024;[Epub]     CrossRef
• GAS6/TAM Axis as Therapeutic Target in Liver Diseases
  Anna Tutusaus, Albert Morales, Pablo García de Frutos, Montserrat Marí
  Seminars in Liver Disease.2024; 44(01): 099.     CrossRef
• Dynamic changes in immune cell populations by AXL kinase targeting diminish liver inflammation and fibrosis in experimental MASH
  Sturla Magnus Grøndal, Anna Tutusaus, Loreto Boix, Maria Reig, Magnus Blø, Linn Hodneland, Gro Gausdal, Akil Jackson, Pablo Garcia de Frutos, James Bradley Lorens, Albert Morales, Montserrat Marí
  Frontiers in Immunology.2024;[Epub]     CrossRef
• Evaluating soluble Axl as a biomarker for glioblastoma: A pilot study
  Daniel Raymond, Melanie Fukui, Samuel Zwernik, Amin Kassam, Richard Rovin, Parvez Akhtar, Salvatore V. Pizzo
  PLOS ONE.2024; 19(7): e0301739.     CrossRef
• A meta-analysis and of clinical values of 11 blood biomarkers, such as AFP, DCP, and GP73 for diagnosis of hepatocellular carcinoma
  Bing-yao Pang, Yan Leng, Xiaoli Wang, Yi-qiang Wang, Li-hong Jiang
  Annals of Medicine.2023; 55(1): 42.     CrossRef
• Updating the Clinical Application of Blood Biomarkers and Their Algorithms in the Diagnosis and Surveillance of Hepatocellular Carcinoma: A Critical Review
  Endrit Shahini, Giuseppe Pasculli, Antonio Giovanni Solimando, Claudio Tiribelli, Raffaele Cozzolongo, Gianluigi Giannelli
  International Journal of Molecular Sciences.2023; 24(5): 4286.     CrossRef
• AXL in cancer: a modulator of drug resistance and therapeutic target
  Yaoxiang Tang, Hongjing Zang, Qiuyuan Wen, Songqing Fan
  Journal of Experimental & Clinical Cancer Research.2023;[Epub]     CrossRef
• Emerging biomolecules for practical theranostics of liver hepatocellular carcinoma
  Miner Hu, Xiaojun Xia, Lichao Chen, Yunpeng Jin, Zhenhua Hu, Shudong Xia, Xudong Yao
  Annals of Hepatology.2023; 28(6): 101137.     CrossRef
• Gas6 in chronic liver disease—a novel blood-based biomarker for liver fibrosis
  Katharina Staufer, Heidemarie Huber, Jasmin Zessner-Spitzenberg, Rudolf Stauber, Armin Finkenstedt, Heike Bantel, Thomas S. Weiss, Markus Huber, Patrick Starlinger, Thomas Gruenberger, Thomas Reiberger, Susanne Sebens, Gail McIntyre, Ray Tabibiazar, Amato
  Cell Death Discovery.2023;[Epub]     CrossRef
• TAM Receptors in the Pathophysiology of Liver Disease
  Emilio Flint, Evangelos Triantafyllou, Christine Bernsmeier
  Livers.2022; 2(1): 15.     CrossRef
• Prognostic Value of Computed Tomography Texture Features in Patients with Hepatocellular Carcinoma Following Stereotactic Ablative Radiotherapy
  Yufeng Zhu, Jie He, Xingcai Luo
  Iranian Journal of Radiology.2022;[Epub]     CrossRef
• Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease
  Agostino Colli, Tin Nadarevic, Damir Miletic, Vanja Giljaca, Mirella Fraquelli, Davor Štimac, Giovanni Casazza
  Cochrane Database of Systematic Reviews.2021;[Epub]     CrossRef
• Accelerating AXL targeting for TNBC therapy
  Lohit Khera, Sima Lev
  The International Journal of Biochemistry & Cell Biology.2021; 139: 106057.     CrossRef
• Hepatocellular Carcinoma in 2021: An Exhaustive Update
  Cyriac A Philips, Sasidharan Rajesh, Dinu C Nair, Rizwan Ahamed, Jinsha K Abduljaleel, Philip Augustine
  Cureus.2021;[Epub]     CrossRef
• AXL Knock-Out in SNU475 Hepatocellular Carcinoma Cells Provides Evidence for Lethal Effect Associated with G2 Arrest and Polyploidization
  Tugce Batur, Ayse Argundogan, Umur Keles, Zeynep Mutlu, Hani Alotaibi, Serif Senturk, Mehmet Ozturk
  International Journal of Molecular Sciences.2021; 22(24): 13247.     CrossRef
• New Blood Biomarkers for the Diagnosis of AFP-Negative Hepatocellular Carcinoma
  Ting Wang, Kun-He Zhang
  Frontiers in Oncology.2020;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Exploring miRNA profile associated with cisplatin resistance in ovarian cancer cells
  Yaman Alghamian, Chadi Soukkarieh, Abdulmunim Aljapawe, Hossam Murad
  Biochemistry and Biophysics Reports.2025; 41: 101906.     CrossRef
• Long Non-Coding RNAs in Ovarian Cancer: Mechanistic Insights and Clinical Applications
  Sneha Basu, Revathy Nadhan, Danny N. Dhanasekaran
  Cancers.2025; 17(3): 472.     CrossRef
• Downregulation of LncRNA CCAT1 Enhances Chemosensitivity in Cisplatin‐Resistant Gastric Cancer Cells
  Qiong Wu, Chenglou Zhu, Tiantian Zhao, Tianxiang Liu, Mingxu Da
  Drug Development Research.2025;[Epub]     CrossRef
• Latest Update on lncRNA in Epithelial Ovarian Cancer—A Scoping Review
  Katarzyna Kwas, Maria Szubert, Jacek Radosław Wilczyński
  Cells.2025; 14(7): 555.     CrossRef
• USP43 impairs cisplatin sensitivity in epithelial ovarian cancer through HDAC2-dependent regulation of Wnt/β-catenin signaling pathway
  Lipeng Pei, Feng Zhao, Yi Zhang
  Apoptosis.2024; 29(1-2): 210.     CrossRef
• BIRC5 facilitates cisplatin‐chemoresistance in a m6A‐dependent manner in ovarian cancer
  Yadan Fan, Yinglian Pan, Liping Jia, Shuzhen Gu, Binxin Liu, Ziman Mei, Chunyan Lv, Haohao Huang, Genhai Zhu, Qingchun Deng
  Cancer Medicine.2024;[Epub]     CrossRef
• CCAT1 lncRNA is chromatin-retained and post-transcriptionally spliced
  Chaya Bohrer, Eli Varon, Eldar Peretz, Gita Reinitz, Noa Kinor, David Halle, Aviram Nissan, Yaron Shav-Tal
  Histochemistry and Cell Biology.2024; 162(1-2): 91.     CrossRef
• Novel players in the development of chemoresistance in ovarian cancer: ovarian cancer stem cells, non-coding RNA and nuclear receptors
  Shahil Alam, Pankaj Kumar Giri
  Cancer Drug Resistance.2024;[Epub]     CrossRef
• The roles of long non-coding RNAs in ovarian cancer: from functions to therapeutic implications
  Zhong Hu, Lijin Yuan, Xiu Yang, Cunjian Yi, Jinzhi Lu
  Frontiers in Oncology.2024;[Epub]     CrossRef
• Proto-oncogene c-Myb potentiates cisplatin resistance of ovarian cancer cells by downregulating lncRNA NKILA and modulating cancer stemness and LIN28A-let7 axis
  Xue-Yan Zhang, Bo-Chi Zhu, Miao He, Shan-Shan Dong
  Journal of Ovarian Research.2024;[Epub]     CrossRef
• Drug resistance biomarkers in ovarian cancer: a bibliometric study from 2017 to 2022
  Sindy Cabarca, Carmen Ili, Carlos Vanegas, Laura Gil, Melba Vertel-Morrinson, Priscilla Brebi
  Frontiers in Oncology.2024;[Epub]     CrossRef
• Targeting miRNAs and Other Non-Coding RNAs as a Therapeutic Approach: An Update
  Emine Bayraktar, Recep Bayraktar, Hulya Oztatlici, Gabriel Lopez-Berestein, Paola Amero, Cristian Rodriguez-Aguayo
  Non-Coding RNA.2023; 9(2): 27.     CrossRef
• Silencing of NLRP3 Sensitizes Chemoresistant Ovarian Cancer Cells to Cisplatin
  Weijia Li, Xibo Zhao, Rujian Zhang, Jiabin Xie, Guangmei Zhang, Jinghua Pan
  Mediators of Inflammation.2023; 2023: 1.     CrossRef
• Long Noncoding RNAs in Ovarian Cancer—Functions and Clinical Applications
  Lili Zhong, Xin Li, Yicun Wang, Bin Liu, Xiangfu Ding, Yinlong Zhao
  Frontiers in Bioscience-Landmark.2023;[Epub]     CrossRef
• Sporoderm-Broken Spores of Ganoderma lucidum Sensitizes Ovarian Cancer to Cisplatin by ROS/ERK Signaling and Attenuates Chemotherapy-Related Toxicity
  Kaili Cen, Ming Chen, Mengye He, Zhenhao Li, Yinjing Song, Pu Liu, Qi Jiang, Suzhen Xu, Yunlu Jia, Peng Shen
  Frontiers in Pharmacology.2022;[Epub]     CrossRef
• Gomisin J attenuates cerebral ischemia/reperfusion injury by inducing anti-apoptotic, anti-inflammatory, and antioxidant effects in rats
  Xiaoli Min, Linping Zhao, Ying Shi, Jian Wang, Hongling Lv, Xiaoxiao Song, Qunyuan Zhao, Qing Zhao, Rui Jing, Jiayi Hu
  Bioengineered.2022; 13(3): 6908.     CrossRef
• MicroRNA as a Potential Therapeutic Molecule in Cancer
  Joanna Szczepanek, Monika Skorupa, Andrzej Tretyn
  Cells.2022; 11(6): 1008.     CrossRef
• LncRNA CCAT1 enhances chemoresistance in hepatocellular carcinoma by targeting QKI-5
  Chongsheng Xia, Yurui Sun, Yang Li, Junli Ma, Jing Shi
  Scientific Reports.2022;[Epub]     CrossRef
• Non-coding RNA in cancer drug resistance: Underlying mechanisms and clinical applications
  Xuehao Zhou, Xiang Ao, Zhaojun Jia, Yiwen Li, Shouxiang Kuang, Chengcheng Du, Jinyu Zhang, Jianxun Wang, Ying Liu
  Frontiers in Oncology.2022;[Epub]     CrossRef
• miR-21 Targets Long Noncoding RNA PCAT29 to Promote Cell Proliferation in Neuroblastoma
  Zhong Jiang, Xianjun Zhou, Lulu Han, Fujiang Li, Xiwei Hao, Qian Dong, Xin Chen
  Critical Reviews in Eukaryotic Gene Expression.2022; 32(8): 1.     CrossRef
• Long noncoding RNAs as therapeutic targets to overcome chemoresistance in ovarian cancer
  Linjiao Chen, Jie Wang, Qian Liu
  Frontiers in Cell and Developmental Biology.2022;[Epub]     CrossRef
• LINC00184 Promotes Ovarian Cancer Cells Proliferation and Cisplatin Resistance by Elevating CNTN1 Expression via Sponging miR-1305
  Yuwen Han, Jun You, Yun Han, Yinglei Liu, Menghui Huang, Xiaoyan Lu, Jingjing Chen, Yanli Zheng
  OncoTargets and Therapy.2021; Volume 14: 2711.     CrossRef
• LncRNA CCAT1 downregulation increases the radiosensitivity of non‐small cell lung cancer cells
  Zhao Wang
  The Kaohsiung Journal of Medical Sciences.2021; 37(8): 654.     CrossRef
• Long noncoding RNA HULC contributes to paclitaxel resistance in ovarian cancer via miR-137/ITGB8 axis
  Bo Huang, Min Wei, Li Hong
  Open Life Sciences.2021; 16(1): 667.     CrossRef
• HOTTIP-miR-205-ZEB2 Axis Confers Cisplatin Resistance to Ovarian Cancer Cells
  Yu-Jie Dong, Wei Feng, Yan Li
  Frontiers in Cell and Developmental Biology.2021;[Epub]     CrossRef
• circ_C20orf11 enhances DDP resistance by inhibiting miR-527/YWHAZ through the promotion of extracellular vesicle-mediated macrophage M2 polarization in ovarian cancer
  Jun Yin, Hai-Yan Huang, Ying Long, Yan Ma, Maerkeya Kamalibaike, Reyanguli Dawuti, Li Li
  Cancer Biology & Therapy.2021; 22(7-9): 440.     CrossRef
• The Emerging Role of Non-coding RNAs in Drug Resistance of Ovarian Cancer
  Hua Lan, Jing Yuan, Da Zeng, Chu Liu, Xiaohui Guo, Jiahui Yong, Xiangyang Zeng, Songshu Xiao
  Frontiers in Genetics.2021;[Epub]     CrossRef
• MicroRNAs as the critical regulators of Cisplatin resistance in ovarian cancer cells
  Meysam Moghbeli
  Journal of Ovarian Research.2021;[Epub]     CrossRef
• The Non-Coding RNAs Inducing Drug Resistance in Ovarian Cancer: A New Perspective for Understanding Drug Resistance
  Gaofeng Li, Jun Gong, Shulong Cao, Zhaoyang Wu, Dong Cheng, Jia Zhu, Xuqun Huang, Jingyi Tang, Yuning Yuan, Wenqi Cai, Haiyuan Zhang
  Frontiers in Oncology.2021;[Epub]     CrossRef
• Analyzing the whole-transcriptome profiles of ncRNAs and predicting the competing endogenous RNA networks in cervical cancer cell lines with cisplatin resistance
  Huimin Lv, Shanshan Jin, Binbin Zou, Yuxiang Liang, Jun Xie, Suhui Wu
  Cancer Cell International.2021;[Epub]     CrossRef
• Study of Neuronal Apoptosis ceRNA Network in Hippocampal Sclerosis of Human Temporal Lobe Epilepsy by RNA-Seq
  Shengkun Yu, Yifei Gu, Tianyu Wang, Long Mu, Haiyang Wang, Shi Yan, Aoweng Wang, Jiabin Wang, Li Liu, Hong Shen, Meng Na, Zhiguo Lin
  Frontiers in Neuroscience.2021;[Epub]     CrossRef
• Crosstalk of Long Non-coding RNAs and EMT: Searching the Missing Pieces of an Incomplete Puzzle for Lung Cancer Therapy
  Milad Ashrafizadeh, Md Shahinozzaman, Sima Orouei, Vahideh Zarrin, Kiavash Hushmandi, Farid Hashemi, Anuj Kumar, Saeed Samarghandian, Masoud Najafi, Ali Zarrabi
  Current Cancer Drug Targets.2021; 21(8): 640.     CrossRef
• The Challenges and Opportunities of LncRNAs in Ovarian Cancer Research and Clinical Use
  Martín Salamini-Montemurri, Mónica Lamas-Maceiras, Aida Barreiro-Alonso, Ángel Vizoso-Vázquez, Esther Rodríguez-Belmonte, María Quindós-Varela, María Esperanza Cerdán
  Cancers.2020; 12(4): 1020.     CrossRef
• Knockdown of long non-coding RNA HOTAIR reverses cisplatin resistance of ovarian cancer cells through inhibiting miR-138-5p-regulated EZH2 and SIRT1
  Yun Zhang, Hao Ai, Xue Fan, Suxian Chen, Yadi Wang, Lili Liu
  Biological Research.2020;[Epub]     CrossRef
• miR-454 suppresses the proliferation and invasion of ovarian cancer by targeting E2F6
  Yunhe An, Jun Zhang, Xiaoyan Cheng, Baoming Li, Yanjie Tian, Xiaoli Zhang, Fangqi Zhao
  Cancer Cell International.2020;[Epub]     CrossRef

• Elevated mRNA Expression Levels of NCAPG are Associated with Poor Prognosis in Ovarian Cancer

  
  Tao Xu, Menglu Dong, Zhi Wang, Hanning Li, Xingrui Li
  Cancer Management and Research.2020; Volume 12: 5773.     CrossRef
• Back to the Future: Rethinking the Great Potential of lncRNAS for Optimizing Chemotherapeutic Response in Ovarian Cancer
  Abdelrahman M. Elsayed, Paola Amero, Salama A. Salama, Abdelaziz H. Abdelaziz, Gabriel Lopez-Berestein, Cristian Rodriguez-Aguayo
  Cancers.2020; 12(9): 2406.     CrossRef
• LncRNAs in Ovarian Cancer Progression, Metastasis, and Main Pathways: ceRNA and Alternative Mechanisms
  Eleonora A. Braga, Marina V. Fridman, Alexey A. Moscovtsev, Elena A. Filippova, Alexey A. Dmitriev, Nikolay E. Kushlinskii
  International Journal of Molecular Sciences.2020; 21(22): 8855.     CrossRef

Citations

Citations to this article as recorded by  

• Integrative analysis of proteomics and lipidomic profiles reveal the fat deposition and meat quality in Duroc × Guangdong small spotted pig
  Zhuosui Wu, Zhonggang Wang, Pan Wang, Leiyan Cheng, Jianhao Li, Yanfeng Luo, Linfang Yang, Linfeng Li, Jianhua Zeng, Bin Hu
  Frontiers in Veterinary Science.2024;[Epub]     CrossRef
• The G Protein-Coupled Estrogen Receptor GPER in the Development and Progression of Cancer
  Liliana Torres-López, Miguel Olivas-Aguirre, Oxana Dobrovinskaya
  Receptors.2024; 3(2): 220.     CrossRef
• ACSL4-Mediated Membrane Phospholipid Remodeling Induces Integrin β1 Activation to Facilitate Triple-Negative Breast Cancer Metastasis
  Yuxiang Qiu, Xing Wang, Yan Sun, Ting Jin, Rui Tang, Xinyue Zhou, Ming Xu, Yubi Gan, Rui Wang, Haojun Luo, Manran Liu, Xi Tang
  Cancer Research.2024; 84(11): 1856.     CrossRef
• The Role of Estrogen across Multiple Disease Mechanisms
  Xiuting Xiang, Praneetha Palasuberniam, Rahmawati Pare
  Current Issues in Molecular Biology.2024; 46(8): 8170.     CrossRef
• Role of Estrogen Receptor β, G-Protein Coupled Estrogen Receptor and Estrogen-Related Receptors in Endometrial and Ovarian Cancer
  Susanne Schüler-Toprak, Maciej Skrzypczak, Carsten Gründker, Olaf Ortmann, Oliver Treeck
  Cancers.2023; 15(10): 2845.     CrossRef
• Divergent Metabolic Effects of Metformin Merge to Enhance Eicosapentaenoic Acid Metabolism and Inhibit Ovarian Cancer In Vivo
  Mary P. Udumula, Laila M. Poisson, Indrani Dutta, Nivedita Tiwari, Seongho Kim, Jasdeep Chinna-Shankar, Ghassan Allo, Sharif Sakr, Miriana Hijaz, Adnan R. Munkarah, Shailendra Giri, Ramandeep Rattan
  Cancers.2022; 14(6): 1504.     CrossRef
• Functional metabolomics revealed functional metabolic-characteristics of chronic hepatitis that is significantly differentiated from acute hepatitis in mice
  Tianyu Wang, Longlong Hu, Jiongjiong Lu, Mengqing Xiao, Jinging Liu, Huiyu Xia, Haitao Lu
  Pharmacological Research.2022; 180: 106248.     CrossRef
• Effects of Omega-3 Intake on Adolescent Health
  Xiuyuan Zhang
  Highlights in Science, Engineering and Technology.2022; 19: 89.     CrossRef
• Determination of lipid profiles of Dezhou donkey meat using an LC‐MS‐based lipidomics method
  Mengmeng Li, Mingxia Zhu, Wenqiong Chai, Yonghui Wang, Dongmei Fan, Mengqing Lv, Xiaojing Jiang, Yongxiang Liu, Qingxin Wei, Changfa Wang
  Journal of Food Science.2021; 86(10): 4511.     CrossRef
• Connexins and cAMP Cross-Talk in Cancer Progression and Metastasis
  Chang-Xu Chen, Kai-Jun Luo, Jia-Peng Yang, Yun-Chao Huang, Eduardo R. Cardenas, Bruce J. Nicholson, Jean X. Jiang
  Cancers.2020; 13(1): 58.     CrossRef

Citations

Citations to this article as recorded by  

• Chronic Stress‐Induced and Tumor Derived SP1+ Exosomes Polarizing IL‐1β+ Neutrophils to Increase Lung Metastasis of Breast Cancer
  Leyi Zhang, Jun Pan, Meijun Wang, Jini Yang, Sangsang Zhu, Lili Li, Xiaoxiao Hu, Zhen Wang, Liwei Pang, Peng Li, Fang Jia, Guohong Ren, Yi Zhang, Danying Xu, Fuming Qiu, Jian Huang
  Advanced Science.2025;[Epub]     CrossRef
• Unraveling the peripheral nervous System's role in tumor: A Double-edged Sword
  Yan-Hao Wang, Xuan Yang, Cui-Cui Liu, Xin Wang, Ke-Da Yu
  Cancer Letters.2025; 611: 217451.     CrossRef
• Stress regulatory hormones and cancer: the contribution of epinephrine and cancer therapeutic value of beta blockers
  Rajan Kumar Tiwari, Shiv Govind Rawat, Siddharth Rai, Ajay Kumar
  Endocrine.2025; 88(2): 359.     CrossRef
• The neuroscience in breast cancer: Current insights and clinical opportunities
  Jia-feng Wang, Meng-chuan Wang, Lei-lei Jiang, Neng-ming Lin
  Heliyon.2025; 11(3): e42293.     CrossRef
• PCBP2 as an intrinsic agi ng factor regulates the senescence of hBMSCs through the ROS-FGF2 signaling axis
  Pengbo Chen, Bo Li, Zeyu Lu, Qingyin Xu, Huoliang Zheng, Shengdan Jiang, Leisheng Jiang, Xinfeng Zheng
  eLife.2025;[Epub]     CrossRef
• Mammary stem cells: molecular cues, orchestrated regulatory mechanisms and its implications in breast cancer
  Mengna Zhang, Lingxian Zhang, Jie Liu, Jiahui Zhao, Jiayu Mei, Jiahua Zou, Yaogan Luo, Cheguo Cai
  Journal of Genetics and Genomics.2025;[Epub]     CrossRef
• Research progress on the role of reactive oxygen species in the initiation, development and treatment of breast cancer
  Jing Zhong, Yan Tang
  Progress in Biophysics and Molecular Biology.2024; 188: 1.     CrossRef
• Inhibition of β2-adrenergic receptor regulates necroptosis in prostate cancer cell
  Shiqi Wu, Meixi Li, Fangfang Chen, Yan Zeng, Chen Xu
  Heliyon.2024; 10(11): e31865.     CrossRef
• The place of beta-adrenergic receptor blockers in the treatment of arterial hypertension: From bench-to-bedside
  Ashot Avagimyan, Nana Kajaia, Luiza Gabunia, Artem Trofimenko, Nodar Sulashvili, Tamar Sanikidze, Nana Gorgaslidze, Abhiram Challa, Mohammad Sheibani
  Current Problems in Cardiology.2024; 49(10): 102734.     CrossRef
• Using heart rate variability to evaluate the association between the autonomic nervous system and coagulation function in patients with endometrial cancer
  Yongqiang Wang, Weizheng Guan, Yifang Zhang, Yuling Wang, Bo Shi, Jian Liu, Sai Zhang
  Oncology Letters.2024;[Epub]     CrossRef
• Deeply Saddening Life Events Play a Carcinogenic Role by Inducing Mutations in ALOX12 and FKBP5 Genes
  Ahmet Kutluhan, Osman Z. Topak, Hakan Akca, Elvan Tokgun, Osman I. Ozdel, Sevda Yilmaz, Ugur Sungurtekin, Ergun Erdem, Arzu Yaren
  Genes.2024; 15(12): 1531.     CrossRef
• The Different Effects of Noradrenaline on Rhabdomyosarcoma and Ewing’s Sarcoma Cancer Hallmarks—Implications for Exercise Oncology
  Peter Weeber, Stephanie Bremer, Jonas Haferanke, Carla Regina, Martin Schönfelder, Henning Wackerhage, Irene von Luettichau
  Onco.2024; 4(4): 397.     CrossRef
• The β3‐Adrenergic Receptor: Structure, Physiopathology of Disease, and Emerging Therapeutic Potential
  Julius T. Dongdem, Axandrah E. Etornam, Solomon Beletaa, Issah Alidu, Hassan Kotey, Cletus A. Wezena, Alamgir Ahmad Dar
  Advances in Pharmacological and Pharmaceutical Sciences.2024;[Epub]     CrossRef
• Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer
  Shan Liu, Xingda Zhang, Wenzheng Wang, Xue Li, Xue Sun, Yuqian Zhao, Qi Wang, Yingpu Li, Fangjie Hu, He Ren
  Molecular Cancer.2024;[Epub]     CrossRef
• Sympathetic nerve signals: orchestrators of mammary development and stem cell vitality
  Zi Ye, Yu Xu, Mengna Zhang, Cheguo Cai, Zhen-Ge Luo
  Journal of Molecular Cell Biology.2024;[Epub]     CrossRef
• Activation of β-Adrenoceptors Promotes Lipid Droplet Accumulation in MCF-7 Breast Cancer Cells via cAMP/PKA/EPAC Pathways
  Dany Silva, Katarzyna Kacprzak, Clara Quintas, Jorge Gonçalves, Paula Fresco
  International Journal of Molecular Sciences.2023; 24(1): 767.     CrossRef
• Neuroepithelial Interactions in Cancer
  Gustavo Ayala
  Annual Review of Pathology: Mechanisms of Disease.2023; 18(1): 493.     CrossRef
• Chronic stress in solid tumor development: from mechanisms to interventions
  Jiajing Yan, Yibing Chen, Minhua Luo, Xinyu Hu, Hongsheng Li, Quentin Liu, Zhengzhi Zou
  Journal of Biomedical Science.2023;[Epub]     CrossRef
• Transcriptomic profiles‐based approach to decode the role of miR‐122 in triple negative breast cancer
  Mauricio Flores Fortis, Isidro X. Perez Añorve, Oscar del Moral Hernandez, Nicolas Villegas, Elena Arechaga Ocampo
  Genes, Chromosomes and Cancer.2023; 62(7): 392.     CrossRef
• Nervous regulation: beta-2-adrenergic signaling in immune homeostasis, cancer immunotherapy, and autoimmune diseases
  Sagarina Thapa, Xuefang Cao
  Cancer Immunology, Immunotherapy.2023; 72(8): 2549.     CrossRef
• PPARG: A Promising Therapeutic Target in Breast Cancer and Regulation by Natural Drugs
  De-Hui Li, Xu-Kuo Liu, Xiao-Tong Tian, Fei Liu, Xu-Jiong Yao, Jing-Fei Dong, Yongqiang Gao
  PPAR Research.2023; 2023: 1.     CrossRef
• The Expression of Trace Amine-Associated Receptors (TAARs) in Breast Cancer Is Coincident with the Expression of Neuroactive Ligand–Receptor Systems and Depends on Tumor Intrinsic Subtype
  Anastasia N. Vaganova, Daria D. Maslennikova, Valeria V. Konstantinova, Evgeny V. Kanov, Raul R. Gainetdinov
  Biomolecules.2023; 13(9): 1361.     CrossRef
• The stress connection in cancer: the adrenergic fuelling of breast tumors
  Angela Albitre, Clara Reglero, Teresa González-Muñoz, Petronila Penela
  Current Opinion in Physiology.2023; 36: 100720.     CrossRef
• β‑adrenergic receptor activation promotes the proliferation of HepG2 cells via the ERK1/2/CREB pathways
  Xingcheng Lin, Jingjing He, Fuhong Liu, Lehui Li, Longhua Sun, Liyan Niu, Haolin Xi, Yuan Zhan, Xiaohua Liu, Ping Hu
  Oncology Letters.2023;[Epub]     CrossRef
• Investigating the crosstalk between chronic stress and immune cells: implications for enhanced cancer therapy
  YongRong Lei, Fenghui Liao, YiChen Tian, YaNi Wang, Feng Xia, JianHua Wang
  Frontiers in Neuroscience.2023;[Epub]     CrossRef
• Psychological intervention to treat distress: An emerging frontier in cancer prevention and therapy
  Mei Yang, Zhe Zhang, Edouard C. Nice, Chuang Wang, Wei Zhang, Canhua Huang
  Biochimica et Biophysica Acta (BBA) - Reviews on Cancer.2022; 1877(1): 188665.     CrossRef
• Contribution of adrenergic mechanisms for the stress‐induced breast cancer carcinogenesis
  Dany Silva, Clara Quintas, Jorge Gonçalves, Paula Fresco
  Journal of Cellular Physiology.2022; 237(4): 2107.     CrossRef
• Biobehavioral Pathways and Cancer Progression: Insights for Improving Well-Being and Cancer Outcomes
  Aeson Chang, Erica K. Sloan, Michael H. Antoni, Jennifer M. Knight, Rachel Telles, Susan K. Lutgendorf
  Integrative Cancer Therapies.2022;[Epub]     CrossRef
• Stress and cancer: The mechanisms of immune dysregulation and management
  Yixin Liu, Sheng Tian, Biao Ning, Tianhe Huang, Yi Li, Yongchang Wei
  Frontiers in Immunology.2022;[Epub]     CrossRef
• Crosstalk between the peripheral nervous system and breast cancer influences tumor progression
  Jianming Hu, Wuzhen Chen, Lesang Shen, Zhigang Chen, Jian Huang
  Biochimica et Biophysica Acta (BBA) - Reviews on Cancer.2022; 1877(6): 188828.     CrossRef
• DHA- and EPA-Enriched Phosphatidylcholine Suppress Human Lung Carcinoma 95D Cells Metastasis via Activating the Peroxisome Proliferator-Activated Receptor γ
  Haowen Yin, Yuanyuan Liu, Hao Yue, Yingying Tian, Ping Dong, Changhu Xue, Yun-Tao Zhao, Zifang Zhao, Jingfeng Wang
  Nutrients.2022; 14(21): 4675.     CrossRef
• Sympathetic activity in breast cancer and metastasis: partners in crime
  Francisco Conceição, Daniela M. Sousa, Joana Paredes, Meriem Lamghari
  Bone Research.2021;[Epub]     CrossRef
• Molecular Dambusters: What Is Behind Hyperpermeability in Bradykinin-Mediated Angioedema?
  Márta L. Debreczeni, Zsuzsanna Németh, Erika Kajdácsi, Henriette Farkas, László Cervenak
  Clinical Reviews in Allergy & Immunology.2021; 60(3): 318.     CrossRef
• Chewing Behavior Attenuates the Tumor Progression-Enhancing Effects of Psychological Stress in a Breast Cancer Model Mouse
  Qian Zhou, Masahisa Katano, Jia-He Zhang, Xiao Liu, Ke-Yong Wang, Mitsuo Iinuma, Kin-ya Kubo, Kagaku Azuma
  Brain Sciences.2021; 11(4): 479.     CrossRef
• Chronic Stress Effects on Tumor: Pathway and Mechanism
  Hanqing Hong, Min Ji, Dongmei Lai
  Frontiers in Oncology.2021;[Epub]     CrossRef
• Chronic Stress: Impacts on Tumor Microenvironment and Implications for Anti-Cancer Treatments
  Wentao Tian, Yi Liu, Chenghui Cao, Yue Zeng, Yue Pan, Xiaohan Liu, Yurong Peng, Fang Wu
  Frontiers in Cell and Developmental Biology.2021;[Epub]     CrossRef
• A Systematic Review on the Role of Adrenergic Receptors in Angiogenesis Regulation in Health and Disease
  Athanasios Xanthopoulos, Iliana Daskalopoulou, Sofia Frountzi, Evangelia Papadimitriou
  International Journal of Translational Medicine.2021; 1(3): 353.     CrossRef
• An Intracellular Tripeptide Arg-His-Trp of Serum Origin Detected in MCF-7 Cells is a Possible Agonist to β2 Adrenoceptor
  Hritik Chandore, Ajay Kumar Raj, Kiran Bharat Lokhande, Krishna Venkateswara Swamy, Jayanta Kumar Pal, Nilesh Kumar Sharma
  Protein & Peptide Letters.2021; 28(10): 1191.     CrossRef
• Cancer and stress: NextGen strategies
  Bai Cui, Fei Peng, Jinxin Lu, Bin He, Qitong Su, Huandong Luo, Ziqian Deng, Tonghui Jiang, Keyu Su, Yanping Huang, Zaheer Ud Din, Eric W.-F. Lam, Keith W. Kelley, Quentin Liu
  Brain, Behavior, and Immunity.2021; 93: 368.     CrossRef
• RETRACTED ARTICLE: β adrenergic receptor modulated signaling in glioma models: promoting β adrenergic receptor-β arrestin scaffold-mediated activation of extracellular-regulated kinase 1/2 may prove to be a panacea in the treatment of intracranial and spi
  George Zaki Ghali, Michael George Zaki Ghali
  Molecular Biology Reports.2020; 47(6): 4631.     CrossRef
• Natural and Synthetic PPARγ Ligands in Tumor Microenvironment: A New Potential Strategy against Breast Cancer
  Giuseppina Augimeri, Luca Gelsomino, Pierluigi Plastina, Cinzia Giordano, Ines Barone, Stefania Catalano, Sebastiano Andò, Daniela Bonofiglio
  International Journal of Molecular Sciences.2020; 21(24): 9721.     CrossRef

Citations

Citations to this article as recorded by  

• Integration of lipidomics with targeted, single cell, and spatial transcriptomics defines an unresolved pro-inflammatory state in colon cancer
  Ramani Soundararajan, Michelle M Maurin, Jetsen Rodriguez-Silva, Gunjan Upadhyay, Ashley J Alden, Siddabasave Gowda B Gowda, Michael J Schell, Mingli Yang, Noah Jhad Levine, Divyavani Gowda, Punith M Sundaraswamy, Shu-Ping Hui, Lance Pflieger, Heiman Wang
  Gut.2025; 74(4): 586.     CrossRef
• Causal Relationship between Omega-6/Omega-3 Fatty Acid Ratio and Risk of Lung Cancer: A Mendelian Randomization Study Base on A European Cohort
  Yue Li, Jun Liu, Guosheng Li, Guanqiang Yan, Xiang Gao, Longqian Wei, Guiyu Feng, Zhanyu Xu, Nuo Yang, Huafu Zhou
  Nutrition and Cancer.2025; 77(6): 666.     CrossRef
• Dietary intake and tissue biomarkers of omega-6 fatty acids and risk of colorectal cancer in adults: a systematic review and dose-response meta-analysis of prospective cohort studies
  Negin Atashi, Niloofar Eshaghian, Javad Anjom-Shoae, Gholamreza Askari, Masoomeh Asadi, Omid Sadeghi
  Nutrition & Diabetes.2025;[Epub]     CrossRef
• Associations between diet and nutritional supplements and colorectal cancer: A systematic review
  Maryam Gholamalizadeh, Shirin Tajadod, Nazanin Majidi, Zohreh Aghakhaninejad, Zahra Mahmoudi, Zahra Mousavi, Arezoo Amjadi, Farkhondeh Alami, Mahdie Torkaman, Zahra Saeedirad, Saeid Doaei, Hanieh Shafaei, Naser Kalantari
  JGH Open.2024;[Epub]     CrossRef
• Adherence to the Mediterranean diet and its protective effects against colorectal cancer: a meta-analysis of 26 studies with 2,217,404 participants
  Zoltan Ungvari, Mónika Fekete, János Tibor Fekete, Giuseppe Grosso, Anna Ungvari, Balázs Győrffy
  GeroScience.2024; 47(1): 1105.     CrossRef
• A higher dietary alpha-linolenic acid intake is associated with lower colorectal cancer risk based on MUC4 rs2246901 variant among Korean adults
  Ha Thi Mien Nguyen, Madhawa Gunathilake, Jeonghee Lee, Jae Hwan Oh, Hee Jin Chang, Dae Kyung Sohn, Aesun Shin, Jeongseon Kim
  Nutrition Research.2024; 131: 71.     CrossRef
• Association between dietary intake of n‐3 polyunsaturated fatty acids and risk of colorectal cancer in the Japanese population: The Japan Collaborative Cohort Study
  Ayako Kato, Chika Okada, Ehab S. Eshak, Hiroyasu Iso, Akiko Tamakoshi
  Cancer Medicine.2023; 12(4): 4690.     CrossRef
• Serum levels of n-3 PUFA and colorectal cancer risk in Chinese population
  Dan-Dan Shi, Yu-Jing Fang, Yi-Ling Jiang, Ting Dong, Zhuo-Lin Zhang, Ting Ma, Ruo-Lin Zhou, Qing-Jian Ou, Cai-Xia Zhang
  British Journal of Nutrition.2023; 130(7): 1239.     CrossRef
• Anti-Inflammatory and Immune Properties of Polyunsaturated Fatty Acids (PUFAs) and Their Impact on Colorectal Cancer (CRC) Prevention and Treatment
  Alireza Tojjari, Khalil Choucair, Arezoo Sadeghipour, Azhar Saeed, Anwaar Saeed
  Cancers.2023; 15(17): 4294.     CrossRef
• Nutritional Issues for Colorectal Cancer Prevention
  Soyeon Jeong, Jung Ho Kim
  Journal of Digestive Cancer Research.2023; 11(2): 77.     CrossRef
• Omega-3 polyunsaturated fatty acids: moving towards precision use for prevention and treatment of colorectal cancer
  Joanna Aldoori, Andrew J Cockbain, Giles J Toogood, Mark A Hull
  Gut.2022; 71(4): 822.     CrossRef
• Inverse Association between Canned Fish Consumption and Colorectal Cancer Risk: Analysis of Two Large Case–Control Studies
  Carlotta Franchi, Ilaria Ardoino, Cristina Bosetti, Eva Negri, Diego Serraino, Anna Crispo, Attilio Giacosa, Elena Fattore, Alberto Dolci, Francesca Bravi, Federica Turati, Carlo La Vecchia, Barbara D’Avanzo
  Nutrients.2022; 14(8): 1663.     CrossRef
• Association of Dietary Intake and Biomarker of α-Linolenic Acid With Incident Colorectal Cancer: A Dose-Response Meta-Analysis of Prospective Cohort Studies
  Ze-Bin Dai, Xiao-Li Ren, Yi-Lang Xue, Ya Tian, Bing-Bing He, Chang-Long Xu, Bo Yang
  Frontiers in Nutrition.2022;[Epub]     CrossRef
• Association between Dietary Fatty Acid Patterns and Colorectal Cancer Risk: A Large-Scale Case-Control Study in China
  Kexin Tu, Ting Ma, Ruolin Zhou, Lei Xu, Yujing Fang, Caixia Zhang
  Nutrients.2022; 14(20): 4375.     CrossRef
• Evaluation of the ability of fatty acid metabolism signature to predict response to neoadjuvant chemoradiotherapy and prognosis of patients with locally advanced rectal cancer
  Han Zhou, Yanping Chen, Yu Xiao, Qian Wu, Hui Li, Yi Li, Guangjian Su, Longfeng Ke, Junxin Wu, Jinluan Li
  Frontiers in Immunology.2022;[Epub]     CrossRef
• Dietary fatty acids and colorectal cancer risk in men: A report from the Shanghai Men's Health Study and a meta‐analysis
  Sang Nguyen, Honglan Li, Danxia Yu, Hui Cai, Jing Gao, Yutang Gao, Hung N. Luu, Huong Tran, Yong‐Bing Xiang, Wei Zheng, Xiao‐Ou Shu
  International Journal of Cancer.2021; 148(1): 77.     CrossRef
• Relationship between microsatellite status and immune microenvironment of colorectal cancer and its application to diagnosis and treatment
  Junge Bai, Hongsheng Chen, Xuefeng Bai
  Journal of Clinical Laboratory Analysis.2021;[Epub]     CrossRef
• The Role of Pro-Resolving Lipid Mediators in Colorectal Cancer-Associated Inflammation: Implications for Therapeutic Strategies
  Federica Ungaro, Silvia D’Alessio, Silvio Danese
  Cancers.2020; 12(8): 2060.     CrossRef
• N-6 Polyunsaturated Fatty Acids and Risk of Cancer: Accumulating Evidence from Prospective Studies
  Youngyo Kim, Jeongseon Kim
  Nutrients.2020; 12(9): 2523.     CrossRef

Citations

Citations to this article as recorded by  

• Risk factors analysis and nomogram for predicting recurrence in periocular basal cell carcinoma
  Xincen Hou, Alexander C. Rokohl, Katharina Berndt, Senmao Li, Xiaojun Ju, Philomena A. Wawer Matos, Wanlin Fan, Ludwig M. Heindl
  Canadian Journal of Ophthalmology.2025;[Epub]     CrossRef
• Advances in Nasopharyngeal Carcinoma Staging: from the 7th to the 9th Edition of the TNM System and Future Outlook
  Binhao Wu, Xiaozhong Chen, Caineng Cao
  Current Oncology Reports.2025; 27(3): 322.     CrossRef
• Treatment outcomes in nasopharyngeal carcinoma patients with parotid lymph node metastasis: An 11‐year experience at a tertiary cancer center
  Linghui Yan, Yuhao Lin, Wenrong Lin, Jiabiao Hong, Muling Deng, Chuanben Chen, Zhaodong Fei, Jianming Ding
  International Journal of Cancer.2025;[Epub]     CrossRef
• Analysis of patients with parotid recurrence after parotid-sparing IMRT for nasopharyngeal carcinoma: case series and review of the literature
  Sezin Yuce Sari, Melek Tugce Yilmaz, Gozde Yazici, Sepideh Mohammadipour, Gokhan Ozyigit, Ibrahim Gullu, Mustafa Cengiz
  Strahlentherapie und Onkologie.2024; 200(12): 1057.     CrossRef
• Nomogram Based on Liver Function Test Indicators for Survival Prediction in Nasopharyngeal Carcinoma Patients Receiving PD-1 Inhibitor Therapy
  Lixia Liang, Yan Li, Yansui Hong, Tianxing Ji, Hao Chen, Zhifang Lin
  Current Oncology.2023; 30(8): 7189.     CrossRef
• A Randomized Controlled Trial on Evaluation of Plasma Epstein-Barr Virus Biomarker for Early Diagnosis in Patients With Nasopharyngeal Carcinoma
  Wen Liu, Huilan Li, Hui Sheng, Xiaohua Liu, Peidong Chi, Xueping Wang, Minjie Mao
  Advances in Therapy.2020; 37(10): 4280.     CrossRef
• Prognosis prediction signature of seven immune genes based on HPV status in cervical cancer
  Qianqian Xia, Hua Jin, Xing Zhang, Wenjing Yan, Dan Meng, Bo Ding, Jian Cao, Dake Li, Shizhi Wang
  International Immunopharmacology.2020; 88: 106935.     CrossRef

Citations

Citations to this article as recorded by  

• CARD9 regulates myocardial inflammation, oxidative stress, and vascular dysfunction in hypertensive rats by activating MAPK/p38 pathway in combination with NOD2
  XiangBin Xin, Jing Zhang, YanQin Du, XiaoTing Jang, XinYi Tian, Fu Ma, Fang Chen
  Molecular & Cellular Toxicology.2025; 21(1): 119.     CrossRef
• The implication of microbiome in lungs cancer: mechanisms and strategies of cancer growth, diagnosis and therapy
  Yasmin Bano, Abhinav Shrivastava, Piyush Shukla, Anis Ahmad Chaudhary, Salah-Ud-Din Khan, Shahanavaj Khan
  Critical Reviews in Microbiology.2025; 51(1): 128.     CrossRef
• Transcriptome Analysis of the Inhibitory Effects of 20(S)-Protopanaxadiol on NCI-H1299 Non-Small Cell Lung Cancer Cells
  Zhongyi Cong, Xinmin Zhang, Zeqi Lv, Jingyuan Jiang, Lei Wang, Jiapeng Li, Jie Wang, Jianjun Zhao
  Molecules.2023; 28(15): 5746.     CrossRef
• Sericin enhances ammonia detoxification by promotes urea cycle enzyme genes and activates hepatic autophagy in relation to CARD-9/MAPK pathway
  Sumate Ampawong, Napatara Tirawanchai, Tapanee Kanjanapruthipong, Kamonpan Fongsodsri, Khwanchanok Tuentam, Duangnate Isarangkul, Pornanong Aramwit
  Heliyon.2023; 9(11): e21563.     CrossRef
• Mycobiota and C-Type Lectin Receptors in Cancers: Know thy Neighbors
  Lilong Zhang, Dongqi Chai, Chen Chen, Chunlei Li, Zhendong Qiu, Tianrui Kuang, Mungur Parveena, Keshuai Dong, Jia Yu, Wenhong Deng, Weixing Wang
  Frontiers in Microbiology.2022;[Epub]     CrossRef
• Alpha1B-adreneroceptor is involved in norepinephrine-induced pulmonary artery smooth muscle cell proliferation via p38 signaling
  Xiaolin Xiao, Ying Zhang, Shuaihu Tian, Xiaoyan Wang, Qianlong Zhang, Lixin Zhang, Xiufeng Yu, Cui Ma, Xiaodong Zheng, Yiying Li, Junting Zhang, Lihui Qu
  European Journal of Pharmacology.2022; 931: 175159.     CrossRef
• Proteomic analysis provides insights into the function of Polian vesicles in the sea cucumber Apostichopus japonicus post-evisceration
  Jinlin Ji, Zhenhui Wang, Wei Zhu, Qiang Li, Yinan Wang
  Journal of Oceanology and Limnology.2022; 40(5): 2028.     CrossRef
• CARD9 as a potential therapeutic target in lung cancer
  Ruanmei Sheng, Zhiwen Yang
  Frontiers in Bioscience-Landmark.2021;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Postoperative factors predicting outcomes in patients with Perihilar cholangiocarcinoma undergoing curative resection—a 10-year single-center experience
  Hasan Ahmad Al-Saffar, Nicolai Schultz, Peter Nørrgaard Larsen, Eva Fallentin, Gro Linno Willemoe, Diana Elena Renteria Ramirez, Lucas Alexander Knøfler, Hans-Christian Pommergaard
  Scandinavian Journal of Gastroenterology.2025; 60(1): 73.     CrossRef
• Depth of Liver Invasion as a Novel Predictor for Outcome of Perihilar Cholangiocarcinoma
  Tao Zhang, Li Li, Dong-Liang Yang, Nan Jiang, Hai-Jing Ge, Ming-Yu Lin, Chang-Zhen Yang, Si-Qiao Shan, Hua Sun, Zhe Yan, Xue-Li Yuan, Kai Sun, Jian-Ping Zeng, Can-Hong Xiang, Si-Yuan Wang, Shuo Jin
  American Journal of Surgical Pathology.2025;[Epub]     CrossRef
• Oncologic Impact of Perineural Invasion in Perihilar Cholangiocarcinoma: an International Multicenter Study
  Jun Kawashima, Miho Akabane, Diamantis I. Tsilimigras, Selamawit Woldesenbet, Mujtaba Khalil, Yutaka Endo, Kota Sahara, Federico Aucejo, Hugo P. Marques, Beatriz Chumbinho, Tom Hugh, Shishir K. Maithel, Bas Groot Koerkamp, Andrea Ruzzenente, Itaru Endo, T
  HPB.2025;[Epub]     CrossRef
• The preoperative scoring system combining neutrophil/lymphocyte ratio and CA19-9 predicts the long-term prognosis of intrahepatic cholangiocarcinoma patients undergoing curative liver resection
  Shilei Bai, Xiaodong Shi, Yizhe Dai, Huifeng Wang, Yong Xia, Jian Liu, Kui Wang
  BMC Cancer.2024;[Epub]     CrossRef
• Preoperative factors predicting outcomes in patients with suspected perihilar cholangiocarcinoma referred for curative resection— a single-center 10-year experience
  HA Al-Saffar, PN Larsen, N Schultz, TS Kristensen, DE Renteria, LA Knøfler, HC Pommergaard
  Langenbeck's Archives of Surgery.2024;[Epub]     CrossRef
• Evaluation of Four Lymph Node Classifications for the Prediction of Survival in Hilar Cholangiocarcinoma
  Zhi-Peng Liu, Qing-Yi Zhang, Wei-Yue Chen, Yu-Yan Huang, Yan-Qi Zhang, Yi Gong, Yan Jiang, Jie Bai, Zhi-Yu Chen, Hai-Su Dai
  Journal of Gastrointestinal Surgery.2022; 26(5): 1030.     CrossRef
• Impact of Positive Lymph Nodes and Resection Margin Status on the Overall Survival of Patients with Resected Perihilar Cholangiocarcinoma: The ENSCCA Registry
  Lynn E. Nooijen, Jesus M. Banales, Marieke T. de Boer, Chiara Braconi, Trine Folseraas, Alejandro Forner, Waclaw Holowko, Frederik J. H. Hoogwater, Heinz-Josef Klümpen, Bas Groot Koerkamp, Angela Lamarca, Adelaida La Casta, Flora López-López, Laura Izquie
  Cancers.2022; 14(10): 2389.     CrossRef
• Modification of the eighth AJCC/UICC staging system for perihilar cholangiocarcinoma: An alternative pathological staging system from cholangiocarcinoma-prevalent Northeast Thailand
  Chaiwat Aphivatanasiri, Prakasit Sa-Ngiamwibool, Sakkarn Sangkhamanon, Piyapharom Intarawichian, Waritta Kunprom, Malinee Thanee, Piya Prajumwongs, Narong Khuntikeo, Attapol Titapun, Apiwat Jareanrat, Vasin Thanasukarn, Tharatip Srisuk, Vor Luvira, Kulyad
  Frontiers in Medicine.2022;[Epub]     CrossRef
• Vascular invasion and lymph node metastasis mediate the effect of CA242 on prognosis in hilar cholangiocarcinoma patients after radical resection
  Gang Heng, Benqi Huang, Yanbing Shen, Dan wang, Zhen Lan, Yuxuan Yao, Jianxin Zhang, Jiankun Jia, Chengcheng Zhang
  Frontiers in Oncology.2022;[Epub]     CrossRef
• Development and validation of preoperative magnetic resonance imaging-based survival predictive nomograms for patients with perihilar cholangiocarcinoma after radical resection: A pilot study
  Jian Zhao, Wei Zhang, Cheng-Lin Fan, Jun Zhang, Fang Yuan, Si-Yun Liu, Fu-Yu Li, Bin Song
  European Journal of Radiology.2021; 138: 109631.     CrossRef
• A Novel Nomogram Based on Log Odds of Metastatic Lymph Nodes to Predict Overall Survival in Patients With Perihilar Cholangiocarcinoma After Surgery
  Wenbo Zou, Chunyu Zhu, Zizheng Wang, Xianglong Tan, Chenggang Li, Zhiming Zhao, Minggen Hu, Rong Liu
  Frontiers in Oncology.2021;[Epub]     CrossRef
• Prognostic Relevance of the Eighth Edition of TNM Classification for Resected Perihilar Cholangiocarcinoma
  Hans-Michael Hau, Felix Meyer, Nora Jahn, Sebastian Rademacher, Robert Sucher, Daniel Seehofer
  Journal of Clinical Medicine.2020; 9(10): 3152.     CrossRef

Citations

Citations to this article as recorded by  

• Trends in Cancer-Screening Rates in Korea: Findings from the National Cancer Screening Survey, 2004-2023
  EunKyo Kang, Kui Son Choi, Jae Kwan Jun, Yeol Kim, Hyeon Ji Lee, Chang Kyun Choi, Tae Hee Kim, Sun Hwa Lee, Mina Suh
  Cancer Research and Treatment.2025; 57(1): 28.     CrossRef
• Association between early job loss and prognosis among hepatocellular carcinoma survivors
  B Yun, J Oh, S H Ahn, B K Kim, J-H Yoon
  Occupational Medicine.2025; 75(2): 113.     CrossRef
• Socioeconomic Burden of Psychiatric Cancer Patients: A Narrative Review
  Gniewko Więckiewicz, Sophie Weber, Iga Florczyk, Piotr Gorczyca
  Cancers.2024; 16(6): 1108.     CrossRef
• Comparison between Nivolumab and Regorafenib as Second-line Systemic Therapies after Sorafenib Failure in Patients with Hepatocellular Carcinoma
  Hong Jun Lee, Jae Seung Lee, Hyesung So, Ja Kyung Yoon, Jin-Young Choi, Hye Won Lee, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Sang Hoon Ahn, Do Young Kim
  Yonsei Medical Journal.2024; 65(7): 371.     CrossRef
• Impact of early economic activity loss on all-cause mortality in gastric cancer survivors following curative treatment: a nationwide study in Korea
  Byungyoon Yun, Juyeon Oh, Heejoo Park, Jinsoo Chung, Juho Sim, Jongmin Lee, Yangwook Kim, Jin-Ha Yoon
  Gastric Cancer.2024; 27(6): 1159.     CrossRef
• Economic Burden of Healthcare Services on Cancer Survivors in Bangladesh
  Md. Shahjalal, Padam Kanta Dahal, Md. Parvez Mosharaf, Mohammad Morshad Alam, Mohammad Delwer Hossain Hawlader, Rashidul Alam Mahumud
  Cancer Reports.2024;[Epub]     CrossRef
• High-Dose Corticosteroid Use in Severe to Critically Ill Patients With COVID-19: A Nationwide Population-Based Matched Cohort Study
  Raeseok Lee, Sung-Yeon Cho, Dong-Gun Lee, Dukhee Nho
  Journal of Korean Medical Science.2024;[Epub]     CrossRef
• Comparative Effectiveness and Safety of Immune Checkpoint Inhibitors in Patients with Hepatocellular Carcinoma Based on Viral Etiology
  Jae Yeon Lee, Min Jung Geum, Jong Hee Ko, Eun Sun Son, Yun Mi Yu
  Journal of Korean Society of Health-System Pharmacists.2024; 41(4): 354.     CrossRef
• 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
  
  Journal of Liver Cancer.2023; 23(1): 1.     CrossRef
• Incidence of dysphagia requiring medical attention in various types of cancers: A nationwide population-based cohort study
  SuYeon Kwon, Gowun Kim, Seungwoo Cha, Kyungdo Han, Nam-Jong Paik, Won-Seok Kim
  Supportive Care in Cancer.2023;[Epub]     CrossRef
• Economic burden of cancer attributable to modifiable risk factors in Japan
  Eiko Saito, Shiori Tanaka, Sarah Krull Abe, Mayo Hirayabashi, Junko Ishihara, Kota Katanoda, Yingsong Lin, Chisato Nagata, Norie Sawada, Ribeka Takachi, Atsushi Goto, Junko Tanaka, Kayo Ueda, Megumi Hori, Tomohiro Matsuda, Manami Inoue
  Global Health & Medicine.2023; 5(4): 238.     CrossRef
• Operational Definitions of Colorectal Cancer in the Korean National Health Insurance Database
  Hyeree Park, Yu Rim Kim, Yerin Pyun, Hyundeok Joo, Aesun Shin
  Journal of Preventive Medicine and Public Health.2023; 56(4): 312.     CrossRef
• The effects of hospice care on healthcare expenditure among cancer patients
  Hoyol Jhang, Wonjeong Jeong, Hyun-Soo Zhang, Dong-Woo Choi, Hyejung Kang, Sohee Park
  BMC Health Services Research.2023;[Epub]     CrossRef
• Validation of Cancer Diagnosis Based on the National Health Insurance Service Database versus the National Cancer Registry Database in Korea
  Min Soo Yang, Minae Park, Joung Hwan Back, Gyeong Hyeon Lee, Ji Hye Shin, Kyuwoong Kim, Hwa Jeong Seo, Young Ae Kim
  Cancer Research and Treatment.2022; 54(2): 352.     CrossRef
• Income Disparities in Cancer Screening: A Cross-Sectional Study of the Korean National Health and Nutrition Examination Survey, 2013–2019
  Vasuki Rajaguru, Tae Hyun Kim, Jaeyong Shin, Sang Gyu Lee
  Frontiers in Public Health.2022;[Epub]     CrossRef
• The cost of oral cancer: A systematic review
  Rejane Faria Ribeiro-Rotta, Eduardo Antônio Rosa, Vanessa Milani, Nadielle Rodrigues Dias, Danielle Masterson, Everton Nunes da Silva, Ana Laura de Sene Amâncio Zara, Antoine Eskander
  PLOS ONE.2022; 17(4): e0266346.     CrossRef
• The effect of cancer on traditional, complementary and alternative medicine utilization in Korea: a fixed effect analysis using Korea Health Panel data
  Dongsu Kim, Soo-Hyun Sung, Seungwon Shin, Minjung Park
  BMC Complementary Medicine and Therapies.2022;[Epub]     CrossRef
• Trend Analysis and Prediction of Hepatobiliary Pancreatic Cancer Incidence and Mortality in Korea
  Hyeong Min Park, Young-Joo Won, Mee Joo Kang, Sang-Jae Park, Sun-Whe Kim, Kyu-Won Jung, Sung-Sik Han
  Journal of Korean Medical Science.2022;[Epub]     CrossRef
• The population-level economic burden of liver cancer in China, 2019–2030: prevalence-based estimations from a societal perspective
  Meng-Di Cao, Cheng-Cheng Liu, Hong Wang, Lin Lei, Maomao Cao, Yuting Wang, He Li, Xin-Xin Yan, Yan-Jie Li, Xin Wang, Ji Peng, Chunfeng Qu, Eleonora Feletto, Ju-Fang Shi, Wanqing Chen
  Cost Effectiveness and Resource Allocation.2022;[Epub]     CrossRef
• Real world evidence study on treatment patterns and health resource utilization in patients with HR+/HER2- locally advanced or metastatic breast cancer in Korea
  Diego Novick, Sae Young Lee, Dong Hyun Koo, Agota Szende, Sam Colman
  Journal of Drug Assessment.2022; 11(1): 12.     CrossRef
• 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
  
  Clinical and Molecular Hepatology.2022; 28(4): 583.     CrossRef
• 2022 KLCA-NCC Korea Practice Guidelines for the Management of Hepatocellular Carcinoma
  
  Korean Journal of Radiology.2022; 23(12): 1126.     CrossRef
• Trends in breast cancer screening rates among Korean women: results from the Korean National Cancer Screening Survey, 2005-2020
  Soo Yeon Song, Yun Yeong Lee, Hye Young Shin, Bomi Park, Mina Suh, Kui Son Choi, Jae Kwan Jun
  Epidemiology and Health.2022; 44: e2022111.     CrossRef
• Mechanisms of resistance to chemotherapy in non-small cell lung cancer
  Hye-Young Min, Ho-Young Lee
  Archives of Pharmacal Research.2021; 44(2): 146.     CrossRef
• Analysis of Medical Use and Treatment Costs of Hepatocellular Carcinoma Patients Using National Patient Sample Data
  Byeong-Chan Oh, Jeong-Yeon Cho, Sun-Hong Kwon, Eui-Kyung Lee, Hye-Lin Kim
  Korean Journal of Clinical Pharmacy.2021; 31(2): 153.     CrossRef
• Liver Stiffness-Based Risk Prediction Model for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease
  Jae Seung Lee, Dong Hyun Sinn, Soo Young Park, Hye Jung Shin, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Joo Hyun Oh, Jung Il Lee, Seung Up Kim
  Cancers.2021; 13(18): 4567.     CrossRef
• Economic burden of alcohol-related cancers in the Republic of Korea
  Minji Han, Binh Thang Tran, Heeyoun Cho, Jin-Kyoung Oh
  Drug and Alcohol Dependence.2020; 217: 108295.     CrossRef

Citations

Citations to this article as recorded by  

• Impact of body weight-based dosing of palonosetron and ondansetron on postoperative nausea and vomiting following laparoscopic sleeve gastrectomy: a randomized, double-blind study
  Büşra Burcu, Nadir Adnan Hacım, Ozan Caliskan, Serdar Demirgan, Talar Vartanoglu Aktokmakyan, Serhat Meric, Tomris Duymaz, Onder Karabay, Ali Solmaz
  Acta Chirurgica Belgica.2024; 124(1): 41.     CrossRef
• 2023 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following high-emetic-risk antineoplastic agents
  Jørn Herrstedt, L Celio, PJ Hesketh, L Zhang, R Navari, A Chan, M Saito, R Chow, M Aapro
  Supportive Care in Cancer.2024;[Epub]     CrossRef
• 2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting
  J. Herrstedt, R. Clark-Snow, C.H. Ruhlmann, A. Molassiotis, I. Olver, B.L. Rapoport, M. Aapro, K. Dennis, P.J. Hesketh, R.M. Navari, L. Schwartzberg, M.L. Affronti, M.A. Garcia-Del-Barrio, A. Chan, L. Celio, R. Chow, M. Fleury, R.J. Gralla, R. Giusti, F.
  ESMO Open.2024; 9(2): 102195.     CrossRef
• Ramosetron 3.0 μg/mL Combining with Dexamethasone (0.05, 0.1, 0.2 mg/mL) in Infusion Solutions: A Physicochemical Stability Study
  Baoxia Fang, Lijun Zhao, Shirong Yu, Fuchao Chen
  Dose-Response.2024;[Epub]     CrossRef
• Efficacy and safety of Antiemetic Regimens for Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: A Systematic Review and Network Meta-Analysis
  Marco Filetti, Pasquale Lombardi, Raffaele Giusti, Rosa Falcone, Florian Scotte, Diana Giannarelli, Antonella Carcagnì, Valeria Altamura, Giovanni Scambia, Gennaro Daniele
  Cancer Treatment Reviews.2023; : 102512.     CrossRef
• Effect of Acupuncture on Delayed Emesis for the Patients Who Received High-Emetogenic Chemotherapy with Standard Antiemetic Prophylaxis (KHMC-HO-01): An Open-Label, Randomized Study
  Chi Hoon Maeng, Seunghoon Lee, Jae Joon Han, Hong Jun Kim, Dongwoo Nam, Junhee Lee, Sun Kyung Baek, Maria Grazia Ferraro
  Evidence-Based Complementary and Alternative Medicine.2022; 2022: 1.     CrossRef
• Cardioprotective action of aprepitant in a rat model of ischemia-reperfusioninduced myocardial injury: role of PI3K-AkT-GSK-3β-HIF-1α signaling pathway
  Mei Qian, Yang Liu
  Acta Cirúrgica Brasileira.2022;[Epub]     CrossRef
• Comparison of the Effectiveness of Palonosetron and Ramosetron in Preventing Postoperative Nausea and Vomiting: Updated Systematic Review and Meta-Analysis with Trial Sequential Analysis
  Hyo Jin Kim, EunJin Ahn, Geun Joo Choi, Hyun Kang
  Journal of Personalized Medicine.2022; 13(1): 82.     CrossRef
• Oliceridine is Associated with Reduced Risk of Vomiting and Need for Rescue Antiemetics Compared to Morphine: Exploratory Analysis from Two Phase 3 Randomized Placebo and Active Controlled Trials
  Timothy L. Beard, Cathy Michalsky, Keith A. Candiotti, Paul Rider, Linda Wase, Ashraf S. Habib, Mark A. Demitrack, Michael J. Fossler, Eugene R. Viscusi
  Pain and Therapy.2021; 10(1): 401.     CrossRef
• Forsythiae Fructus aqueous extract attenuates cisplatin-induced kaolin consumption (pica) by inhibiting NLRP3 inflammasome activation in rats
  Qi Meng, Pingping Bi, Guanglong Zhang, Yaqi Li, Siqi Chen, Ke Nie
  Bioscience, Biotechnology, and Biochemistry.2021; 85(9): 2054.     CrossRef
• Antiemetics for adults for prevention of nausea and vomiting caused by moderately or highly emetogenic chemotherapy: a network meta-analysis
  Vanessa Piechotta, Anne Adams, Madhuri Haque, Benjamin Scheckel, Nina Kreuzberger, Ina Monsef, Karin Jordan, Kathrin Kuhr, Nicole Skoetz
  Cochrane Database of Systematic Reviews.2021;[Epub]     CrossRef
• Duration of dexamethasone administration for the prevention of chemotherapy-induced nausea and vomiting – A systematic review and meta-analysis
  Ajay Raghunath, Sahan D. Chandrasekara, Shane N. Anthony, Ben Markman
  Critical Reviews in Oncology/Hematology.2020; 152: 103012.     CrossRef

Citations

Citations to this article as recorded by  

• Factors Affecting Life-Sustaining Treatment Decisions and Changes in Clinical Practice after Enforcement of the Life-Sustaining Treatment (LST) Decision Act: A Tertiary Hospital Experience in Korea
  Yoon Jung Jang, Yun Jung Yang, Hoi Jung Koo, Hye Won Yoon, Seongbeom Uhm, Sun Young Kim, Jeong Eun Kim, Jin Won Huh, Tae Won Kim, Seyoung Seo
  Cancer Research and Treatment.2025; 57(1): 280.     CrossRef
• Development of Public Health Center‐Based Culturally Tailored Hypertension Self‐Care Intervention Among Adults in Rural Ghana
  Kennedy Diema Konlan, Hyeonkyeong Lee, Yeonsoo Jang, Seung Eun Lee, Soyoon Kim
  Public Health Nursing.2025; 42(3): 1235.     CrossRef
• The Impact of Advanced Care Planning on Hospice Utilization in Patients with Cancer: A Nationwide Analysis in Korea
  Woorim Kim, Boram Kim, Minju Kim, Jin Young Choi
  Cancers.2025; 17(9): 1471.     CrossRef
• The impact of withholding and withdrawal life-sustaining treatment issues on patients with sepsis: a prospective, nationwide, multicenter cohort study
  So-yun Kim, Da Hyun Kang, Hyekyeong Ju, Dong Kyu Oh, Su Yeon Lee, Mi Hyeon Park, Chae-Man Lim, Song I Lee, Chae-Man Lim, Sang-Bum Hong, Dong Kyu Oh, Su Yeon Lee, Gee Young Suh, Kyeongman Jeon, Ryoung-Eun Ko, Young-Jae Cho, Yeon Joo Lee, Sung Yoon Lim, Sun
  Scientific Reports.2025;[Epub]     CrossRef
• Recent Trends in the Withdrawal of Life-Sustaining Treatment in Patients with Acute Cerebrovascular Disease : 2017–2021
  Seung Hwan Kim, Ji Hwan Jang, Young Zoon Kim, Kyu Hong Kim, Taek Min Nam
  Journal of Korean Neurosurgical Society.2024; 67(1): 73.     CrossRef
• Characteristics and outcomes of patients with do-not-resuscitate and physician orders for life-sustaining treatment in a medical intensive care unit: a retrospective cohort study
  Song-I Lee, Ye-Rin Ju, Da Hyun Kang, Jeong Eun Lee
  BMC Palliative Care.2024;[Epub]     CrossRef
• Comparison of factors influencing the decision to withdraw life-sustaining treatment in intensive care unit patients after implementation of the Life-Sustaining Treatment Act in Korea
  Claire Junga Kim, Kyung Sook Hong, Sooyoung Cho, Jin Park
  Acute and Critical Care.2024; 39(2): 294.     CrossRef
• End-of-life care in the intensive care unit: the optimal process of decision to withdrawing life-sustaining treatment based on the Korean medical environment and culture
  Ho Jin Yong, Dohhyung Kim
  Acute and Critical Care.2024; 39(2): 321.     CrossRef
• Inpatient Hospice Care in Korea during the COVID-19 Pandemic: A Preliminary Study
  Youn Seon Choi, Sun Wook Hwang, In Cheol Hwang
  Journal of Hospice and Palliative Care.2024; 27(2): 82.     CrossRef
• Issues and implications of the life-sustaining treatment decision act: comparing the data from the survey and clinical data of inpatients at the end-of-life process
  Eunjeong Song, Dongsoon Shin, Jooseon Lee, Seonyoung Yun, Minjeong Eom, Suhee Oh, Heejung Lee, Jiwan Lee, Rhayun Song
  BMC Medical Ethics.2024;[Epub]     CrossRef
• Epidemiology of patients who died in the emergency departments and need of end-of-life care in Korea from 2016 to 2019
  Sun Young Lee, Young Sun Ro, Sang Do Shin, Eunsil Ko, Seong Jung Kim
  Scientific Reports.2023;[Epub]     CrossRef
• Modification of termination of resuscitation rule with compression time interval in South Korea
  Song Yi Park, Daesung Lim, Ji Ho Ryu, Yong Hwan Kim, Byungho Choi, Sun Hyu Kim
  Scientific Reports.2023;[Epub]     CrossRef
• Use of high‐flow nasal cannula oxygen therapy for patients with terminal cancer at the end of life
  Jung Sun Kim, Jeongmi Shin, Nam Hee Kim, Sun Young Lee, Shin Hye Yoo, Bhumsuk Keam, Dae Seog Heo
  Cancer Medicine.2023; 12(13): 14612.     CrossRef
• Participation and Influencing Factors in the Decision-Making of Life-Sustaining Treatment: A Focus on Deceased Patients with Hematologic Neoplasms
  Jae Eun Jang, Jeong Moon Ryu, Min Hee Heo, Do Eun Kwon, Ji Yeon Seo, Dong Yeon Kim
  The Korean Journal of Hospice and Palliative Care.2023; 26(2): 69.     CrossRef
• Advance Care Planning in South Korea
  Yu Jung Kim, Sun-Hyun Kim
  Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen.2023; 180: 68.     CrossRef
• Preferred versus Actual Place of Care and Factors Associated with Home Discharge among Korean Patients with Advanced Cancer: A Retrospective Cohort Study
  In Young Hwang, Yohan Han, Min Sun Kim, Kyae Hyung Kim, Belong Cho, Wonho Choi, Yejin Kim, Shin Hye Yoo, Sun Young Lee
  Healthcare.2023; 11(13): 1939.     CrossRef
• Patient and hospital characteristics associated with do-not-resuscitate/do-not-intubate orders: a cross-sectional study based on the Taiwan stroke registry
  Hsu-Ling Yeh, Fang-I Hsieh, Li-Ming Lien, Wen-Hua Kuo, Jiann-Shing Jeng, Yu Sun, Cheng-Yu Wei, Po-Yen Yeh, Hei-Tung Yip, Cheng-Li Lin, Nicole Huang, Kai-Cheng Hsu
  BMC Palliative Care.2023;[Epub]     CrossRef
• Analysis of Cancer Patient Decision-Making and Health Service Utilization after Enforcement of the Life-Sustaining Treatment Decision-Making Act in Korea
  Dalyong Kim, Shin Hye Yoo, Seyoung Seo, Hyun Jung Lee, Min Sun Kim, Sung Joon Shin, Chi-Yeon Lim, Do Yeun Kim, Dae Seog Heo, Chae-Man Lim
  Cancer Research and Treatment.2022; 54(1): 20.     CrossRef
• Problems Related to the Act on Decisions on Life-Sustaining Treatment and Directions for Improvement
  Dae Seog Heo, Shin Hye Yoo, Bhumsuk Keam, Sang Ho Yoo, Younsuck Koh
  The Korean Journal of Hospice and Palliative Care.2022; 25(1): 1.     CrossRef
• Use of antimicrobial agents in actively dying inpatients after suspension of life-sustaining treatments: Suggestion for antimicrobial stewardship
  Dayeong Kim, Subin Kim, Kyoung Hwa Lee, Sang Hoon Han
  Journal of Microbiology, Immunology and Infection.2022; 55(4): 651.     CrossRef
• Will implementation of the Life-sustaining Treatment Decisions Act reduce the incidence of cardiopulmonary resuscitation?
  In-Ae Song
  Acute and Critical Care.2022; 37(2): 256.     CrossRef
• Changes in the incidence of cardiopulmonary resuscitation before and after implementation of the Life-Sustaining Treatment Decisions Act
  Hyunjae Im, Hyun Woo Choe, Seung-Young Oh, Ho Geol Ryu, Hannah Lee
  Acute and Critical Care.2022; 37(2): 237.     CrossRef
• Aggressiveness of care in the last days of life in the emergency department of a tertiary hospital in Korea
  Jung Sun Kim, Sun Young Lee, Min Sung Lee, Shin Hye Yoo, Jeongmi Shin, Wonho Choi, Yejin Kim, Hyung Sook Han, Jinui Hong, Bhumsuk Keam, Dae Seog Heo
  BMC Palliative Care.2022;[Epub]     CrossRef
• The Medical Needs and Characteristics of Cancer and Progressive Neurologic Disease Patients Who Use Home-Based Medical Care in Korea: A Retrospective Study for 2011-2020
  Yo Han Han, Shin Hye Yoo, Sun Young Lee, In Young Hwang, Kyae Hyung Kim, Belong Cho, Min Sun Kim, Wonho Choi, Yejin Kim
  Journal of the American Medical Directors Association.2022; 23(10): 1634.     CrossRef
• Association of perceived life satisfaction with attitudes toward life-sustaining treatment among the elderly in South Korea: a cross-sectional study
  Il Yun, Hyunkyu Kim, Eun-Cheol Park, Suk-Yong Jang
  BMC Palliative Care.2022;[Epub]     CrossRef
• Type of bystander and rate of cardiopulmonary resuscitation in nursing home patients suffering out-of-hospital cardiac arrest
  Seung Hyo Lee, Sun Young Lee, Jeong Ho Park, Kyoung Jun Song, Sang Do Shin
  The American Journal of Emergency Medicine.2021; 47: 17.     CrossRef
• A National Study of Life-Sustaining Treatments in South Korea: What Factors Affect Decision-Making?
  So-Youn Park, Bomyee Lee, Jeong Yeon Seon, In-Hwan Oh
  Cancer Research and Treatment.2021; 53(2): 593.     CrossRef
• Difficulties Doctors Experience during Life-Sustaining Treatment Discussion after Enactment of the Life-Sustaining Treatment Decisions Act: A Cross-Sectional Study
  Shin Hye Yoo, Wonho Choi, Yejin Kim, Min Sun Kim, Hye Yoon Park, Bhumsuk Keam, Dae Seog Heo
  Cancer Research and Treatment.2021; 53(2): 584.     CrossRef
• Family Members' Knowledge and Attitude Toward Life-Sustaining Treatment Decisions for Patients in the Intensive Care Unit
  Sunjung Kim, Sunghee H. Tak
  Journal of Hospice & Palliative Nursing.2021; 23(3): 256.     CrossRef
• Changes in decision-making process for life-sustaining treatment in patients with advanced cancer after the life-sustaining treatment decisions-making act
  Hyeyeong Kim, Hyeon-Su Im, Kyong Og Lee, Young Joo Min, Jae-Cheol Jo, Yunsuk Choi, Yoo Jin Lee, Daseul Kang, Changyoung Kim, Su-Jin Koh, Jaekyung Cheon
  BMC Palliative Care.2021;[Epub]     CrossRef
• Life-Sustaining Treatment States in Korean Cancer Patients after Enforcement of Act on Decisions on Life-Sustaining Treatment for Patients at the End of Life
  Young-Woong Won, Hwa Jung Kim, Jung Hye Kwon, Ha Yeon Lee, Sun Kyung Baek, Yu Jung Kim, Do Yeun Kim, Hyewon Ryu
  Cancer Research and Treatment.2021; 53(4): 908.     CrossRef
• The Situation of Life-Sustaining Treatment One Year after Enforcement of the Act on Decisions on Life-Sustaining Treatment for Patients at the End-of-Life in Korea: Data of National Agency for Management of Life-Sustaining Treatment
  Ha Yeon Lee, Hwa Jung Kim, Jung Hye Kwon, Sun Kyung Baek, Young-Woong Won, Yu Jung Kim, Su Jin Baik, Hyewon Ryu
  Cancer Research and Treatment.2021; 53(4): 897.     CrossRef
• Preparation and Practice of the Necessary Documents in Hospital for the “Act on Decision of Life-Sustaining Treatment for Patients at the End-of-Life”
  Sun Kyung Baek, Hwa Jung Kim, Jung Hye Kwon, Ha Yeon Lee, Young-Woong Won, Yu Jung Kim, Sujin Baik, Hyewon Ryu
  Cancer Research and Treatment.2021; 53(4): 926.     CrossRef
• Current Status and Cardinal Features of Patient Autonomy after Enactment of the Life-Sustaining Treatment Decisions Act in Korea
  Hwa Jung Kim, Yu Jung Kim, Jung Hye Kwon, Young-Woong Won, Ha Yeon Lee, Sun Kyung Baek, Hyewon Ryu, Do Yeun Kim
  Cancer Research and Treatment.2021; 53(4): 917.     CrossRef
• Hospice and Palliative Care Education for Medical Students in Korea
  Do Yeun Kim, Soon Nam Lee
  Korean Medical Education Review.2020; 22(3): 146.     CrossRef

Citations

Citations to this article as recorded by  

• Therapeutic efficacy and prognostic indicators in re-resection for recurrent hepatocellular carcinoma: Insights from a retrospective study
  Qi Fan, Pengcheng Wei, Delin Ma, Qian Cheng, Jie Gao, Jiye Zhu, Zhao Li
  Surgery Open Science.2025; 23: 16.     CrossRef
• TP53 Mutation Predicts Worse Survival and Earlier Local Progression in Patients with Hepatocellular Carcinoma Treated with Transarterial Embolization
  Ken Zhao, Anita Karimi, Luke Kelly, Elena Petre, Brett Marinelli, Erica S. Alexander, Vlasios S. Sotirchos, Joseph P. Erinjeri, Anne Covey, Constantinos T. Sofocleous, James J. Harding, William Jarnagin, Carlie Sigel, Efsevia Vakiani, Etay Ziv, Hooman Yar
  Current Oncology.2025; 32(1): 51.     CrossRef
• Clinical Therapy: HAIC Combined with Tyrosine Kinase Inhibitors and Programmed Cell Death Protein-1 Inhibitors versus HAIC Alone for Unresectable Hepatocellular Carcinoma
  Baokun Liu, Lujun Shen, Wen Liu, Zhiyong Zhang, Jieqiong Lei, Zhengguo Li, Qinquan Tan, Hengfei Huang, Xingdong Wang, Weijun Fan
  Journal of Hepatocellular Carcinoma.2024; Volume 11: 1557.     CrossRef
• Enhanced interactions within microenvironment accelerates dismal prognosis in HBV-related HCC after TACE
  Libo Wang, Jiahui Cao, Zaoqu Liu, Shitao Wu, Yin Liu, Ruopeng Liang, Rongtao Zhu, Weijie Wang, Jian Li, Yuling Sun
  Hepatology Communications.2024;[Epub]     CrossRef
• Development and validation of survival prediction models for patients with hepatocellular carcinoma treated with transcatheter arterial chemoembolization plus tyrosine kinase inhibitors
  Kun Huang, Haikuan Liu, Yanqin Wu, Wenzhe Fan, Yue Zhao, Miao Xue, Yiyang Tang, Shi-Ting Feng, Jiaping Li
  La radiologia medica.2024; 129(11): 1597.     CrossRef
• Identification of BRD7 by whole-exome sequencing as a predictor for intermediate-stage hepatocellular carcinoma in patients undergoing TACE
  Kun Huang, Yanqin Wu, Wenzhe Fan, Yue Zhao, Miao Xue, Haikuan Liu, Yiyang Tang, Jiaping Li
  Journal of Cancer Research and Clinical Oncology.2023; 149(13): 11247.     CrossRef
• Prediction model of no-response before the first transarterial chemoembolization for hepatocellular carcinoma: TACF score
  Jia-Wei Zhong, Dan-Dan Nie, Ji-Lan Huang, Rong-Guang Luo, Qing-He Cheng, Qiao-Ting Du, Gui-Hai Guo, Liang-Liang Bai, Xue-Yun Guo, Yan Chen, Si-Hai Chen
  Discover Oncology.2023;[Epub]     CrossRef
• Mechanisms of Pharmacoresistance in Hepatocellular Carcinoma: New Drugs but Old Problems
  Jose J.G. Marin, Marta R. Romero, Elisa Herraez, Maitane Asensio, Sara Ortiz-Rivero, Anabel Sanchez-Martin, Luca Fabris, Oscar Briz
  Seminars in Liver Disease.2022; 42(01): 087.     CrossRef
• Non-Apoptotic Programmed Cell Death-Related Gene Signature Correlates With Stemness and Immune Status and Predicts the Responsiveness of Transarterial Chemoembolization in Hepatocellular Carcinoma
  Guixiong Zhang, Wenzhe Fan, Hongyu Wang, Jie Wen, Jizhou Tan, Miao Xue, Jiaping Li
  Frontiers in Cell and Developmental Biology.2022;[Epub]     CrossRef
• Plasma arginase-1 as a predictive marker for early transarterial chemoembolization refractoriness in unresectable hepatocellular carcinoma
  Wei-Li Xia, Shi-Jun Xu, Yuan Guo, Xiao-Hui Zhao, Hong-Tao Hu, Yan Zhao, Quan-Jun Yao, Lin Zheng, Dong-Yang Zhang, Chen-Yang Guo, Wei-Jun Fan, Hai-Liang Li
  Frontiers in Oncology.2022;[Epub]     CrossRef
• Useful genes for predicting the efficacy of transarterial chemoembolization in hepatocellular carcinoma
  Yuan Guo, Hongtao Hu, Shijun Xu, Weili Xia, Hailiang Li
  Journal of Cancer Research and Therapeutics.2022; 18(7): 1860.     CrossRef
• Development and Validation of a Predictive Model for Early Refractoriness of Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma
  Tian-Cheng Wang, Tian-Zhi An, Jun-Xiang Li, Zi-Shu Zhang, Yu-Dong Xiao
  Frontiers in Molecular Biosciences.2021;[Epub]     CrossRef
• Transcatheter arterial chemoembolization followed by surgical resection for hepatocellular carcinoma: a focus on its controversies and screening of patients most likely to benefit
  Zhan-Qi Wei, Yue-Wei Zhang
  Chinese Medical Journal.2021; 134(19): 2275.     CrossRef
• Recent Updates of Transarterial Chemoembolilzation in Hepatocellular Carcinoma
  Young Chang, Soung Won Jeong, Jae Young Jang, Yong Jae Kim
  International Journal of Molecular Sciences.2020; 21(21): 8165.     CrossRef

Citations

Citations to this article as recorded by  

• Cost-effectiveness and readmission rates of laparoscopic vs. open surgery for colorectal cancer: evidence from the health insurance review and assessment service dataset in South Korea
  Sanghyun An, Sung Eun Hong, Moo Hyun Kim, Ik Yong Kim
  Frontiers in Surgery.2025;[Epub]     CrossRef
• Laparoscopic and robotic surgery for colorectal cancer in Korea: a nationwide health insurance database analysis from 2019 to 2023
  Eun Ji Park, Hyun Gu Lee, Youn Young Park, Sun Jin Park, Kil Yeon Lee, Suk-Hwan Lee
  Journal of Minimally Invasive Surgery.2025; 28(1): 25.     CrossRef
• Label‐Free Typing of Colorectal Cancer by Optical Time‐Stretch Imaging Flow Cytometry With Multi‐Instance Learning
  Sini Pi, Liye Mei, Liang Tao, Sisi Mei, Zhaoyi Ye
  Journal of Biophotonics.2025;[Epub]     CrossRef
• Learning curve for single-port robot-assisted colectomy
  Moon Suk Choi, Seong Hyeon Yun, Sung Chul Lee, Jung Kyong Shin, Yoon Ah Park, Jungwook Huh, Yong Beom Cho, Hee Cheol Kim, Woo Yong Lee
  Annals of Coloproctology.2024; 40(1): 44.     CrossRef
• Clinical effect of laparoscopic radical resection of colorectal cancer based on propensity score matching
  Yang Liu, Xian-Xue Wang, Yu-Lin Li, Wen-Tao He, Hong Li, Hua Chen
  World Journal of Gastrointestinal Surgery.2024; 16(1): 124.     CrossRef
• The impact of surgical volume on outcomes in newly diagnosed colorectal cancer patients receiving definitive surgeries
  Chiu-Mei Yeh, Tzu-Yu Lai, Yu-Wen Hu, Chung-Jen Teng, Nicole Huang, Chia-Jen Liu
  Scientific Reports.2024;[Epub]     CrossRef
• Essential knowledge and technical tips for total mesorectal excision and related procedures for rectal cancer
  Min Soo Cho, Hyeon Woo Bae, Nam Kyu Kim
  Annals of Coloproctology.2024; 40(4): 384.     CrossRef
• Robotic surgery may lead to reduced postoperative inflammatory stress in colon cancer: a propensity score–matched analysis
  Eun Ji Park, Gyong Tae Noh, Yong Joon Lee, Min Young Park, Seung Yoon Yang, Yoon Dae Han, Min Soo Cho, Hyuk Hur, Kang Young Lee, Byung Soh Min
  Annals of Coloproctology.2024; 40(6): 594.     CrossRef
• Incidence of incisional hernia after major colorectal cancer surgery & analysis of associated risk factors in Asian population: Is laparoscopy any better?
  Shao Nan Khor, S.H.X. Cheok, Rehena Sultana, Emile Kwong Wei Tan
  Asian Journal of Surgery.2023; 46(1): 99.     CrossRef
• Intracorporeal anastomosis for minimally invasive right colectomy – is it time for wider uptake?
  Kim‐Chi Phan‐Thien, Edward A. Cooper, David Z. Lubowski
  ANZ Journal of Surgery.2023; 93(3): 454.     CrossRef
• Laparoscopic versus open surgery for colonoscopic perforation: A systematic review and meta-analysis
  Wu Zhong, Chuanyuan Liu, Chuanfa Fang, Lei Zhang, Xianping He, Weiquan Zhu, Xueyun Guan
  Medicine.2023; 102(24): e34057.     CrossRef
• Results of Laparoscopic Surgery and D3 Lymph Node Dissection Combined With Chemotherapy for the Radical Treatment of Advanced-Stage Right Colon Cancer: A Single-Center Observational Study in Vietnam
  Long Huynh Thanh, Khiem Nguyen Manh, Minh Nguyen Thi, Anh Nguyen Tri Trung, Kien Nguyen Trung, Thang Le Viet, Nung Vu Huy
  Cureus.2023;[Epub]     CrossRef
• Learning curve of single-incision laparoscopic totally extraperitoneal repair (SILTEP) for inguinal hernia
  Y. Y. Park, K. Lee, S. T. Oh, J. Lee
  Hernia.2022; 26(3): 959.     CrossRef
• Laparoscopic Radical Resection of Colorectal Cancer in the Treatment of Elderly Colorectal Cancer and Its Effect on Gastrointestinal Function
  Biao Liu, Chuanhui Yao, Haiying Li
  Frontiers in Surgery.2022;[Epub]     CrossRef
• Learning curve for single-port robot-assisted rectal cancer surgery
  Moon Suk Choi, Seong Hyeon Yun, Chang Kyu Oh, Jung Kyong Shin, Yoon Ah Park, Jung Wook Huh, Yong Beom Cho, Hee Cheol Kim, Woo Yong Lee
  Annals of Surgical Treatment and Research.2022; 102(3): 159.     CrossRef
• Comparison of clinical efficacy and postoperative inflammatory response between laparoscopic and open radical resection of colorectal cancer
  Long-Hai He, Bo Yang, Xiao-Qin Su, Yue Zhou, Zhen Zhang
  World Journal of Clinical Cases.2022; 10(13): 4042.     CrossRef
• Risk factors and economic burden of postoperative anastomotic leakage related events in patients who underwent surgeries for colorectal cancer
  Jeonghyun Kang, Hyesung Kim, HyeJin Park, Bora Lee, Kang Young Lee, Alberto Meyer
  PLOS ONE.2022; 17(5): e0267950.     CrossRef
• Minimally Invasive Pancreatoduodenectomy: Contemporary Practice, Evidence, and Knowledge Gaps
  Jacob Ghotbi, Mushegh Sahakyan, Kjetil Søreide, Åsmund Avdem Fretland, Bård Røsok, Tore Tholfsen, Anne Waage, Bjørn Edwin, Knut Jørgen Labori, Sheraz Yaqub, Dyre Kleive
  Oncology and Therapy.2022; 10(2): 301.     CrossRef
• A retrospective study of post-operative complications and cost analysis in robotic rectal resection versus laparoscopic rectal resection
  Muhammad Ali, Xiaodong Zhu, Yang Wang, Jianyue Ding, Qi Zhang, Qiannan Sun, Shantanu Baral, Daorong Wang
  Frontiers in Surgery.2022;[Epub]     CrossRef
• Multidisciplinary treatment strategy for early colon cancer
  Gyung Mo Son, Su Bum Park, Tae Un Kim, Byung-Soo Park, In Young Lee, Joo-Young Na, Dong Hoon Shin, Sang Bo Oh, Sung Hwan Cho, Hyun Sung Kim, Hyung Wook Kim
  Journal of the Korean Medical Association.2022; 65(9): 558.     CrossRef
• Epidemiology, risk factors, and prevention of colorectal cancer
  Kyung Uk Jung, Hyung Ook Kim, Hungdai Kim
  Journal of the Korean Medical Association.2022; 65(9): 549.     CrossRef
• Multidisciplinary Treatment Strategy for Early Colon Cancer: A Review-An English Version
  Gyung Mo Son, Su Bum Park, Tae Un Kim, Byung-Soo Park, In Young Lee, Joo-Young Na, Dong Hoon Shin, Sang Bo Oh, Sung Hwan Cho, Hyun Sung Kim, Hyung Wook Kim
  Journal of the Anus, Rectum and Colon.2022; 6(4): 203.     CrossRef
• Epidemiology, Risk Factors, and Prevention of Colorectal Cancer-An English Version
  Kyung Uk Jung, Hyung Ook Kim, Hungdai Kim
  Journal of the Anus, Rectum and Colon.2022; 6(4): 231.     CrossRef
• Postoperative complications observed with robotic versus laparoscopic surgery for the treatment of rectal cancer
  Chengkui Liu, Xiaoqing Li, Qingfeng Wang
  Medicine.2021; 100(36): e27158.     CrossRef
• Is Laparoscopic Complete Mesocolic Excision and Central Vascular Ligation Really Necessary for All Patients With Right-Sided Colon Cancer?
  Gyung Mo Son, In Young Lee, Yoon Suk Lee, Bong-Hyeon Kye, Hyeon-Min Cho, Je-Ho Jang, Chang-Nam Kim, Kil Yeon Lee, Suk-Hwan Lee, Jun-Gi Kim
  Annals of Coloproctology.2021; 37(6): 434.     CrossRef
• Preoperative Colonoscopic Tattooing Using a Direct Injection Method with Indocyanine Green for Localization of Colorectal Tumors: An Efficacy and Safety Comparison Study
  Young Jin Kim, Ji Won Park, Han-Ki Lim, Yoon-Hye Kwon, Min Jung Kim, Eun Kyung Choe, Sang Hui Moon, Seung-Bum Ryoo, Seung-Yong Jeong, Kyu Joo Park
  The Journal of Minimally Invasive Surgery.2020; 23(4): 186.     CrossRef

Citations

Citations to this article as recorded by  

• Senescence-associated secretory phenotype in lung cancer: remodeling the tumor microenvironment for metastasis and immune suppression
  Chen Chen, Ji Chen, Yanling Zhang, Qijun Zhang, Haixia Shi
  Frontiers in Oncology.2025;[Epub]     CrossRef
• Current and Future Therapeutic Targets for Directed Molecular Therapies in Cholangiocarcinoma
  Philipp Heumann, Andreas Albert, Karsten Gülow, Denis Tümen, Martina Müller, Arne Kandulski
  Cancers.2024; 16(9): 1690.     CrossRef
• Inhibition of the ATR-DNAPKcs-RB axis drives G1/S-phase transition and sensitizes triple-negative breast cancer (TNBC) to DNA holliday junctions
  Yue-miao Hu, Xue-cun Liu, Lei Hu, Zhi-wen Dong, Hong-ying Yao, Ying-jie Wang, Wen-jing Zhao, Yu-ke Xiang, Yi Liu, Hong-bo Wang, Qi-kun Yin
  Biochemical Pharmacology.2024; 225: 116310.     CrossRef
• Combination of S-1 and the oral ATR inhibitor ceralasertib is effective against pancreatic cancer cells
  Yoshihito Morimoto, Kimihiko Takada, Ami Nakano, Osamu Takeuchi, Kazuhiro Watanabe, Masayoshi Hirohara, Yutaka Masuda
  Cancer Chemotherapy and Pharmacology.2024; 94(6): 763.     CrossRef
• Immunomodulatory effects of trastuzumab deruxtecan through the cGAS-STING pathway in gastric cancer cells
  Kyoung-Seok Oh, Ah-Rong Nam, Ju-Hee Bang, Yoojin Jeong, Sea Young Choo, Hyo Jung Kim, Su In Lee, Jae-Min Kim, Jeesun Yoon, Tae-Yong Kim, Do-Youn Oh
  Cell Communication and Signaling.2024;[Epub]     CrossRef
• Targeting replication stress in cancer therapy
  Alexandre André B. A. da Costa, Dipanjan Chowdhury, Geoffrey I. Shapiro, Alan D. D’Andrea, Panagiotis A. Konstantinopoulos
  Nature Reviews Drug Discovery.2023; 22(1): 38.     CrossRef
• Combined Inhibition of Smoothened and the DNA Damage Checkpoint WEE1 Exerts Antitumor Activity in Cholangiocarcinoma
  Giulia Anichini, Chiara Raggi, Mirella Pastore, Laura Carrassa, Luisa Maresca, Enrica Crivaro, Tiziano Lottini, Lea Duwe, Jesper B. Andersen, Lorenzo Tofani, Luca Di Tommaso, Jesus M. Banales, Annarosa Arcangeli, Fabio Marra, Barbara Stecca
  Molecular Cancer Therapeutics.2023; 22(3): 343.     CrossRef
• Inhibiting WEE1 Augments the Antitumor Efficacy of Cisplatin in Urothelial Carcinoma by Enhancing the DNA Damage Process
  Yu-Li Su, Ling-Yi Xiao, Shih-Yu Huang, Chia-Che Wu, Li-Chung Chang, Yi-Hua Chen, Hao-Lun Luo, Chun-Chieh Huang, Ting-Ting Liu, Jei-Ming Peng
  Cells.2023; 12(11): 1471.     CrossRef
• The mechanism and clinical application of DNA damage repair inhibitors combined with immune checkpoint inhibitors in the treatment of urologic cancer
  Deqian Xie, Bowen Jiang, Shijin Wang, Qifei Wang, Guangzhen Wu
  Frontiers in Cell and Developmental Biology.2023;[Epub]     CrossRef
• Enrichment of Wee1/CDC2 and NF-κB Signaling Pathway Constituents Mutually Contributes to CDDP Resistance in Human Osteosarcoma
  Zhengbo Hu, Lugen Li, Wenxing Lan, Xiao Wei, Xiangyuan Wen, Penghuan Wu, Xianliao Zhang, Xinhua Xi, Yufa Li, Liqi Wu, Wenhu Li, Xiaohong Liao
  Cancer Research and Treatment.2022; 54(1): 277.     CrossRef
• ATR inhibitor AZD6738 increases the sensitivity of colorectal cancer cells to 5‑fluorouracil by inhibiting repair of DNA damage
  Takuya Suzuki, Takahisa Hirokawa, Anri Maeda, Shinnosuke Harata, Kaori Watanabe, Takeshi Yanagita, Hajime Ushigome, Nozomi Nakai, Yuzo Maeda, Kazuyoshi Shiga, Ryo Ogawa, Akira Mitsui, Masahiro Kimura, Yoichi Matsuo, Hiroki Takahashi, Shuji Takiguchi
  Oncology Reports.2022;[Epub]     CrossRef
• Inhibition of WEE1 Potentiates Sensitivity to PARP Inhibitor in Biliary Tract Cancer
  Hye-Rim Seo, Ah-Rong Nam, Ju-Hee Bang, Kyoung-Seok Oh, Jae-Min Kim, Jeesun Yoon, Tae-Yong Kim, Do-Youn Oh
  Cancer Research and Treatment.2022; 54(2): 541.     CrossRef
• DNA Damage Response Inhibitors in Cholangiocarcinoma: Current Progress and Perspectives
  Öykü Gönül Geyik, Giulia Anichini, Engin Ulukaya, Fabio Marra, Chiara Raggi
  Cells.2022; 11(9): 1463.     CrossRef
• Multiple-low-dose therapy: effective killing of high-grade serous ovarian cancer cells with ATR and CHK1 inhibitors
  Anya Golder, Louisa Nelson, Anthony Tighe, Bethany Barnes, Camilla Coulson-Gilmer, Robert D Morgan, Joanne C McGrail, Stephen S Taylor
  NAR Cancer.2022;[Epub]     CrossRef
• Differential Effects of Combined ATR/WEE1 Inhibition in Cancer Cells
  Gro Elise Rødland, Sissel Hauge, Grete Hasvold, Lilli T. E. Bay, Tine T. H. Raabe, Mrinal Joel, Randi G. Syljuåsen
  Cancers.2021; 13(15): 3790.     CrossRef
• Beyond the Double-Strand Breaks: The Role of DNA Repair Proteins in Cancer Stem-Cell Regulation
  Jacqueline Nathansen, Felix Meyer, Luise Müller, Marc Schmitz, Kerstin Borgmann, Anna Dubrovska
  Cancers.2021; 13(19): 4818.     CrossRef
• The Role of the Hedgehog Pathway in Cholangiocarcinoma
  Giulia Anichini, Laura Carrassa, Barbara Stecca, Fabio Marra, Chiara Raggi
  Cancers.2021; 13(19): 4774.     CrossRef
• Targeting P53 as a Future Strategy to Overcome Gemcitabine Resistance in Biliary Tract Cancers
  Chiao-En Wu, Yi-Ru Pan, Chun-Nan Yeh, John Lunec
  Biomolecules.2020; 10(11): 1474.     CrossRef

Citations

Citations to this article as recorded by  

• The Weight of Nutrition on Post-Resection Oncologic Morbidity and Mortality: A Systematic Review and Meta-Analysis of Nutritional Indices
  Katherine Pierce, Jeremy Gaskins, Robert C G Martin II
  Nutrition Reviews.2025; 83(6): 988.     CrossRef
• Comparative study of imputation strategies to improve the sarcopenia prediction task
  Shakhzod Karimov, Dilmurod Turimov, Wooseong Kim, Jiyoun Kim
  DIGITAL HEALTH.2025;[Epub]     CrossRef
• The Impact of Sarcopenia on Postoperative Outcomes in Colorectal Cancer Surgery: An Updated Systematic Review and Meta-Analysis
  Sara Keshavjee, Tyler Mckechnie, Victoria Shi, Muhammad Abbas, Elena Huang, Nalin Amin, Dennis Hong, Cagla Eskicioglu
  The American Surgeon™.2025; 91(5): 887.     CrossRef
• Sarcopenia as a Prognostic Factor for the Outcomes of Surgical Treatment of Colorectal Carcinoma
  Šimon Leščák, Martina Košíková, Sylvia Jenčová
  Healthcare.2025; 13(7): 726.     CrossRef
• Preoperative body composition metrics as predictors for outcomes in colorectal cancer surgeries
  Dorsa Salabat, Asma Mousavi, Shayan Shojaei, Razman Arabzadeh Bahri, Hanieh Radkhah
  Annals of Medicine & Surgery.2025; 87(4): 2243.     CrossRef
• Radiological Assessment of Sarcopenia and Its Clinical Impact in Patients with Hepatobiliary, Pancreatic, and Gastrointestinal Diseases: A Comprehensive Review
  Shameema Farook, Saumya Soni, Arpit Shantagiri, Pankaj Gupta, Anindita Sinha, Mahesh Prakash
  Journal of Gastrointestinal and Abdominal Radiology.2024; 07(01): 027.     CrossRef
• Developing sarcopenia during neoadjuvant therapy is associated with worse survival in esophageal adenocarcinoma patients
  Katherine Pierce, Prejesh Philips, Michael E Egger, Charles R Scoggins, Robert CG Martin
  Surgery.2024; 175(3): 718.     CrossRef
• PEX26 Functions as a Metastasis Suppressor in Colorectal Cancer
  Bianbian Yan, Lichao Cao, Liyang Gao, Shangqing Wei, Mengwei Wang, Ye Tian, Jin Yang, Erfei Chen
  Digestive Diseases and Sciences.2024; 69(1): 112.     CrossRef
• Post‐diagnosis adiposity and colorectal cancer prognosis: A Global Cancer Update Programme (CUP Global) systematic literature review and meta‐analysis
  Nerea Becerra‐Tomás, Georgios Markozannes, Margarita Cariolou, Katia Balducci, Rita Vieira, Sonia Kiss, Dagfinn Aune, Darren C. Greenwood, Laure Dossus, Ellen Copson, Andrew G. Renehan, Martijn Bours, Wendy Demark‐Wahnefried, Melissa M. Hudson, Anne M. Ma
  International Journal of Cancer.2024; 155(3): 400.     CrossRef
• Predictive role of preoperative sarcopenia for long-term survival in rectal cancer patients: A meta-analysis
  Qiutong Su, Jia Shen, Zubing Mei
  PLOS ONE.2024; 19(5): e0303494.     CrossRef
• CT‐determined low skeletal muscle index predicts poor prognosis in patients with colorectal cancer
  Yue Feng, Xiao‐Hong Cheng, Mei Xu, Rui Zhao, Qian‐Yi Wan, Wei‐Hua Feng, Hua‐Tian Gan
  Cancer Medicine.2024;[Epub]     CrossRef
• Serum tumor marker and CT body composition scoring system predicts outcomes in colorectal cancer surgical patients
  Mingming Song, Zhihao Liu, Feihong Wu, Tong Nie, Yixin Heng, Jiaxin Xu, Ning Huang, Xiaoyu Wu, Yinghao Cao, Gang Hu
  European Radiology.2024; 34(12): 7596.     CrossRef
• Aminotransferase-to-lymphocyte ratio as a valuable prognostic marker for patients with stage I-III colorectal cancer: a retrospective study
  Hailun Xie, Lishuang Wei, Shuangyi Tang, Jialiang Gan
  Frontiers in Oncology.2024;[Epub]     CrossRef
• Impact of sarcopenia on outcomes in surgical patients:A systematic review and meta-analysis
  Samuel Knoedler, Rainer Schliermann, Leonard Knoedler, Mengfan Wu, Frederik J. Hansen, Dany Y. Matar, Doha Obed, Dominique Vervoort, Valentin Haug, Gabriel Hundeshagen, Angie Paik, Martin Kauke-Navarro, Ulrich Kneser, Bohdan Pomahac, Dennis P. Orgill, Adr
  International Journal of Surgery.2023;[Epub]     CrossRef
• Hand grip strength‐based cachexia index as a predictor of cancer cachexia and prognosis in patients with cancer
  Hailun Xie, Guotian Ruan, Lishuang Wei, Heyang Zhang, Yizhong Ge, Qi Zhang, Shiqi Lin, Mengmeng Song, Xi Zhang, Xiaoyue Liu, Xiangrui Li, Kangping Zhang, Ming Yang, Meng Tang, Chun‐Hua Song, Jialiang Gan, Han‐Ping Shi
  Journal of Cachexia, Sarcopenia and Muscle.2023; 14(1): 382.     CrossRef
• Impact of Sarcopenia on Clinical Course of Inflammatory Bowel Disease in Korea
  Kwangwoo Nam, Jae Yong Lee, Yousun Ko, Kyung Won Kim, Ho-Su Lee, Seung Wook Hong, Jin Hwa Park, Sung Wook Hwang, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byoun, Seung-Jae Myung, Suk-Kyun Yang, Sang Hyoung Park
  Digestive Diseases and Sciences.2023; 68(6): 2165.     CrossRef
• Perioperative Nutritional Considerations in Colon and Rectal Surgery
  Thomas Curran
  Clinics in Colon and Rectal Surgery.2023; 36(03): 192.     CrossRef
• Prognostic significance of sarcopenia diagnosed based on the anthropometric equation for progression-free survival and overall survival in patients with colorectal cancer
  Hailun Xie, Lishuang Wei, Shunhui Gao, Mingxiang Liu, Yanren Liang, Guanghui Yuan, Qiwen Wang, Yansong Xu, Shuangyi Tang, Jialiang Gan
  Frontiers in Nutrition.2023;[Epub]     CrossRef
• The prognostic value of the combination of body composition and systemic inflammation in patients with cancer cachexia
  Hai‐Lun Xie, Guo‐Tian Ruan, Lishuang Wei, Qi Zhang, Yi‐Zhong Ge, Meng‐Meng Song, Xi Zhang, Shi‐qi Lin, Xiao‐yue Liu, Xiao‐Wei Zhang, Xiang‐Rui Li, Kang‐Ping Zhang, Chun‐Lei Hu, Ming Yang, Meng Tang, Chun‐Hua Song, Ming‐Hua Cong, Min Weng, Zeng‐Ning Li, We
  Journal of Cachexia, Sarcopenia and Muscle.2023; 14(2): 879.     CrossRef
• The predictive value of computerized tomography‐assessed sarcopenia for complicated appendicitis in geriatric patients
  Ali Cihat Yildirim, Şahinde Atlanoğlu, Mehmet Ali Gedik, Sezgin Zeren, Mehmet Fatih Ekici
  AGING MEDICINE.2023; 6(3): 222.     CrossRef
• Improving the assessment of malnutrition in cancer: Using systemic inflammation markers as a supplement to the inflammation items of the GLIM criteria
  Hailun Xie, Kaitao Yuan, Guotian Ruan, Lishuang Wei, Heyang Zhang, Yizhong Ge, Shiqi Lin, Mengmeng Song, Ziwen Wang, Chenan Liu, Jinyu Shi, Xiaoyue Liu, Ming Yang, Xin Zheng, Yue Chen, Xiaowei Zhang, Hanping Shi
  Clinical Nutrition.2023; 42(10): 2036.     CrossRef
• Computed tomography–assessed presarcopenia and clinical outcomes after laparoscopic surgery for rectal cancer
  Ji Hyeong Song, Rak Kyun Oh, Jeong Eun Lee, Kyung Ha Lee, Ji Yeon Kim, Jin Soo Kim
  Annals of Coloproctology.2023; 39(6): 513.     CrossRef
• CT-derived relationship between low relative muscle mass and bone damage in patients with multiple myeloma undergoing stem cells transplantation
  Alberto Stefano Tagliafico, Federica Rossi, Bianca Bignotti, Lorenzo Torri, Alessandro Bonsignore, Liliana Belgioia, Alida Domineitto
  The British Journal of Radiology.2022;[Epub]     CrossRef
• The Clinical Impact of Combining Neutrophil-to-Lymphocyte Ratio with Sarcopenia for Improved Discrimination of Progression-Free Survival in Patients with Colorectal Cancer
  Su Young Lee, Eric Chung, Eun-Suk Cho, Jae-Hoon Lee, Eun Jung Park, Su-Jin Shin, Seung Hyuk Baik, Kang Young Lee, Jeonghyun Kang
  Journal of Clinical Medicine.2022; 11(2): 431.     CrossRef
• Ability of malnutrition screening and assessment tools to identify computed tomography defined low muscle mass in colorectal cancer surgery
  Aleksandra Djordjevic, Irene Deftereos, Vanessa M. Carter, Stephanie Morris, Roland Shannon, Nicole Kiss, Justin M. C. Yeung
  Nutrition in Clinical Practice.2022; 37(3): 666.     CrossRef
• Clinical Relevance of Myopenia and Myosteatosis in Colorectal Cancer
  Yoshinaga Okugawa, Takahito Kitajima, Akira Yamamoto, Tadanobu Shimura, Mikio Kawamura, Takumi Fujiwara, Ikuyo Mochiki, Yoshiki Okita, Masahiro Tsujiura, Takeshi Yokoe, Masaki Ohi, Yuji Toiyama
  Journal of Clinical Medicine.2022; 11(9): 2617.     CrossRef
• Sarcopenia among older patients with cancer: A scoping review of the literature
  Qian Sun, Xiaohan Jiang, Rui Qin, Yuanyuan Yang, Yabo Gong, Kunyuan Wang, Junsheng Peng
  Journal of Geriatric Oncology.2022; 13(7): 924.     CrossRef
• Comparison of absolute and relative handgrip strength to predict cancer prognosis: A prospective multicenter cohort study
  Hailun Xie, Guotian Ruan, Li Deng, Heyang Zhang, Yizhong Ge, Qi Zhang, Shiqi Lin, Mengmeng Song, Xi Zhang, Xiaoyue Liu, Xiangrui Li, Kangping Zhang, Ming Yang, Meng Tang, Wen Hu, Min Weng, Hanping Shi
  Clinical Nutrition.2022; 41(8): 1636.     CrossRef
• Prognostic value of cachexia index in patients with colorectal cancer: A retrospective study
  Qianyi Wan, Qian Yuan, Rui Zhao, Xiaoding Shen, Yi Chen, Tao Li, Yinghan Song
  Frontiers in Oncology.2022;[Epub]     CrossRef
• Acute Sarcopenia after Elective and Emergency Surgery
  Alvin Shrestha, Melanie Dani, Paul Kemp, Michael Fertleman
  Aging and disease.2022; 13(6): 1759.     CrossRef
• Prognostic Significance of Preoperative Fibrinogen‐to‐Prealbumin Ratio in Patients with Stage I–III Colorectal Cancer Undergoing Surgical Resection: A Retrospective Cohort Study
  Hailun Xie, Shizhen Huang, Guanghui Yuan, Shuangyi Tang, Jialiang Gan, Bing Wang
  BioMed Research International.2021;[Epub]     CrossRef
• Sarcopenia predicts worse postoperative outcomes and decreased survival rates in patients with colorectal cancer: a systematic review and meta-analysis
  Mario Trejo-Avila, Katya Bozada-Gutiérrez, Carlos Valenzuela-Salazar, Jesús Herrera-Esquivel, Mucio Moreno-Portillo
  International Journal of Colorectal Disease.2021; 36(6): 1077.     CrossRef
• Preoperative optimization and enhanced recovery for colorectal surgery
  Alexander T. Booth, Thomas Curran
  Seminars in Colon and Rectal Surgery.2021; 32(3): 100827.     CrossRef
• Low CT attenuation and high fatty infiltration rate of psoas are risk factors for incisional hernias after appendicectomy: a cross-sectional single-center study from China
  Xuechao Du, Pengtao Sun, Yuchang Yan, Xiang Gong, Yufei Lian, Zhenyu Pan
  BMC Musculoskeletal Disorders.2021;[Epub]     CrossRef
• Oral Nutritional Supplements and Enteral Nutrition in Patients with Gastrointestinal Surgery
  Maria Wobith, Arved Weimann
  Nutrients.2021; 13(8): 2655.     CrossRef
• Preoperative computed tomography-assessed sarcopenia as a predictor of complications and long-term prognosis in patients with colorectal cancer: a systematic review and meta-analysis
  Hailun Xie, Lishuang Wei, Mingxiang Liu, Guanghui Yuan, Shuangyi Tang, Jialiang Gan
  Langenbeck's Archives of Surgery.2021; 406(6): 1775.     CrossRef
• Comparison of revised EWGSOP2 criteria of sarcopenia in patients with cancer using different parameters of muscle mass
  Ana Paula Trussardi Fayh, Iasmin Matias de Sousa, Stephen E. Alway
  PLOS ONE.2021; 16(9): e0257446.     CrossRef
• Impact of Computed Tomography-Based, Artificial Intelligence-Driven Volumetric Sarcopenia on Survival Outcomes in Early Cervical Cancer
  Qingling Han, Se Ik Kim, Soon Ho Yoon, Taek Min Kim, Hyun-Cheol Kang, Hak Jae Kim, Jeong Yeon Cho, Jae-Weon Kim
  Frontiers in Oncology.2021;[Epub]     CrossRef
• Geriatric nutritional risk index as a predictor of complications and long-term outcomes in patients with gastrointestinal malignancy: a systematic review and meta-analysis
  Hailun Xie, Shuangyi Tang, Lishuang Wei, Jialiang Gan
  Cancer Cell International.2020;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Humanized dual-targeting antibody–drug conjugates specific to MET and RON receptors as a pharmaceutical strategy for the treatment of cancers exhibiting phenotypic heterogeneity
  Minghai Wang, Qi Ma, Sreedhar Reddy Suthe, Rachel E. Hudson, Jing-ying Pan, Constantinos Mikelis, Miao-jin Zhu, Zhi-gang Wu, Dan-rong Shi, Hang-ping Yao
  Acta Pharmacologica Sinica.2025; 46(5): 1375.     CrossRef
• Nuclear translocation of RON receptor tyrosine kinase. New mechanistic and functional insights
  Yi-Lin Chen, Chien-An Chu, Jiu-Yao Wang, Wan-Li Chen, Yi-Wen Wang, Chung-Liang Ho, Chung-Ta Lee, Nan-Haw Chow
  Cytokine & Growth Factor Reviews.2025; 81: 9.     CrossRef
• c-MET-positive circulating tumor cells and cell-free DNA as independent prognostic factors in hormone receptor-positive/HER2-negative metastatic breast cancer
  Jieun Park, Eun Sol Chang, Ji-Yeon Kim, Chaithanya Chelakkot, Minjung Sung, Ji-Young Song, Kyungsoo Jung, Ji Hye Lee, Jun Young Choi, Na Young Kim, Hyegyeong Lee, Mi-Ran Kang, Mi Jeong Kwon, Young Kee Shin, Yeon Hee Park, Yoon-La Choi
  Breast Cancer Research.2024;[Epub]     CrossRef
• MET alterations detection platforms and clinical implications in solid tumors: a comprehensive review of literature
  Pei Yuan, Xuemin Xue, Tian Qiu, Jianming Ying
  Therapeutic Advances in Medical Oncology.2024;[Epub]     CrossRef
• Targeting Receptor Tyrosine Kinases as a Novel Strategy for the Treatment of Triple-Negative Breast Cancer
  Sara K. Jaradat, Nehad M. Ayoub, Ahmed H. Al Sharie, Julia M. Aldaod
  Technology in Cancer Research & Treatment.2024;[Epub]     CrossRef
• Recent advancement in developing small molecular inhibitors targeting key kinase pathways against triple-negative breast cancer
  Rajibul Islam, Khor Poh Yen, Nur Najihah ’Izzati Mat Rani, Md. Selim Hossain
  Bioorganic & Medicinal Chemistry.2024; 112: 117877.     CrossRef
• TYRO3 and EPHA2 Expression Are Dysregulated in Breast Cancer
  Ananda Cristina Fernandes de Aguiar, Nancy Cristina Ferraz de Lucena Ferreira, Maria Amelia Carlos Souto Maior Borba, Darley de Lima Ferreira Filho, Glauber Moreira Leitão, Luiz Alberto Mattos, José Luiz de Lima Filho, Danyelly Bruneska Gondim Martins
  Cell Biochemistry and Function.2024;[Epub]     CrossRef
• The MET Oncogene Network of Interacting Cell Surface Proteins
  Simona Gallo, Consolata Beatrice Folco, Tiziana Crepaldi
  International Journal of Molecular Sciences.2024; 25(24): 13692.     CrossRef
• Targeting RTKs/nRTKs as promising therapeutic strategies for the treatment of triple-negative breast cancer: evidence from clinical trials
  Kasshish Mehta, Mangala Hegde, Sosmitha Girisa, Ravichandran Vishwa, Mohammed S. Alqahtani, Mohamed Abbas, Mehdi Shakibaei, Gautam Sethi, Ajaikumar B. Kunnumakkara
  Military Medical Research.2024;[Epub]     CrossRef
• Defining the Emergence of New Immunotherapy Approaches in Breast Cancer: Role of Myeloid-Derived Suppressor Cells
  María Luisa Sánchez-León, Carlos Jiménez-Cortegana, Silvia Silva Romeiro, Carmen Garnacho, Luis de la Cruz-Merino, Daniel J. García-Domínguez, Lourdes Hontecillas-Prieto, Víctor Sánchez-Margalet
  International Journal of Molecular Sciences.2023; 24(6): 5208.     CrossRef
• 2D Nanosilicate for additive manufacturing: Rheological modifier, sacrificial ink and support bath
  Satyam Rajput, Kaivalya A. Deo, Tanmay Mathur, Giriraj Lokhande, Kanwar Abhay Singh, Yuxiang Sun, Daniel L. Alge, Abhishek Jain, Tapasree Roy Sarkar, Akhilesh K. Gaharwar
  Bioprinting.2022; 25: e00187.     CrossRef
• The MST1R/RON Tyrosine Kinase in Cancer: Oncogenic Functions and Therapeutic Strategies
  Alex Cazes, Betzaira G. Childers, Edgar Esparza, Andrew M. Lowy
  Cancers.2022; 14(8): 2037.     CrossRef
• Antibody-drug Conjugate PCMC1D3-Duocarmycin SA as a Novel Therapeutic Entity for Targeted Treatment of Cancers Aberrantly Expressing MET Receptor Tyrosine Kinase
  Rachel Hudson, Hang-Ping Yao, Sreedhar Reddy Suthe, Dhavalkumar Patel, Ming-Hai Wang
  Current Cancer Drug Targets.2022; 22(4): 312.     CrossRef
• Pharmaceutical strategies in the emerging era of antibody-based biotherapeutics for the treatment of cancers overexpressing MET receptor tyrosine kinase
  Hang-Ping Yao, Xiang-Min Tong, Ming-Hai Wang
  Drug Discovery Today.2021; 26(1): 106.     CrossRef
• Small-Molecule Drug Discovery in Triple Negative Breast Cancer: Current Situation and Future Directions
  Minru Liao, Jin Zhang, Guan Wang, Leiming Wang, Jie Liu, Liang Ouyang, Bo Liu
  Journal of Medicinal Chemistry.2021; 64(5): 2382.     CrossRef
• The MSP‐RON pathway regulates liver fibrosis through transforming growth factor beta‐dependent epithelial–mesenchymal transition
  Tianhao Weng, Dong Yan, Danrong Shi, Miaojin Zhu, Yizhi Liu, Zhigang Wu, Taoming Tang, Linwei Zhu, Hong Zhang, Hangping Yao, Lanjuan Li
  Liver International.2021; 41(8): 1956.     CrossRef
• MicroRNA Expression Profiling of Lung Cancer with Differential Expression of the RON Receptor Tyrosine Kinase
  Huilin Ou, Keda Chen, Hongcheng Wu, Yuan Seng Wu
  Journal of Oncology.2021; 2021: 1.     CrossRef
• RON Mediates Tumor‐Promoting Effects in Endometrial Adenocarcinoma
  Qin Yu, Jianzhang Wang, Tiantian Li, Xinxin Xu, Xinyue Guo, Shaojie Ding, Libo Zhu, Gen Zou, Yichen Chen, Xinmei Zhang, Bing Wang
  BioMed Research International.2021;[Epub]     CrossRef
• Drug Repositioning and Subgroup Discovery for Precision Medicine Implementation in Triple Negative Breast Cancer
  Zainab Al-Taie, Mark Hannink, Jonathan Mitchem, Christos Papageorgiou, Chi-Ren Shyu
  Cancers.2021; 13(24): 6278.     CrossRef
• Clinical value and potential mechanisms of COL8A1 upregulation in breast cancer: a comprehensive analysis
  Wei Peng, Jian-Di Li, Jing-Jing Zeng, Xiao-Ping Zou, Deng Tang, Wei Tang, Min-Hua Rong, Ying Li, Wen-Bin Dai, Zhong-Qing Tang, Zhen-Bo Feng, Gang Chen
  Cancer Cell International.2020;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• A Review of Clonal Relationships in Myeloproliferative Neoplasms With Co-Mutations of JAK2, CALR or MPL and BCR::ABL1
  Mohammadamin Noorafrooz, Sanaz Ghods, Robert Peter Gale, Ramin Noorafrooz
  Clinical Lymphoma Myeloma and Leukemia.2025; 25(4): 249.     CrossRef
• Co-occurrence of JAK2-V617 F mutation and BCR::ABL1 translocation in chronic myeloproliferative neoplasms: a potentially confounding genetic combination
  Magda Zanelli, Alessandra Bisagni, Francesca Sanguedolce, Giuseppe Broggi, Valentina Fragliasso, Maurizio Zizzo, Andrea Palicelli, Giovanni Martino, Camilla Cresta, Cecilia Caprera, Matteo Corsi, Pietro Gentile, Fabrizio Gozzi, Domenico Trombetta, Paola P
  Frontiers in Oncology.2024;[Epub]     CrossRef
• Insights from a rare myeloproliferative neoplasm with coexisting BCR‐ABL1 fusion gene, CALR, and TET2 mutations treated with nilotinib and ruxolitinib
  Li Huo, Jundan Xie, Qian Wang, Hongjie Shen, Zixuan Ding, Lijun Wen, Zhao Zeng, Yi Xu, Changgeng Ruan, Suning Chen, Mengxing Xue
  Clinical Case Reports.2023;[Epub]     CrossRef
• BCR::ABL1‐positive chronic myeloid leukaemia with CALR mutation
  Haili Geng, Zhengjin Zheng, Shaoyuan Wang
  Clinical and Experimental Pharmacology and Physiology.2023; 50(5): 425.     CrossRef
• Cytological Diagnosis of Classic Myeloproliferative Neoplasms at the Age of Molecular Biology
  Sophie Combaluzier, Julie Quessada, Norman Abbou, Robin Arcani, Antoine Tichadou, Jean Gabert, Régis Costello, Marie Loosveld, Geoffroy Venton, Yaël Berda-Haddad
  Cells.2023; 12(6): 946.     CrossRef
• The use of genetic tests to diagnose and manage patients with myeloproliferative and myeloproliferative/myelodysplastic neoplasms, and related disorders
  Nicholas C. P. Cross, Anna L. Godfrey, Catherine Cargo, Mamta Garg, Adam J. Mead
  British Journal of Haematology.2021; 195(3): 338.     CrossRef